
<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://proteopedia.org/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Judith+Weber</id>
	<title>Proteopedia - User contributions [en]</title>
	<link rel="self" type="application/atom+xml" href="https://proteopedia.org/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Judith+Weber"/>
	<link rel="alternate" type="text/html" href="https://proteopedia.org/Special:Contributions/Judith_Weber"/>
	<updated>2026-10-03T21:25:53Z</updated>
	<subtitle>User contributions</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1103&amp;diff=3144144</id>
		<title>Sandbox Reserved 1103</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1103&amp;diff=3144144"/>
		<updated>2020-01-17T14:52:43Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== TRF1 TRFH domain and TIN2 peptide complex, pdb=3BQO ==&lt;br /&gt;
The TRFH (Telomeric Repeat Factor Homology) is a domain which is in the centre of the [https://en.wikipedia.org/wiki/TERF1 TRF1](Telomeric Repeat-Binding Factor) and of about 200 amino acids.In humans TERF1 is encoded by the TERF1 gene. [https://en.wikipedia.org/wiki/TINF2 TIN2](TERF1-interacting Nuclear Factor) is a protein encoded in humans by the TINF2 gene that can bind to TRFH TRF1.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;Dimer2.pdb&#039; size=&#039;350&#039; frame=&#039;true&#039; align=&#039;centre up&#039; scene=&#039;82/829356/Dimer/3&#039;&amp;gt;&#039;&#039;&#039;&#039;&#039;&lt;br /&gt;
== Function ==&lt;br /&gt;
&lt;br /&gt;
[https://en.wikipedia.org/wiki/TERF1 TRF1]TRF1 also called [https://en.wikipedia.org/wiki/TERF1 TERF1] is a protein part of the  [https://en.wikipedia.org/wiki/Shelterin Shelterin] complex (also called telosome) that has a crucial role in the regulation of telomeres &amp;lt;ref&amp;gt;PMID: 31261825&amp;lt;/ref&amp;gt;. TRF1 is an inhibitor of [[Telomerase]], the protein that elongates telomeres. Indeed, when TRF1 is inactivated, telomeres are getting longer with no regulation. &lt;br /&gt;
The TRFH (telomeric repeat factor homology [[1h6o]]) domain is essential to the TRF1 because it’s the sequence where the protein dimerize to form a functional homodimer. Then, the protein can interact with DNA by fixing to the repeated sequence TTAGGG, and can then remodel DNA. This activity of remodeling is enhanced by the TIN2&amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt; PMID: 18202258&amp;lt;/ref&amp;gt; . TIN2 or [https://en.wikipedia.org/wiki/TINF2 TINF2] (TERF1 interacting nuclear factor 2) is also a protein of the Shelterin that can bind to TRF1. It acts as a bridge or a link between TRF1 and TPP or [https://en.wikipedia.org/wiki/TERF2 TRF2] that are others proteins of the shelterin complex. This link will regulate their activity and can also stabilize TRF1’s interaction with DNA. &lt;br /&gt;
When TIN2 is mutated, telomeres are no longer regulated. TRF1 alone doesn’t seems to be efficient to regulate [[Telomerase]]. &lt;br /&gt;
Because of their function in telomeres regulation, TRF1 TIN2 are key proteins involved in cell aging and their dysfunction can directly leads to disease like cancer or other cell cycle diseases. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref group=&amp;quot;xtra&amp;quot;&amp;gt;PMID: 10669743&amp;lt;/ref&amp;gt;&amp;lt;ref group=&amp;quot;xtra&amp;quot;&amp;gt;PMID: 16166375&amp;lt;/ref&amp;gt;&amp;lt;ref group=&amp;quot;xtra&amp;quot;&amp;gt;PMID: 30352022&amp;lt;/ref&amp;gt;&amp;lt;ref group=&amp;quot;xtra&amp;quot;&amp;gt;PMID: 31026066&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
=== The TRF1 TRFH domain ===&lt;br /&gt;
&lt;br /&gt;
The [https://en.wikipedia.org/wiki/TERF1 TRF1] TRFH domain is a sequence motif of about 200 amino acids located in the centre of TRF1. It is entirely constituted of α helices and binds to another TRF1 TRFH to form a homodimer. The two monomers are antiparallel and form a homodimer which is symmetrical. There are three α-helices from each monomer involved in this homodimerization: &amp;lt;scene name=&#039;82/829356/Helices_1/1&#039;&amp;gt;the helices 1&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829356/Helices_2/1&#039;&amp;gt;2&amp;lt;/scene&amp;gt; &amp;lt;scene name=&#039;82/829356/Helices_9/1&#039;&amp;gt;9&amp;lt;/scene&amp;gt;. To form a dimer, the helix 1 of one monomer comes into contact with helix 1 of the other monomer, its helix 2 does it with the helix 2, and so does the helix 9. The two helices 9 stabilize the dimer interface and are perpendicular to the helices 1, forming a cross brace at the top and the bottom of it. The two helices 1 are the core of the dimer interface. This interface involves many hydrophobic interactions and a few hydrogen bonds. The amino acids &amp;lt;scene name=&#039;82/829356/Trp77/3&#039;&amp;gt;Trp77&amp;lt;/scene&amp;gt; of each helix 1 are central to the formation of the hydrophobic core. “Trp77 packs against &amp;lt;scene name=&#039;82/829356/Phe255/1&#039;&amp;gt;Phe255&amp;lt;/scene&amp;gt; (helix 9) within the monomer and between &amp;lt;scene name=&#039;82/829356/Ala259/1&#039;&amp;gt;Ala259&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829356/Ala259/1&#039;&amp;gt;Ala260&amp;lt;/scene&amp;gt; and against &amp;lt;scene name=&#039;82/829356/Val263/1&#039;&amp;gt;Val263&amp;lt;/scene&amp;gt; of helix 9 from its partner” (Fairall L et al Mol Cell.&amp;lt;ref&amp;gt;PMID: 11545737&amp;lt;/ref&amp;gt;) The hydrogen bonds involved in the dimer interface are formed between &amp;lt;scene name=&#039;82/829356/Glu71/1&#039;&amp;gt;Glu71&amp;lt;/scene&amp;gt; of one monomer with &amp;lt;scene name=&#039;82/829356/Ser85/1&#039;&amp;gt;Ser85&amp;lt;/scene&amp;gt; of the other monomer. Overall, this dimer interface is highly hydrophobic and packed. &lt;br /&gt;
&lt;br /&gt;
=== The TRF1 TRFH-TIN2 interaction ===&lt;br /&gt;
&lt;br /&gt;
The interaction between TRF1 TRFH and the TIN2 peptide involves the C-terminus of the peptide which is called TIN2 TBM (TIN2-TRFH binding motif). TIN2 TBM is the sequence of the peptide that goes from amino acid 256 to the amino acid 276. In the homodimer of TRF1 TRFH, each TRF1 TRFH interacts with one TIN2 peptide. There are not many differences between the conformation of unliganded TRF1 TRFH and TRF1 TRFH bound to TIN2, the only one is the loop L34. When “TIN2 TBM is bound, loop L34 folds back upon helices 3 and 4, sandwiched between the helices and TIN2 TBM”. “The N-terminus of TIN2 TBM (H257-F-N-L-A-Phe262) adopts an extended conformation stabilized by an extensive intermolecular hydrogen-bonding network. The side chain of L260 is therefore positioned into a deep hydrophobic pocket of TRF1 TRFH. In addition, F258 and P262 also make hydrophobic contacts with TRF1 TRFH: F258 sits on concave surface, whereas P262 stacks with TRF1-F142.” (Chen Y et al Science &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;) C-terminus of TIN2 TBM (L263-G-R-R-R-V268) and D139-A-Q141 of TRF1 TRFH form an antiparallel β sheet. This arrangement positions the C-terminus of TIN2 TBM on the surface of loop L34, allowing R265-R-R267 of TIN2 TBM to be in contact with TRF1 TRFH through electrostatic interactions. “, R266 is nested within an acidic depression on the surface of loop L34 through a network of salt bridges and hydrogen bonds.” (Chen Y et al Science &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;) TIN2 TBM also has the sequence F-X-L-X-P at its N-terminus, the sequence F/Y-X-L-X-P being involved in the binding of several [https://en.wikipedia.org/wiki/Shelterin shelterin]-associated proteins to TRF1 TRFH.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Disease ==&lt;br /&gt;
&lt;br /&gt;
Since TIN2 is a protein part of the shelterin complex that regulate the length of telomere, a mutation of the TINF2 gene can lead to alter the binding of TIN2 to TRF1, causing,  telomeropathies:&lt;br /&gt;
[https://en.wikipedia.org/wiki/Dyskeratosis_congenita Dyskeratosis congenita] and [https://en.wikipedia.org/wiki/Revesz_syndrome Revesz syndrome] . &lt;br /&gt;
&lt;br /&gt;
=== Dyskeratosis congenita ===&lt;br /&gt;
&lt;br /&gt;
Dyskeratosis congenita is a disorder which is characterised by bone marrow dysfunction, abnormality of the skin, mucocutaneous triad of oral leucoplakia, nail dystrophy, as well as a predisposition to cancer. &lt;br /&gt;
TINF2 is one of the nine identified genes that when mutated are related to the Dyskeratosis congenita, the others being [https://en.wikipedia.org/wiki/Dyskerin DKC1],[https://en.wikipedia.org/wiki/Telomerase_RNA_component TERC],[https://en.wikipedia.org/wiki/Telomerase_reverse_transcriptase TERT], NOP10, NHP2, C16orf57, TCAB1 and [https://en.wikipedia.org/wiki/Poly(A)-specific_ribonuclease PARN]. TIN2 mutations are imply in several different mechanims. &lt;br /&gt;
&lt;br /&gt;
The majority of identified TIN2 dyskeratosis congenita mutations cluster is a highly conserved 30-amino-acid region near the ends of its TRF1 binding domain &amp;lt;ref&amp;gt;PMID: 15316005 &amp;lt;/ref&amp;gt;. A disruption of this domain causes a loss of TRF1 binding to TIN2, resulting in a telomeric instability &amp;lt;ref name=&amp;quot;doc2&amp;quot;/&amp;gt;.&lt;br /&gt;
Another proposal is that TIN2 helps TPP1, another component of the shelterin complex, in the recruitment of telomerase through an unknown mechanism that is disrupted by the TIN2 dyskeratosis congenita mutations, leading once again to a telomeric instability &amp;lt;ref name=&amp;quot;doc2&amp;quot;&amp;gt; PMID: 18252230&amp;lt;/ref&amp;gt; &lt;br /&gt;
Finally, TIN2 seems to regulate the effect of the [https://en.wikipedia.org/wiki/Tankyrase tankyrase 1], an poly ADP-ribose polymerase, by stabilising the formation of a TIN2–tankyrase 1–TRF1 complex. This prevent the binding of TRF1 to the telomere ends. In the case of amino acid mutations in TIN2 this might act by the same mechanism as a knock-down and leave telomere ends permanently unprotected, causing a shortening of telomere length &amp;lt;ref&amp;gt;PMID: 19419704 &amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
=== Revesz syndrome ===&lt;br /&gt;
&lt;br /&gt;
Revesz syndrome is characterised by bone marrow hypoplasia, nail dystrophy, growth retardation, exudative retinopathy, severe aplastic anemia &amp;lt;ref&amp;gt;PMID: 17901676 &amp;lt;/ref&amp;gt;. Revesz syndrome also appears to be part of the DKC disease spectrum. Patients with Revesz syndrome have presented with heterozygous mutations in TINF2 gene which is located on chromosome 14q12 &amp;lt;ref name=&amp;quot;doc2&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;references group=&amp;quot;xtra&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== External Ressources ==&lt;br /&gt;
{{Wikipedia|TERF1}}&lt;br /&gt;
{{Wikipedia|TINF2}}&lt;br /&gt;
{{Wikipedia|Shelterin}&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1103&amp;diff=3144142</id>
		<title>Sandbox Reserved 1103</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1103&amp;diff=3144142"/>
		<updated>2020-01-17T14:51:37Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== TRF1 TRFH domain and TIN2 peptide complex, pdb=3BQO ==&lt;br /&gt;
The TRFH (Telomeric Repeat Factor Homology) is a domain which is in the centre of the [https://en.wikipedia.org/wiki/TERF1 TRF1](Telomeric Repeat-Binding Factor) and of about 200 amino acids.In humans TERF1 is encoded by the TERF1 gene. [https://en.wikipedia.org/wiki/TINF2 TIN2](TERF1-interacting Nuclear Factor) is a protein encoded in humans by the TINF2 gene that can bind to TRFH TRF1.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;Dimer2.pdb&#039; size=&#039;350&#039; frame=&#039;true&#039; align=&#039;centre up&#039; scene=&#039;82/829356/Dimer/3&#039;&amp;gt;&#039;&#039;&#039;&#039;&#039;&lt;br /&gt;
== Function ==&lt;br /&gt;
&lt;br /&gt;
[https://en.wikipedia.org/wiki/TERF1 TRF1]TRF1 also called [https://en.wikipedia.org/wiki/TERF1 TERF1] is a protein part of the  [https://en.wikipedia.org/wiki/Shelterin Shelterin] complex (also called telosome) that has a crucial role in the regulation of telomeres &amp;lt;ref&amp;gt;PMID: 31261825&amp;lt;/ref&amp;gt;. TRF1 is an inhibitor of [[Telomerase]], the protein that elongates telomeres. Indeed, when TRF1 is inactivated, telomeres are getting longer with no regulation. &lt;br /&gt;
The TRFH (telomeric repeat factor homology [[1h6o]]) domain is essential to the TRF1 because it’s the sequence where the protein dimerize to form a functional homodimer. Then, the protein can interact with DNA by fixing to the repeated sequence TTAGGG, and can then remodel DNA. This activity of remodeling is enhanced by the TIN2&amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt; PMID: 18202258&amp;lt;/ref&amp;gt; . TIN2 or [https://en.wikipedia.org/wiki/TINF2 TINF2] (TERF1 interacting nuclear factor 2) is also a protein of the Shelterin that can bind to TRF1. It acts as a bridge or a link between TRF1 and TPP or [https://en.wikipedia.org/wiki/TERF2 TRF2] that are others proteins of the shelterin complex. This link will regulate their activity and can also stabilize TRF1’s interaction with DNA. &lt;br /&gt;
When TIN2 is mutated, telomeres are no longer regulated. TRF1 alone doesn’t seems to be efficient to regulate [[Telomerase]]. &lt;br /&gt;
Because of their function in telomeres regulation, TRF1 TIN2 are key proteins involved in cell aging and their dysfunction can directly leads to disease like cancer or other cell cycle diseases. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref group=&amp;quot;xtra&amp;quot;&amp;gt;PMID: 10669743&amp;lt;/ref&amp;gt;&amp;lt;ref group=&amp;quot;xtra&amp;quot;&amp;gt;PMID: 16166375&amp;lt;/ref&amp;gt;&amp;lt;ref group=&amp;quot;xtra&amp;quot;&amp;gt;PMID: 30352022&amp;lt;/ref&amp;gt;&amp;lt;ref group=&amp;quot;xtra&amp;quot;&amp;gt;PMID: 31026066&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
=== The TRF1 TRFH domain ===&lt;br /&gt;
&lt;br /&gt;
The [https://en.wikipedia.org/wiki/TERF1 TRF1] TRFH domain is a sequence motif of about 200 amino acids located in the centre of TRF1. It is entirely constituted of α helices and binds to another TRF1 TRFH to form a homodimer. The two monomers are antiparallel and form a homodimer which is symmetrical. There are three α-helices from each monomer involved in this homodimerization: &amp;lt;scene name=&#039;82/829356/Helices_1/1&#039;&amp;gt;the helices 1&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829356/Helices_2/1&#039;&amp;gt;2&amp;lt;/scene&amp;gt; &amp;lt;scene name=&#039;82/829356/Helices_9/1&#039;&amp;gt;9&amp;lt;/scene&amp;gt;. To form a dimer, the helix 1 of one monomer comes into contact with helix 1 of the other monomer, its helix 2 does it with the helix 2, and so does the helix 9. The two helices 9 stabilize the dimer interface and are perpendicular to the helices 1, forming a cross brace at the top and the bottom of it. The two helices 1 are the core of the dimer interface. This interface involves many hydrophobic interactions and a few hydrogen bonds. The amino acids &amp;lt;scene name=&#039;82/829356/Trp77/3&#039;&amp;gt;Trp77&amp;lt;/scene&amp;gt; of each helix 1 are central to the formation of the hydrophobic core. “Trp77 packs against &amp;lt;scene name=&#039;82/829356/Phe255/1&#039;&amp;gt;Phe255&amp;lt;/scene&amp;gt; (helix 9) within the monomer and between &amp;lt;scene name=&#039;82/829356/Ala259/1&#039;&amp;gt;Ala259&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829356/Ala259/1&#039;&amp;gt;Ala260&amp;lt;/scene&amp;gt; and against &amp;lt;scene name=&#039;82/829356/Val263/1&#039;&amp;gt;Val263&amp;lt;/scene&amp;gt; of helix 9 from its partner” (Fairall L et al Mol Cell.&amp;lt;ref&amp;gt;PMID: 11545737&amp;lt;/ref&amp;gt;) The hydrogen bonds involved in the dimer interface are formed between &amp;lt;scene name=&#039;82/829356/Glu71/1&#039;&amp;gt;Glu71&amp;lt;/scene&amp;gt; of one monomer with &amp;lt;scene name=&#039;82/829356/Ser85/1&#039;&amp;gt;Ser85&amp;lt;/scene&amp;gt; of the other monomer. Overall, this dimer interface is highly hydrophobic and packed. &lt;br /&gt;
&lt;br /&gt;
=== The TRF1 TRFH-TIN2 interaction ===&lt;br /&gt;
&lt;br /&gt;
The interaction between TRF1 TRFH and the TIN2 peptide involves the C-terminus of the peptide which is called TIN2 TBM (TIN2-TRFH binding motif). TIN2 TBM is the sequence of the peptide that goes from amino acid 256 to the amino acid 276. In the homodimer of TRF1 TRFH, each TRF1 TRFH interacts with one TIN2 peptide. There are not many differences between the conformation of unliganded TRF1 TRFH and TRF1 TRFH bound to TIN2, the only one is the loop L34. When “TIN2 TBM is bound, loop L34 folds back upon helices 3 and 4, sandwiched between the helices and TIN2 TBM”. “The N-terminus of TIN2 TBM (H257-F-N-L-A-Phe262) adopts an extended conformation stabilized by an extensive intermolecular hydrogen-bonding network. The side chain of L260 is therefore positioned into a deep hydrophobic pocket of TRF1 TRFH. In addition, F258 and P262 also make hydrophobic contacts with TRF1 TRFH: F258 sits on concave surface, whereas P262 stacks with TRF1-F142.” (Chen Y et al Science &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;) C-terminus of TIN2 TBM (L263-G-R-R-R-V268) and D139-A-Q141 of TRF1 TRFH form an antiparallel β sheet. This arrangement positions the C-terminus of TIN2 TBM on the surface of loop L34, allowing R265-R-R267 of TIN2 TBM to be in contact with TRF1 TRFH through electrostatic interactions. “, R266 is nested within an acidic depression on the surface of loop L34 through a network of salt bridges and hydrogen bonds.” (Chen Y et al Science &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;) TIN2 TBM also has the sequence F-X-L-X-P at its N-terminus, the sequence F/Y-X-L-X-P being involved in the binding of several [https://en.wikipedia.org/wiki/Shelterin shelterin]-associated proteins to TRF1 TRFH.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Disease ==&lt;br /&gt;
&lt;br /&gt;
Since TIN2 is a protein part of the shelterin complex that regulate the length of telomere, a mutation of the TINF2 gene can lead to alter the binding of TIN2 to TRF1, causing,  telomeropathies:&lt;br /&gt;
[https://en.wikipedia.org/wiki/Dyskeratosis_congenita Dyskeratosis congenita] and [https://en.wikipedia.org/wiki/Revesz_syndrome Revesz syndrome] . &lt;br /&gt;
&lt;br /&gt;
=== Dyskeratosis congenita ===&lt;br /&gt;
&lt;br /&gt;
Dyskeratosis congenita is a disorder which is characterised by bone marrow dysfunction, abnormality of the skin, mucocutaneous triad of oral leucoplakia, nail dystrophy, as well as a predisposition to cancer. &lt;br /&gt;
TINF2 is one of the nine identified genes that when mutated are related to the Dyskeratosis congenita, the others being [https://en.wikipedia.org/wiki/Dyskerin DKC1],[https://en.wikipedia.org/wiki/Telomerase_RNA_component TERC],[https://en.wikipedia.org/wiki/Telomerase_reverse_transcriptase TERT], NOP10, NHP2, C16orf57, TCAB1 and [https://en.wikipedia.org/wiki/Poly(A)-specific_ribonuclease PARN]. TIN2 mutations are imply in several different mechanims. &lt;br /&gt;
&lt;br /&gt;
The majority of identified TIN2 dyskeratosis congenita mutations cluster is a highly conserved 30-amino-acid region near the ends of its TRF1 binding domain &amp;lt;ref&amp;gt;PMID: 15316005 &amp;lt;/ref&amp;gt;. A disruption of this domain causes a loss of TRF1 binding to TIN2, resulting in a telomeric instability&amp;lt;ref&amp;gt;PMID: 18252230 &amp;lt;/ref&amp;gt;. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;.&lt;br /&gt;
Another proposal is that TIN2 helps TPP1, another component of the shelterin complex, in the recruitment of telomerase through an unknown mechanism that is disrupted by the TIN2 dyskeratosis congenita mutations, leading once again to a telomeric instability &amp;lt;ref name=&amp;quot;doc2&amp;quot;&amp;gt; PMID: 18252230&amp;lt;/ref&amp;gt; &lt;br /&gt;
Finally, TIN2 seems to regulate the effect of the [https://en.wikipedia.org/wiki/Tankyrase tankyrase 1], an poly ADP-ribose polymerase, by stabilising the formation of a TIN2–tankyrase 1–TRF1 complex. This prevent the binding of TRF1 to the telomere ends. In the case of amino acid mutations in TIN2 this might act by the same mechanism as a knock-down and leave telomere ends permanently unprotected, causing a shortening of telomere length &amp;lt;ref&amp;gt;PMID: 19419704 &amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
=== Revesz syndrome ===&lt;br /&gt;
&lt;br /&gt;
Revesz syndrome is characterised by bone marrow hypoplasia, nail dystrophy, growth retardation, exudative retinopathy, severe aplastic anemia &amp;lt;ref&amp;gt;PMID: 17901676 &amp;lt;/ref&amp;gt;. Revesz syndrome also appears to be part of the DKC disease spectrum. Patients with Revesz syndrome have presented with heterozygous mutations in TINF2 gene which is located on chromosome 14q12 &amp;lt;ref name=&amp;quot;doc2&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;references group=&amp;quot;xtra&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== External Ressources ==&lt;br /&gt;
{{Wikipedia|TERF1}}&lt;br /&gt;
{{Wikipedia|TINF2}}&lt;br /&gt;
{{Wikipedia|Shelterin}&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1103&amp;diff=3144140</id>
		<title>Sandbox Reserved 1103</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1103&amp;diff=3144140"/>
		<updated>2020-01-17T14:47:38Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== TRF1 TRFH domain and TIN2 peptide complex, pdb=3BQO ==&lt;br /&gt;
The TRFH (Telomeric Repeat Factor Homology) is a domain which is in the centre of the [https://en.wikipedia.org/wiki/TERF1 TRF1](Telomeric Repeat-Binding Factor) and of about 200 amino acids.In humans TERF1 is encoded by the TERF1 gene. [https://en.wikipedia.org/wiki/TINF2 TIN2](TERF1-interacting Nuclear Factor) is a protein encoded in humans by the TINF2 gene that can bind to TRFH TRF1.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;Dimer2.pdb&#039; size=&#039;350&#039; frame=&#039;true&#039; align=&#039;centre up&#039; scene=&#039;82/829356/Dimer/3&#039;&amp;gt;&#039;&#039;&#039;&#039;&#039;&lt;br /&gt;
== Function ==&lt;br /&gt;
&lt;br /&gt;
[https://en.wikipedia.org/wiki/TERF1 TRF1]TRF1 also called [https://en.wikipedia.org/wiki/TERF1 TERF1] is a protein part of the  [https://en.wikipedia.org/wiki/Shelterin Shelterin] complex (also called telosome) that has a crucial role in the regulation of telomeres &amp;lt;ref&amp;gt;PMID: 31261825&amp;lt;/ref&amp;gt;. TRF1 is an inhibitor of [[Telomerase]], the protein that elongates telomeres. Indeed, when TRF1 is inactivated, telomeres are getting longer with no regulation. &lt;br /&gt;
The TRFH (telomeric repeat factor homology [[1h6o]]) domain is essential to the TRF1 because it’s the sequence where the protein dimerize to form a functional homodimer. Then, the protein can interact with DNA by fixing to the repeated sequence TTAGGG, and can then remodel DNA. This activity of remodeling is enhanced by the TIN2&amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt; PMID: 18202258&amp;lt;/ref&amp;gt; . TIN2 or [https://en.wikipedia.org/wiki/TINF2 TINF2] (TERF1 interacting nuclear factor 2) is also a protein of the Shelterin that can bind to TRF1. It acts as a bridge or a link between TRF1 and TPP or [https://en.wikipedia.org/wiki/TERF2 TRF2] that are others proteins of the shelterin complex. This link will regulate their activity and can also stabilize TRF1’s interaction with DNA. &lt;br /&gt;
When TIN2 is mutated, telomeres are no longer regulated. TRF1 alone doesn’t seems to be efficient to regulate [[Telomerase]]. &lt;br /&gt;
Because of their function in telomeres regulation, TRF1 TIN2 are key proteins involved in cell aging and their dysfunction can directly leads to disease like cancer or other cell cycle diseases. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref group=&amp;quot;xtra&amp;quot;&amp;gt;PMID: 10669743&amp;lt;/ref&amp;gt;&amp;lt;ref group=&amp;quot;xtra&amp;quot;&amp;gt;PMID: 16166375&amp;lt;/ref&amp;gt;&amp;lt;ref group=&amp;quot;xtra&amp;quot;&amp;gt;PMID: 30352022&amp;lt;/ref&amp;gt;&amp;lt;ref group=&amp;quot;xtra&amp;quot;&amp;gt;PMID: 31026066&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
=== The TRF1 TRFH domain ===&lt;br /&gt;
&lt;br /&gt;
The [https://en.wikipedia.org/wiki/TERF1 TRF1] TRFH domain is a sequence motif of about 200 amino acids located in the centre of TRF1. It is entirely constituted of α helices and binds to another TRF1 TRFH to form a homodimer. The two monomers are antiparallel and form a homodimer which is symmetrical. There are three α-helices from each monomer involved in this homodimerization: &amp;lt;scene name=&#039;82/829356/Helices_1/1&#039;&amp;gt;the helices 1&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829356/Helices_2/1&#039;&amp;gt;2&amp;lt;/scene&amp;gt; &amp;lt;scene name=&#039;82/829356/Helices_9/1&#039;&amp;gt;9&amp;lt;/scene&amp;gt;. To form a dimer, the helix 1 of one monomer comes into contact with helix 1 of the other monomer, its helix 2 does it with the helix 2, and so does the helix 9. The two helices 9 stabilize the dimer interface and are perpendicular to the helices 1, forming a cross brace at the top and the bottom of it. The two helices 1 are the core of the dimer interface. This interface involves many hydrophobic interactions and a few hydrogen bonds. The amino acids &amp;lt;scene name=&#039;82/829356/Trp77/3&#039;&amp;gt;Trp77&amp;lt;/scene&amp;gt; of each helix 1 are central to the formation of the hydrophobic core. “Trp77 packs against &amp;lt;scene name=&#039;82/829356/Phe255/1&#039;&amp;gt;Phe255&amp;lt;/scene&amp;gt; (helix 9) within the monomer and between &amp;lt;scene name=&#039;82/829356/Ala259/1&#039;&amp;gt;Ala259&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829356/Ala259/1&#039;&amp;gt;Ala260&amp;lt;/scene&amp;gt; and against &amp;lt;scene name=&#039;82/829356/Val263/1&#039;&amp;gt;Val263&amp;lt;/scene&amp;gt; of helix 9 from its partner” (Fairall L et al Mol Cell.&amp;lt;ref&amp;gt;PMID: 11545737&amp;lt;/ref&amp;gt;) The hydrogen bonds involved in the dimer interface are formed between &amp;lt;scene name=&#039;82/829356/Glu71/1&#039;&amp;gt;Glu71&amp;lt;/scene&amp;gt; of one monomer with &amp;lt;scene name=&#039;82/829356/Ser85/1&#039;&amp;gt;Ser85&amp;lt;/scene&amp;gt; of the other monomer. Overall, this dimer interface is highly hydrophobic and packed. &lt;br /&gt;
&lt;br /&gt;
=== The TRF1 TRFH-TIN2 interaction ===&lt;br /&gt;
&lt;br /&gt;
The interaction between TRF1 TRFH and the TIN2 peptide involves the C-terminus of the peptide which is called TIN2 TBM (TIN2-TRFH binding motif). TIN2 TBM is the sequence of the peptide that goes from amino acid 256 to the amino acid 276. In the homodimer of TRF1 TRFH, each TRF1 TRFH interacts with one TIN2 peptide. There are not many differences between the conformation of unliganded TRF1 TRFH and TRF1 TRFH bound to TIN2, the only one is the loop L34. When “TIN2 TBM is bound, loop L34 folds back upon helices 3 and 4, sandwiched between the helices and TIN2 TBM”. “The N-terminus of TIN2 TBM (H257-F-N-L-A-Phe262) adopts an extended conformation stabilized by an extensive intermolecular hydrogen-bonding network. The side chain of L260 is therefore positioned into a deep hydrophobic pocket of TRF1 TRFH. In addition, F258 and P262 also make hydrophobic contacts with TRF1 TRFH: F258 sits on concave surface, whereas P262 stacks with TRF1-F142.” (Chen Y et al Science &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;) C-terminus of TIN2 TBM (L263-G-R-R-R-V268) and D139-A-Q141 of TRF1 TRFH form an antiparallel β sheet. This arrangement positions the C-terminus of TIN2 TBM on the surface of loop L34, allowing R265-R-R267 of TIN2 TBM to be in contact with TRF1 TRFH through electrostatic interactions. “, R266 is nested within an acidic depression on the surface of loop L34 through a network of salt bridges and hydrogen bonds.” (Chen Y et al Science &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;) TIN2 TBM also has the sequence F-X-L-X-P at its N-terminus, the sequence F/Y-X-L-X-P being involved in the binding of several [https://en.wikipedia.org/wiki/Shelterin shelterin]-associated proteins to TRF1 TRFH.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Disease ==&lt;br /&gt;
&lt;br /&gt;
Since TIN2 is a protein part of the shelterin complex that regulate the length of telomere, a mutation of the TINF2 gene can lead to alter the binding of TIN2 to TRF1, causing,  telomeropathies:&lt;br /&gt;
[https://en.wikipedia.org/wiki/Dyskeratosis_congenita Dyskeratosis congenita] and [https://en.wikipedia.org/wiki/Revesz_syndrome Revesz syndrome] . &lt;br /&gt;
&lt;br /&gt;
=== Dyskeratosis congenita ===&lt;br /&gt;
&lt;br /&gt;
Dyskeratosis congenita is a disorder which is characterised by bone marrow dysfunction, abnormality of the skin, mucocutaneous triad of oral leucoplakia, nail dystrophy, as well as a predisposition to cancer. &lt;br /&gt;
TINF2 is one of the nine identified genes that when mutated are related to the Dyskeratosis congenita, the others being [https://en.wikipedia.org/wiki/Dyskerin DKC1],[https://en.wikipedia.org/wiki/Telomerase_RNA_component TERC],[https://en.wikipedia.org/wiki/Telomerase_reverse_transcriptase TERT], NOP10, NHP2, C16orf57, TCAB1 and [https://en.wikipedia.org/wiki/Poly(A)-specific_ribonuclease PARN]. TIN2 mutations are imply in several different mechanims. &lt;br /&gt;
&lt;br /&gt;
The majority of identified TIN2 dyskeratosis congenita mutations cluster is a highly conserved 30-amino-acid region near the ends of its TRF1 binding domain &amp;lt;ref&amp;gt;PMID: 15316005 &amp;lt;/ref&amp;gt;. A disruption of this domain causes a loss of TRF1 binding to TIN2, resulting in a telomeric instability&amp;lt;ref&amp;gt;PMID: 18252230 &amp;lt;/ref&amp;gt;. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;.&lt;br /&gt;
Another proposal is that TIN2 helps TPP1, another component of the shelterin complex, in the recruitment of telomerase through an unknown mechanism that is disrupted by the TIN2 dyskeratosis congenita mutations, leading once again to a telomeric instability &amp;lt;ref name=&amp;quot;doc2&amp;quot;&amp;gt; PMID: 18252230&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Moreover,TIN2 seems to regulate the effect of the [https://en.wikipedia.org/wiki/Tankyrase tankyrase 1], a poly ADP-ribose polymerase, by stabilising the formation of a TIN2–tankyrase 1–TRF1 complex. The formation of this complex stops the binding of TRF1 to the ends of telomeres. Another cause of the disease can be amino acids mutations in TIN2. There are different types of mutations involved. There are some that block the formation of the TIN2-tankyrase 1-TRF1 complex. This let TRF1 fully available to inhibitit the addition of telomeres units to telomeres ends, which is problematic during period of rapid cell growth like embryogenesis. Also, when TRF1 binds to telomeres, it recruits a protein called POT1 and form a complex with it. It&#039;s a complex that blocks access to telomerase and protects the ends of telomeres. And so, there are amino acids mutations of TIN2 that prevent TRF1 binding to telomeres when needed, an so also prevent the protection of telomeres ends that can be the target of non-specific degradation. Thus leading to telomeres shortening. &amp;lt;ref&amp;gt;PMID: 19419704 &amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
=== Revesz syndrome ===&lt;br /&gt;
&lt;br /&gt;
Revesz syndrome is characterised by bone marrow hypoplasia, nail dystrophy, growth retardation, exudative retinopathy, severe aplastic anemia &amp;lt;ref&amp;gt;PMID: 17901676 &amp;lt;/ref&amp;gt;. Revesz syndrome also appears to be part of the DKC disease spectrum. Patients with Revesz syndrome have presented with heterozygous mutations in TINF2 gene which is located on chromosome 14q12 &amp;lt;ref name=&amp;quot;doc2&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;references group=&amp;quot;xtra&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== External Ressources ==&lt;br /&gt;
{{Wikipedia|TERF1}}&lt;br /&gt;
{{Wikipedia|TINF2}}&lt;br /&gt;
{{Wikipedia|Shelterin}&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1103&amp;diff=3144139</id>
		<title>Sandbox Reserved 1103</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1103&amp;diff=3144139"/>
		<updated>2020-01-17T14:46:07Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== TRF1 TRFH domain and TIN2 peptide complex, pdb=3BQO ==&lt;br /&gt;
The TRFH (Telomeric Repeat Factor Homology) is a domain which is in the centre of the [https://en.wikipedia.org/wiki/TERF1 TRF1](Telomeric Repeat-Binding Factor) and of about 200 amino acids.In humans TERF1 is encoded by the TERF1 gene. [https://en.wikipedia.org/wiki/TINF2 TIN2](TERF1-interacting Nuclear Factor) is a protein encoded in humans by the TINF2 gene that can bind to TRFH TRF1.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;Dimer2.pdb&#039; size=&#039;350&#039; frame=&#039;true&#039; align=&#039;centre up&#039; scene=&#039;82/829356/Dimer/3&#039;&amp;gt;&#039;&#039;&#039;&#039;&#039;&lt;br /&gt;
== Function ==&lt;br /&gt;
&lt;br /&gt;
[https://en.wikipedia.org/wiki/TERF1 TRF1]TRF1 also called [https://en.wikipedia.org/wiki/TERF1 TERF1] is a protein part of the  [https://en.wikipedia.org/wiki/Shelterin Shelterin] complex (also called telosome) that has a crucial role in the regulation of telomeres &amp;lt;ref&amp;gt;PMID: 31261825&amp;lt;/ref&amp;gt;. TRF1 is an inhibitor of [[Telomerase]], the protein that elongates telomeres. Indeed, when TRF1 is inactivated, telomeres are getting longer with no regulation. &lt;br /&gt;
The TRFH (telomeric repeat factor homology [[1h6o]]) domain is essential to the TRF1 because it’s the sequence where the protein dimerize to form a functional homodimer. Then, the protein can interact with DNA by fixing to the repeated sequence TTAGGG, and can then remodel DNA. This activity of remodeling is enhanced by the TIN2&amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt; PMID: 18202258&amp;lt;/ref&amp;gt; . TIN2 or [https://en.wikipedia.org/wiki/TINF2 TINF2] (TERF1 interacting nuclear factor 2) is also a protein of the Shelterin that can bind to TRF1. It acts as a bridge or a link between TRF1 and TPP or [https://en.wikipedia.org/wiki/TERF2 TRF2] that are others proteins of the shelterin complex. This link will regulate their activity and can also stabilize TRF1’s interaction with DNA. &lt;br /&gt;
When TIN2 is mutated, telomeres are no longer regulated. TRF1 alone doesn’t seems to be efficient to regulate [[Telomerase]]. &lt;br /&gt;
Because of their function in telomeres regulation, TRF1 TIN2 are key proteins involved in cell aging and their dysfunction can directly leads to disease like cancer or other cell cycle diseases. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref group=&amp;quot;xtra&amp;quot;&amp;gt;PMID: 10669743&amp;lt;/ref&amp;gt;&amp;lt;ref group=&amp;quot;xtra&amp;quot;&amp;gt;PMID: 16166375&amp;lt;/ref&amp;gt;&amp;lt;ref group=&amp;quot;xtra&amp;quot;&amp;gt;PMID: 30352022&amp;lt;/ref&amp;gt;&amp;lt;ref group=&amp;quot;xtra&amp;quot;&amp;gt;PMID: 31026066&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
=== The TRF1 TRFH domain ===&lt;br /&gt;
&lt;br /&gt;
The [https://en.wikipedia.org/wiki/TERF1 TRF1] TRFH domain is a sequence motif of about 200 amino acids located in the centre of TRF1. It is entirely constituted of α helices and binds to another TRF1 TRFH to form a homodimer. The two monomers are antiparallel and form a homodimer which is symmetrical. There are three α-helices from each monomer involved in this homodimerization: &amp;lt;scene name=&#039;82/829356/Helices_1/1&#039;&amp;gt;the helices 1&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829356/Helices_2/1&#039;&amp;gt;2&amp;lt;/scene&amp;gt; &amp;lt;scene name=&#039;82/829356/Helices_9/1&#039;&amp;gt;9&amp;lt;/scene&amp;gt;. To form a dimer, the helix 1 of one monomer comes into contact with helix 1 of the other monomer, its helix 2 does it with the helix 2, and so does the helix 9. The two helices 9 stabilize the dimer interface and are perpendicular to the helices 1, forming a cross brace at the top and the bottom of it. The two helices 1 are the core of the dimer interface. This interface involves many hydrophobic interactions and a few hydrogen bonds. The amino acids &amp;lt;scene name=&#039;82/829356/Trp77/3&#039;&amp;gt;Trp77&amp;lt;/scene&amp;gt; of each helix 1 are central to the formation of the hydrophobic core. “Trp77 packs against &amp;lt;scene name=&#039;82/829356/Phe255/1&#039;&amp;gt;Phe255&amp;lt;/scene&amp;gt; (helix 9) within the monomer and between &amp;lt;scene name=&#039;82/829356/Ala259/1&#039;&amp;gt;Ala259&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829356/Ala259/1&#039;&amp;gt;Ala260&amp;lt;/scene&amp;gt; and against &amp;lt;scene name=&#039;82/829356/Val263/1&#039;&amp;gt;Val263&amp;lt;/scene&amp;gt; of helix 9 from its partner” (Fairall L et al Mol Cell.&amp;lt;ref&amp;gt;PMID: 11545737&amp;lt;/ref&amp;gt;) The hydrogen bonds involved in the dimer interface are formed between &amp;lt;scene name=&#039;82/829356/Glu71/1&#039;&amp;gt;Glu71&amp;lt;/scene&amp;gt; of one monomer with &amp;lt;scene name=&#039;82/829356/Ser85/1&#039;&amp;gt;Ser85&amp;lt;/scene&amp;gt; of the other monomer. Overall, this dimer interface is highly hydrophobic and packed. &lt;br /&gt;
&lt;br /&gt;
=== The TRF1 TRFH-TIN2 interaction ===&lt;br /&gt;
&lt;br /&gt;
The interaction between TRF1 TRFH and the TIN2 peptide involves the C-terminus of the peptide which is called TIN2 TBM (TIN2-TRFH binding motif). TIN2 TBM is the sequence of the peptide that goes from amino acid 256 to the amino acid 276. In the homodimer of TRF1 TRFH, each TRF1 TRFH interacts with one TIN2 peptide. There are not many differences between the conformation of unliganded TRF1 TRFH and TRF1 TRFH bound to TIN2, the only one is the loop L34. When “TIN2 TBM is bound, loop L34 folds back upon helices 3 and 4, sandwiched between the helices and TIN2 TBM”. “The N-terminus of TIN2 TBM (H257-F-N-L-A-Phe262) adopts an extended conformation stabilized by an extensive intermolecular hydrogen-bonding network. The side chain of L260 is therefore positioned into a deep hydrophobic pocket of TRF1 TRFH. In addition, F258 and P262 also make hydrophobic contacts with TRF1 TRFH: F258 sits on concave surface, whereas P262 stacks with TRF1-F142.” (Chen Y et al Science &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;) C-terminus of TIN2 TBM (L263-G-R-R-R-V268) and D139-A-Q141 of TRF1 TRFH form an antiparallel β sheet. This arrangement positions the C-terminus of TIN2 TBM on the surface of loop L34, allowing R265-R-R267 of TIN2 TBM to be in contact with TRF1 TRFH through electrostatic interactions. “, R266 is nested within an acidic depression on the surface of loop L34 through a network of salt bridges and hydrogen bonds.” (Chen Y et al Science &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;) TIN2 TBM also has the sequence F-X-L-X-P at its N-terminus, the sequence F/Y-X-L-X-P being involved in the binding of several [https://en.wikipedia.org/wiki/Shelterin shelterin]-associated proteins to TRF1 TRFH.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Disease ==&lt;br /&gt;
&lt;br /&gt;
Since TIN2 is a protein part of the shelterin complex that regulate the length of telomere, a mutation of the TINF2 gene can lead to alter the binding of TIN2 to TRF1, causing,  telomeropathies:&lt;br /&gt;
[https://en.wikipedia.org/wiki/Dyskeratosis_congenita Dyskeratosis congenita] and [https://en.wikipedia.org/wiki/Revesz_syndrome Revesz syndrome] . &lt;br /&gt;
&lt;br /&gt;
=== Dyskeratosis congenita ===&lt;br /&gt;
&lt;br /&gt;
Dyskeratosis congenita is a disorder which is characterised by bone marrow dysfunction, abnormality of the skin, mucocutaneous triad of oral leucoplakia, nail dystrophy, as well as a predisposition to cancer. &lt;br /&gt;
TINF2 is one of the nine identified genes that when mutated are related to the Dyskeratosis congenita, the others being [https://en.wikipedia.org/wiki/Dyskerin DKC1],[https://en.wikipedia.org/wiki/Telomerase_RNA_component TERC],[https://en.wikipedia.org/wiki/Telomerase_reverse_transcriptase TERT], NOP10, NHP2, C16orf57, TCAB1 and [https://en.wikipedia.org/wiki/Poly(A)-specific_ribonuclease PARN]. TIN2 mutations are imply in several different mechanims. &lt;br /&gt;
&lt;br /&gt;
The majority of identified TIN2 dyskeratosis congenita mutations cluster is a highly conserved 30-amino-acid region near the ends of its TRF1 binding domain &amp;lt;ref&amp;gt;PMID: 15316005 &amp;lt;/ref&amp;gt;. A disruption of this domain causes a loss of TRF1 binding to TIN2, resulting in a telomeric instability&amp;lt;ref&amp;gt;PMID: 18252230 &amp;lt;/ref&amp;gt;. &lt;br /&gt;
Another proposal is that TIN2 helps TPP1, another component of the shelterin complex, in the recruitment of telomerase through an unknown mechanism that is disrupted by the TIN2 dyskeratosis congenita mutations, leading once again to a telomeric instability &amp;lt;ref name=&amp;quot;doc2&amp;quot;&amp;gt; PMID: 18252230&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Moreover,TIN2 seems to regulate the effect of the [https://en.wikipedia.org/wiki/Tankyrase tankyrase 1], a poly ADP-ribose polymerase, by stabilising the formation of a TIN2–tankyrase 1–TRF1 complex. The formation of this complex stops the binding of TRF1 to the ends of telomeres. Another cause of the disease can be amino acids mutations in TIN2. There are different types of mutations involved. There are some that block the formation of the TIN2-tankyrase 1-TRF1 complex. This let TRF1 fully available to inhibitit the addition of telomeres units to telomeres ends, which is problematic during period of rapid cell growth like embryogenesis. Also, when TRF1 binds to telomeres, it recruits a protein called POT1 and form a complex with it. It&#039;s a complex that blocks access to telomerase and protects the ends of telomeres. And so, there are amino acids mutations of TIN2 that prevent TRF1 binding to telomeres when needed, an so also prevent the protection of telomeres ends that can be the target of non-specific degradation. Thus leading to telomeres shortening. &amp;lt;ref&amp;gt;PMID: 19419704 &amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
=== Revesz syndrome ===&lt;br /&gt;
&lt;br /&gt;
Revesz syndrome is characterised by bone marrow hypoplasia, nail dystrophy, growth retardation, exudative retinopathy, severe aplastic anemia &amp;lt;ref&amp;gt;PMID: 17901676 &amp;lt;/ref&amp;gt;. Revesz syndrome also appears to be part of the DKC disease spectrum. Patients with Revesz syndrome have presented with heterozygous mutations in TINF2 gene which is located on chromosome 14q12 &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;references group=&amp;quot;xtra&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== External Ressources ==&lt;br /&gt;
{{Wikipedia|TERF1}}&lt;br /&gt;
{{Wikipedia|TINF2}}&lt;br /&gt;
{{Wikipedia|Shelterin}&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1103&amp;diff=3144137</id>
		<title>Sandbox Reserved 1103</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1103&amp;diff=3144137"/>
		<updated>2020-01-17T14:44:54Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== TRF1 TRFH domain and TIN2 peptide complex, pdb=3BQO ==&lt;br /&gt;
The TRFH (Telomeric Repeat Factor Homology) is a domain which is in the centre of the [https://en.wikipedia.org/wiki/TERF1 TRF1](Telomeric Repeat-Binding Factor) and of about 200 amino acids.In humans TERF1 is encoded by the TERF1 gene. [https://en.wikipedia.org/wiki/TINF2 TIN2](TERF1-interacting Nuclear Factor) is a protein encoded in humans by the TINF2 gene that can bind to TRFH TRF1.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;Dimer2.pdb&#039; size=&#039;350&#039; frame=&#039;true&#039; align=&#039;centre up&#039; scene=&#039;82/829356/Dimer/3&#039;&amp;gt;&#039;&#039;&#039;&#039;&#039;&lt;br /&gt;
== Function ==&lt;br /&gt;
&lt;br /&gt;
[https://en.wikipedia.org/wiki/TERF1 TRF1]TRF1 also called [https://en.wikipedia.org/wiki/TERF1 TERF1] is a protein part of the  [https://en.wikipedia.org/wiki/Shelterin Shelterin] complex (also called telosome) that has a crucial role in the regulation of telomeres &amp;lt;ref&amp;gt;PMID: 31261825&amp;lt;/ref&amp;gt;. TRF1 is an inhibitor of [[Telomerase]], the protein that elongates telomeres. Indeed, when TRF1 is inactivated, telomeres are getting longer with no regulation. &lt;br /&gt;
The TRFH (telomeric repeat factor homology [[1h6o]]) domain is essential to the TRF1 because it’s the sequence where the protein dimerize to form a functional homodimer. Then, the protein can interact with DNA by fixing to the repeated sequence TTAGGG, and can then remodel DNA. This activity of remodeling is enhanced by the TIN2&amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt; PMID: 18202258&amp;lt;/ref&amp;gt; . TIN2 or [https://en.wikipedia.org/wiki/TINF2 TINF2] (TERF1 interacting nuclear factor 2) is also a protein of the Shelterin that can bind to TRF1. It acts as a bridge or a link between TRF1 and TPP or [https://en.wikipedia.org/wiki/TERF2 TRF2] that are others proteins of the shelterin complex. This link will regulate their activity and can also stabilize TRF1’s interaction with DNA. &lt;br /&gt;
When TIN2 is mutated, telomeres are no longer regulated. TRF1 alone doesn’t seems to be efficient to regulate [[Telomerase]]. &lt;br /&gt;
Because of their function in telomeres regulation, TRF1 TIN2 are key proteins involved in cell aging and their dysfunction can directly leads to disease like cancer or other cell cycle diseases. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref group=&amp;quot;xtra&amp;quot;&amp;gt;PMID: 10669743&amp;lt;/ref&amp;gt;&amp;lt;ref group=&amp;quot;xtra&amp;quot;&amp;gt;PMID: 16166375&amp;lt;/ref&amp;gt;&amp;lt;ref group=&amp;quot;xtra&amp;quot;&amp;gt;PMID: 30352022&amp;lt;/ref&amp;gt;&amp;lt;ref group=&amp;quot;xtra&amp;quot;&amp;gt;PMID: 31026066&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
=== The TRF1 TRFH domain ===&lt;br /&gt;
&lt;br /&gt;
The [https://en.wikipedia.org/wiki/TERF1 TRF1] TRFH domain is a sequence motif of about 200 amino acids located in the centre of TRF1. It is entirely constituted of α helices and binds to another TRF1 TRFH to form a homodimer. The two monomers are antiparallel and form a homodimer which is symmetrical. There are three α-helices from each monomer involved in this homodimerization: &amp;lt;scene name=&#039;82/829356/Helices_1/1&#039;&amp;gt;the helices 1&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829356/Helices_2/1&#039;&amp;gt;2&amp;lt;/scene&amp;gt; &amp;lt;scene name=&#039;82/829356/Helices_9/1&#039;&amp;gt;9&amp;lt;/scene&amp;gt;. To form a dimer, the helix 1 of one monomer comes into contact with helix 1 of the other monomer, its helix 2 does it with the helix 2, and so does the helix 9. The two helices 9 stabilize the dimer interface and are perpendicular to the helices 1, forming a cross brace at the top and the bottom of it. The two helices 1 are the core of the dimer interface. This interface involves many hydrophobic interactions and a few hydrogen bonds. The amino acids &amp;lt;scene name=&#039;82/829356/Trp77/3&#039;&amp;gt;Trp77&amp;lt;/scene&amp;gt; of each helix 1 are central to the formation of the hydrophobic core. “Trp77 packs against &amp;lt;scene name=&#039;82/829356/Phe255/1&#039;&amp;gt;Phe255&amp;lt;/scene&amp;gt; (helix 9) within the monomer and between &amp;lt;scene name=&#039;82/829356/Ala259/1&#039;&amp;gt;Ala259&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829356/Ala259/1&#039;&amp;gt;Ala260&amp;lt;/scene&amp;gt; and against &amp;lt;scene name=&#039;82/829356/Val263/1&#039;&amp;gt;Val263&amp;lt;/scene&amp;gt; of helix 9 from its partner” (Fairall L et al Mol Cell.&amp;lt;ref&amp;gt;PMID: 11545737&amp;lt;/ref&amp;gt;) The hydrogen bonds involved in the dimer interface are formed between &amp;lt;scene name=&#039;82/829356/Glu71/1&#039;&amp;gt;Glu71&amp;lt;/scene&amp;gt; of one monomer with &amp;lt;scene name=&#039;82/829356/Ser85/1&#039;&amp;gt;Ser85&amp;lt;/scene&amp;gt; of the other monomer. Overall, this dimer interface is highly hydrophobic and packed. &lt;br /&gt;
&lt;br /&gt;
=== The TRF1 TRFH-TIN2 interaction ===&lt;br /&gt;
&lt;br /&gt;
The interaction between TRF1 TRFH and the TIN2 peptide involves the C-terminus of the peptide which is called TIN2 TBM (TIN2-TRFH binding motif). TIN2 TBM is the sequence of the peptide that goes from amino acid 256 to the amino acid 276. In the homodimer of TRF1 TRFH, each TRF1 TRFH interacts with one TIN2 peptide. There are not many differences between the conformation of unliganded TRF1 TRFH and TRF1 TRFH bound to TIN2, the only one is the loop L34. When “TIN2 TBM is bound, loop L34 folds back upon helices 3 and 4, sandwiched between the helices and TIN2 TBM”. “The N-terminus of TIN2 TBM (H257-F-N-L-A-Phe262) adopts an extended conformation stabilized by an extensive intermolecular hydrogen-bonding network. The side chain of L260 is therefore positioned into a deep hydrophobic pocket of TRF1 TRFH. In addition, F258 and P262 also make hydrophobic contacts with TRF1 TRFH: F258 sits on concave surface, whereas P262 stacks with TRF1-F142.” (Chen Y et al Science &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;) C-terminus of TIN2 TBM (L263-G-R-R-R-V268) and D139-A-Q141 of TRF1 TRFH form an antiparallel β sheet. This arrangement positions the C-terminus of TIN2 TBM on the surface of loop L34, allowing R265-R-R267 of TIN2 TBM to be in contact with TRF1 TRFH through electrostatic interactions. “, R266 is nested within an acidic depression on the surface of loop L34 through a network of salt bridges and hydrogen bonds.” (Chen Y et al Science &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;) TIN2 TBM also has the sequence F-X-L-X-P at its N-terminus, the sequence F/Y-X-L-X-P being involved in the binding of several [https://en.wikipedia.org/wiki/Shelterin shelterin]-associated proteins to TRF1 TRFH.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Disease ==&lt;br /&gt;
&lt;br /&gt;
Since TIN2 is a protein part of the shelterin complex that regulate the length of telomere, a mutation of the TINF2 gene can lead to alter the binding of TIN2 to TRF1, causing,  telomeropathies:&lt;br /&gt;
[https://en.wikipedia.org/wiki/Dyskeratosis_congenita Dyskeratosis congenita] and [https://en.wikipedia.org/wiki/Revesz_syndrome Revesz syndrome] . &lt;br /&gt;
&lt;br /&gt;
=== Dyskeratosis congenita ===&lt;br /&gt;
&lt;br /&gt;
Dyskeratosis congenita is a disorder which is characterised by bone marrow dysfunction, abnormality of the skin, mucocutaneous triad of oral leucoplakia, nail dystrophy, as well as a predisposition to cancer. &lt;br /&gt;
TINF2 is one of the nine identified genes that when mutated are related to the Dyskeratosis congenita, the others being [https://en.wikipedia.org/wiki/Dyskerin DKC1],[https://en.wikipedia.org/wiki/Telomerase_RNA_component TERC],[https://en.wikipedia.org/wiki/Telomerase_reverse_transcriptase TERT], NOP10, NHP2, C16orf57, TCAB1 and [https://en.wikipedia.org/wiki/Poly(A)-specific_ribonuclease PARN]. TIN2 mutations are imply in several different mechanims. &lt;br /&gt;
&lt;br /&gt;
The majority of identified TIN2 dyskeratosis congenita mutations cluster is a highly conserved 30-amino-acid region near the ends of its TRF1 binding domain &amp;lt;ref&amp;gt;PMID: 15316005 &amp;lt;/ref&amp;gt;. A disruption of this domain causes a loss of TRF1 binding to TIN2, resulting in a telomeric instability&amp;lt;ref&amp;gt;PMID: 18252230 &amp;lt;/ref&amp;gt;. &lt;br /&gt;
Another proposal is that TIN2 helps TPP1, another component of the shelterin complex, in the recruitment of telomerase through an unknown mechanism that is disrupted by the TIN2 dyskeratosis congenita mutations, leading once again to a telomeric instability &amp;lt;ref name=&amp;quot;doc2&amp;quot;&amp;gt; PMID: 18252230&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Moreover,TIN2 seems to regulate the effect of the [https://en.wikipedia.org/wiki/Tankyrase tankyrase 1], a poly ADP-ribose polymerase, by stabilising the formation of a TIN2–tankyrase 1–TRF1 complex. The formation of this complex stops the binding of TRF1 to the ends of telomeres. Another cause of the disease can be amino acids mutations in TIN2. There are different types of mutations involved. There are some that block the formation of the TIN2-tankyrase 1-TRF1 complex. This let TRF1 fully available to inhibitit the addition of telomeres units to telomeres ends, which is problematic during period of rapid cell growth like embryogenesis. Also, when TRF1 binds to telomeres, it recruits a protein called POT1 and form a complex with it. It&#039;s a complex that blocks access to telomerase and protects the ends of telomeres. And so, there are amino acids mutations of TIN2 that prevent TRF1 binding to telomeres when needed, an so also prevent the protection of telomeres ends that can be the target of non-specific degradation. Thus leading to telomeres shortening. &amp;lt;ref&amp;gt;PMID: 19419704 &amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
=== Revesz syndrome ===&lt;br /&gt;
&lt;br /&gt;
Revesz syndrome is characterised by bone marrow hypoplasia, nail dystrophy, growth retardation, exudative retinopathy, severe aplastic anemia &amp;lt;ref&amp;gt;PMID: 17901676 &amp;lt;/ref&amp;gt;. Revesz syndrome also appears to be part of the DKC disease spectrum. Patients with Revesz syndrome have presented with heterozygous mutations in TINF2 gene which is located on chromosome 14q12 &amp;lt;ref&amp;gt;PMID: 18252230 &amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;references group=&amp;quot;xtra&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== External Ressources ==&lt;br /&gt;
{{Wikipedia|TERF1}}&lt;br /&gt;
{{Wikipedia|TINF2}}&lt;br /&gt;
{{Wikipedia|Shelterin}&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1103&amp;diff=3144132</id>
		<title>Sandbox Reserved 1103</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1103&amp;diff=3144132"/>
		<updated>2020-01-17T14:41:41Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== TRF1 TRFH domain and TIN2 peptide complex, pdb=3BQO ==&lt;br /&gt;
The TRFH (Telomeric Repeat Factor Homology) is a domain which is in the centre of the [https://en.wikipedia.org/wiki/TERF1 TRF1](Telomeric Repeat-Binding Factor) and of about 200 amino acids.In humans TERF1 is encoded by the TERF1 gene. [https://en.wikipedia.org/wiki/TINF2 TIN2](TERF1-interacting Nuclear Factor) is a protein encoded in humans by the TINF2 gene that can bind to TRFH TRF1.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;Dimer2.pdb&#039; size=&#039;350&#039; frame=&#039;true&#039; align=&#039;centre up&#039; scene=&#039;82/829356/Dimer/3&#039;&amp;gt;&#039;&#039;&#039;&#039;&#039;&lt;br /&gt;
== Function ==&lt;br /&gt;
&lt;br /&gt;
[https://en.wikipedia.org/wiki/TERF1 TRF1]TRF1 also called [https://en.wikipedia.org/wiki/TERF1 TERF1] is a protein part of the  [https://en.wikipedia.org/wiki/Shelterin Shelterin] complex (also called telosome) that has a crucial role in the regulation of telomeres &amp;lt;ref&amp;gt;PMID: 31261825&amp;lt;/ref&amp;gt;. TRF1 is an inhibitor of [[Telomerase]], the protein that elongates telomeres. Indeed, when TRF1 is inactivated, telomeres are getting longer with no regulation. &lt;br /&gt;
The TRFH (telomeric repeat factor homology [[1h6o]]) domain is essential to the TRF1 because it’s the sequence where the protein dimerize to form a functional homodimer. Then, the protein can interact with DNA by fixing to the repeated sequence TTAGGG, and can then remodel DNA. This activity of remodeling is enhanced by the TIN2&amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt; PMID: 18202258&amp;lt;/ref&amp;gt; . TIN2 or [https://en.wikipedia.org/wiki/TINF2 TINF2] (TERF1 interacting nuclear factor 2) is also a protein of the Shelterin that can bind to TRF1. It acts as a bridge or a link between TRF1 and TPP or [https://en.wikipedia.org/wiki/TERF2 TRF2] that are others proteins of the shelterin complex. This link will regulate their activity and can also stabilize TRF1’s interaction with DNA. &lt;br /&gt;
When TIN2 is mutated, telomeres are no longer regulated. TRF1 alone doesn’t seems to be efficient to regulate [[Telomerase]]. &lt;br /&gt;
Because of their function in telomeres regulation, TRF1 TIN2 are key proteins involved in cell aging and their dysfunction can directly leads to disease like cancer or other cell cycle diseases. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref group=&amp;quot;xtra&amp;quot;&amp;gt;PMID: 10669743&amp;lt;/ref&amp;gt;&amp;lt;ref group=&amp;quot;xtra&amp;quot;&amp;gt;PMID: 16166375&amp;lt;/ref&amp;gt;&amp;lt;ref group=&amp;quot;xtra&amp;quot;&amp;gt;PMID: 30352022&amp;lt;/ref&amp;gt;&amp;lt;ref group=&amp;quot;xtra&amp;quot;&amp;gt;PMID: 31026066&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
=== The TRF1 TRFH domain ===&lt;br /&gt;
&lt;br /&gt;
The [https://en.wikipedia.org/wiki/TERF1 TRF1] TRFH domain is a sequence motif of about 200 amino acids located in the centre of TRF1. It is entirely constituted of α helices and binds to another TRF1 TRFH to form a homodimer. The two monomers are antiparallel and form a homodimer which is symmetrical. There are three α-helices from each monomer involved in this homodimerization: &amp;lt;scene name=&#039;82/829356/Helices_1/1&#039;&amp;gt;the helices 1&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829356/Helices_2/1&#039;&amp;gt;2&amp;lt;/scene&amp;gt; &amp;lt;scene name=&#039;82/829356/Helices_9/1&#039;&amp;gt;9&amp;lt;/scene&amp;gt;. To form a dimer, the helix 1 of one monomer comes into contact with helix 1 of the other monomer, its helix 2 does it with the helix 2, and so does the helix 9. The two helices 9 stabilize the dimer interface and are perpendicular to the helices 1, forming a cross brace at the top and the bottom of it. The two helices 1 are the core of the dimer interface. This interface involves many hydrophobic interactions and a few hydrogen bonds. The amino acids &amp;lt;scene name=&#039;82/829356/Trp77/3&#039;&amp;gt;Trp77&amp;lt;/scene&amp;gt; of each helix 1 are central to the formation of the hydrophobic core. “Trp77 packs against &amp;lt;scene name=&#039;82/829356/Phe255/1&#039;&amp;gt;Phe255&amp;lt;/scene&amp;gt; (helix 9) within the monomer and between &amp;lt;scene name=&#039;82/829356/Ala259/1&#039;&amp;gt;Ala259&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829356/Ala259/1&#039;&amp;gt;Ala260&amp;lt;/scene&amp;gt; and against &amp;lt;scene name=&#039;82/829356/Val263/1&#039;&amp;gt;Val263&amp;lt;/scene&amp;gt; of helix 9 from its partner” (Fairall L et al Mol Cell.&amp;lt;ref&amp;gt;PMID: 11545737&amp;lt;/ref&amp;gt;) The hydrogen bonds involved in the dimer interface are formed between &amp;lt;scene name=&#039;82/829356/Glu71/1&#039;&amp;gt;Glu71&amp;lt;/scene&amp;gt; of one monomer with &amp;lt;scene name=&#039;82/829356/Ser85/1&#039;&amp;gt;Ser85&amp;lt;/scene&amp;gt; of the other monomer. Overall, this dimer interface is highly hydrophobic and packed. &lt;br /&gt;
&lt;br /&gt;
=== The TRF1 TRFH-TIN2 interaction ===&lt;br /&gt;
&lt;br /&gt;
The interaction between TRF1 TRFH and the TIN2 peptide involves the C-terminus of the peptide which is called TIN2 TBM (TIN2-TRFH binding motif). TIN2 TBM is the sequence of the peptide that goes from amino acid 256 to the amino acid 276. In the homodimer of TRF1 TRFH, each TRF1 TRFH interacts with one TIN2 peptide. There are not many differences between the conformation of unliganded TRF1 TRFH and TRF1 TRFH bound to TIN2, the only one is the loop L34. When “TIN2 TBM is bound, loop L34 folds back upon helices 3 and 4, sandwiched between the helices and TIN2 TBM”. “The N-terminus of TIN2 TBM (H257-F-N-L-A-Phe262) adopts an extended conformation stabilized by an extensive intermolecular hydrogen-bonding network. The side chain of L260 is therefore positioned into a deep hydrophobic pocket of TRF1 TRFH. In addition, F258 and P262 also make hydrophobic contacts with TRF1 TRFH: F258 sits on concave surface, whereas P262 stacks with TRF1-F142.” (Chen Y et al Science &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;) C-terminus of TIN2 TBM (L263-G-R-R-R-V268) and D139-A-Q141 of TRF1 TRFH form an antiparallel β sheet. This arrangement positions the C-terminus of TIN2 TBM on the surface of loop L34, allowing R265-R-R267 of TIN2 TBM to be in contact with TRF1 TRFH through electrostatic interactions. “, R266 is nested within an acidic depression on the surface of loop L34 through a network of salt bridges and hydrogen bonds.” (Chen Y et al Science &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;) TIN2 TBM also has the sequence F-X-L-X-P at its N-terminus, the sequence F/Y-X-L-X-P being involved in the binding of several [https://en.wikipedia.org/wiki/Shelterin shelterin]-associated proteins to TRF1 TRFH.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Disease ==&lt;br /&gt;
&lt;br /&gt;
Since TIN2 is a protein part of the shelterin complex that regulate the length of telomere, a mutation of the TINF2 gene can lead to alter the binding of TIN2 to TRF1, causing,  telomeropathies:&lt;br /&gt;
[https://en.wikipedia.org/wiki/Dyskeratosis_congenita Dyskeratosis congenita] and [https://en.wikipedia.org/wiki/Revesz_syndrome Revesz syndrome] . &lt;br /&gt;
&lt;br /&gt;
=== Dyskeratosis congenita ===&lt;br /&gt;
&lt;br /&gt;
Dyskeratosis congenita is a disorder which is characterised by bone marrow dysfunction, abnormality of the skin, mucocutaneous triad of oral leucoplakia, nail dystrophy, as well as a predisposition to cancer. &lt;br /&gt;
TINF2 is one of the nine identified genes that when mutated are related to the Dyskeratosis congenita, the others being [https://en.wikipedia.org/wiki/Dyskerin DKC1],[https://en.wikipedia.org/wiki/Telomerase_RNA_component TERC],[https://en.wikipedia.org/wiki/Telomerase_reverse_transcriptase TERT], NOP10, NHP2, C16orf57, TCAB1 and [https://en.wikipedia.org/wiki/Poly(A)-specific_ribonuclease PARN]. TIN2 mutations are imply in several different mechanims. &lt;br /&gt;
&lt;br /&gt;
The majority of identified TIN2 dyskeratosis congenita mutations cluster is a highly conserved 30-amino-acid region near the ends of its TRF1 binding domain &amp;lt;ref&amp;gt;PMID: 15316005 &amp;lt;/ref&amp;gt;. A disruption of this domain causes a loss of TRF1 binding to TIN2, resulting in a telomeric instability&amp;lt;ref&amp;gt;PMID: 18252230 &amp;lt;/ref&amp;gt;. &lt;br /&gt;
Another proposal is that TIN2 helps TPP1, another component of the shelterin complex, in the recruitment of telomerase through an unknown mechanism that is disrupted by the TIN2 dyskeratosis congenita mutations, leading once again to a telomeric instability &amp;lt;ref&amp;gt;PMID: 18252230 &amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Moreover,TIN2 seems to regulate the effect of the [https://en.wikipedia.org/wiki/Tankyrase tankyrase 1], a poly ADP-ribose polymerase, by stabilising the formation of a TIN2–tankyrase 1–TRF1 complex. The formation of this complex stops the binding of TRF1 to the ends of telomeres. Another cause of the disease can be amino acids mutations in TIN2. There are different types of mutations involved. There are some that block the formation of the TIN2-tankyrase 1-TRF1 complex. This let TRF1 fully available to inhibitit the addition of telomeres units to telomeres ends, which is problematic during period of rapid cell growth like embryogenesis. Also, when TRF1 binds to telomeres, it recruits a protein called POT1 and form a complex with it. It&#039;s a complex that blocks access to telomerase and protects the ends of telomeres. And so, there are amino acids mutations of TIN2 that prevent TRF1 binding to telomeres when needed, an so also prevent the protection of telomeres ends that can be the target of non-specific degradation. Thus leading to telomeres shortening. &amp;lt;ref&amp;gt;PMID: 19419704 &amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
=== Revesz syndrome ===&lt;br /&gt;
&lt;br /&gt;
Revesz syndrome is characterised by bone marrow hypoplasia, nail dystrophy, growth retardation, exudative retinopathy, severe aplastic anemia &amp;lt;ref&amp;gt;PMID: 17901676 &amp;lt;/ref&amp;gt;. Revesz syndrome also appears to be part of the DKC disease spectrum. Patients with Revesz syndrome have presented with heterozygous mutations in TINF2 gene which is located on chromosome 14q12 &amp;lt;ref&amp;gt;PMID: 18252230 &amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;references group=&amp;quot;xtra&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== External Ressources ==&lt;br /&gt;
{{Wikipedia|TERF1}}&lt;br /&gt;
{{Wikipedia|TINF2}}&lt;br /&gt;
{{Wikipedia|Shelterin}&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1103&amp;diff=3144130</id>
		<title>Sandbox Reserved 1103</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1103&amp;diff=3144130"/>
		<updated>2020-01-17T14:40:37Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== TRF1 TRFH domain and TIN2 peptide complex, pdb=3BQO ==&lt;br /&gt;
The TRFH (Telomeric Repeat Factor Homology) is a domain which is in the centre of the [https://en.wikipedia.org/wiki/TERF1 TRF1](Telomeric Repeat-Binding Factor) and of about 200 amino acids.In humans TERF1 is encoded by the TERF1 gene. [https://en.wikipedia.org/wiki/TINF2 TIN2](TERF1-interacting Nuclear Factor) is a protein encoded in humans by the TINF2 gene that can bind to TRFH TRF1.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;Dimer2.pdb&#039; size=&#039;350&#039; frame=&#039;true&#039; align=&#039;centre up&#039; scene=&#039;82/829356/Dimer/3&#039;&amp;gt;&#039;&#039;&#039;&#039;&#039;&lt;br /&gt;
== Function ==&lt;br /&gt;
&lt;br /&gt;
[https://en.wikipedia.org/wiki/TERF1 TRF1]TRF1 also called [https://en.wikipedia.org/wiki/TERF1 TERF1] is a protein part of the  [https://en.wikipedia.org/wiki/Shelterin Shelterin] complex (also called telosome) that has a crucial role in the regulation of telomeres &amp;lt;ref&amp;gt;PMID: 31261825&amp;lt;/ref&amp;gt;. TRF1 is an inhibitor of [[Telomerase]], the protein that elongates telomeres. Indeed, when TRF1 is inactivated, telomeres are getting longer with no regulation. &lt;br /&gt;
The TRFH (telomeric repeat factor homology [[1h6o]]) domain is essential to the TRF1 because it’s the sequence where the protein dimerize to form a functional homodimer. Then, the protein can interact with DNA by fixing to the repeated sequence TTAGGG, and can then remodel DNA. This activity of remodeling is enhanced by the TIN2&amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt; PMID: 18202258&amp;lt;/ref&amp;gt; . TIN2 or [https://en.wikipedia.org/wiki/TINF2 TINF2] (TERF1 interacting nuclear factor 2) is also a protein of the Shelterin that can bind to TRF1. It acts as a bridge or a link between TRF1 and TPP or [https://en.wikipedia.org/wiki/TERF2 TRF2] that are others proteins of the shelterin complex. This link will regulate their activity and can also stabilize TRF1’s interaction with DNA. &lt;br /&gt;
When TIN2 is mutated, telomeres are no longer regulated. TRF1 alone doesn’t seems to be efficient to regulate [[Telomerase]]. &lt;br /&gt;
Because of their function in telomeres regulation, TRF1 TIN2 are key proteins involved in cell aging and their dysfunction can directly leads to disease like cancer or other cell cycle diseases. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref group=&amp;quot;xtra&amp;quot;&amp;gt;PMID: 10669743&amp;lt;/ref&amp;gt;&amp;lt;ref group=&amp;quot;xtra&amp;quot;&amp;gt;PMID: 16166375&amp;lt;/ref&amp;gt;&amp;lt;ref group=&amp;quot;xtra&amp;quot;&amp;gt;PMID: 30352022&amp;lt;/ref&amp;gt;&amp;lt;ref group=&amp;quot;xtra&amp;quot;&amp;gt;PMID: 31026066&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
=== The TRF1 TRFH domain ===&lt;br /&gt;
&lt;br /&gt;
The [https://en.wikipedia.org/wiki/TERF1 TRF1] TRFH domain is a sequence motif of about 200 amino acids located in the centre of TRF1. It is entirely constituted of α helices and binds to another TRF1 TRFH to form a homodimer. The two monomers are antiparallel and form a homodimer which is symmetrical. There are three α-helices from each monomer involved in this homodimerization: &amp;lt;scene name=&#039;82/829356/Helices_1/1&#039;&amp;gt;the helices 1&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829356/Helices_2/1&#039;&amp;gt;2&amp;lt;/scene&amp;gt; &amp;lt;scene name=&#039;82/829356/Helices_9/1&#039;&amp;gt;9&amp;lt;/scene&amp;gt;. To form a dimer, the helix 1 of one monomer comes into contact with helix 1 of the other monomer, its helix 2 does it with the helix 2, and so does the helix 9. The two helices 9 stabilize the dimer interface and are perpendicular to the helices 1, forming a cross brace at the top and the bottom of it. The two helices 1 are the core of the dimer interface. This interface involves many hydrophobic interactions and a few hydrogen bonds. The amino acids &amp;lt;scene name=&#039;82/829356/Trp77/3&#039;&amp;gt;Trp77&amp;lt;/scene&amp;gt; of each helix 1 are central to the formation of the hydrophobic core. “Trp77 packs against &amp;lt;scene name=&#039;82/829356/Phe255/1&#039;&amp;gt;Phe255&amp;lt;/scene&amp;gt; (helix 9) within the monomer and between &amp;lt;scene name=&#039;82/829356/Ala259/1&#039;&amp;gt;Ala259&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829356/Ala259/1&#039;&amp;gt;Ala260&amp;lt;/scene&amp;gt; and against &amp;lt;scene name=&#039;82/829356/Val263/1&#039;&amp;gt;Val263&amp;lt;/scene&amp;gt; of helix 9 from its partner” (Fairall L et al Mol Cell.&amp;lt;ref&amp;gt;PMID: 11545737&amp;lt;/ref&amp;gt;) The hydrogen bonds involved in the dimer interface are formed between &amp;lt;scene name=&#039;82/829356/Glu71/1&#039;&amp;gt;Glu71&amp;lt;/scene&amp;gt; of one monomer with &amp;lt;scene name=&#039;82/829356/Ser85/1&#039;&amp;gt;Ser85&amp;lt;/scene&amp;gt; of the other monomer. Overall, this dimer interface is highly hydrophobic and packed. &lt;br /&gt;
&lt;br /&gt;
=== The TRF1 TRFH-TIN2 interaction ===&lt;br /&gt;
&lt;br /&gt;
The interaction between TRF1 TRFH and the TIN2 peptide involves the C-terminus of the peptide which is called TIN2 TBM (TIN2-TRFH binding motif). TIN2 TBM is the sequence of the peptide that goes from amino acid 256 to the amino acid 276. In the homodimer of TRF1 TRFH, each TRF1 TRFH interacts with one TIN2 peptide. There are not many differences between the conformation of unliganded TRF1 TRFH and TRF1 TRFH bound to TIN2, the only one is the loop L34. When “TIN2 TBM is bound, loop L34 folds back upon helices 3 and 4, sandwiched between the helices and TIN2 TBM”. “The N-terminus of TIN2 TBM (H257-F-N-L-A-Phe262) adopts an extended conformation stabilized by an extensive intermolecular hydrogen-bonding network. The side chain of L260 is therefore positioned into a deep hydrophobic pocket of TRF1 TRFH. In addition, F258 and P262 also make hydrophobic contacts with TRF1 TRFH: F258 sits on concave surface, whereas P262 stacks with TRF1-F142.” (Chen Y et al Science &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;) C-terminus of TIN2 TBM (L263-G-R-R-R-V268) and D139-A-Q141 of TRF1 TRFH form an antiparallel β sheet. This arrangement positions the C-terminus of TIN2 TBM on the surface of loop L34, allowing R265-R-R267 of TIN2 TBM to be in contact with TRF1 TRFH through electrostatic interactions. “, R266 is nested within an acidic depression on the surface of loop L34 through a network of salt bridges and hydrogen bonds.” (Chen Y et al Science &amp;lt;ref&amp;gt;PMID:18202258&amp;lt;/ref&amp;gt;) TIN2 TBM also has the sequence F-X-L-X-P at its N-terminus, the sequence F/Y-X-L-X-P being involved in the binding of several [https://en.wikipedia.org/wiki/Shelterin shelterin]-associated proteins to TRF1 TRFH.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Disease ==&lt;br /&gt;
&lt;br /&gt;
Since TIN2 is a protein part of the shelterin complex that regulate the length of telomere, a mutation of the TINF2 gene can lead to alter the binding of TIN2 to TRF1, causing,  telomeropathies:&lt;br /&gt;
[https://en.wikipedia.org/wiki/Dyskeratosis_congenita Dyskeratosis congenita] and [https://en.wikipedia.org/wiki/Revesz_syndrome Revesz syndrome] . &lt;br /&gt;
&lt;br /&gt;
=== Dyskeratosis congenita ===&lt;br /&gt;
&lt;br /&gt;
Dyskeratosis congenita is a disorder which is characterised by bone marrow dysfunction, abnormality of the skin, mucocutaneous triad of oral leucoplakia, nail dystrophy, as well as a predisposition to cancer. &lt;br /&gt;
TINF2 is one of the nine identified genes that when mutated are related to the Dyskeratosis congenita, the others being [https://en.wikipedia.org/wiki/Dyskerin DKC1],[https://en.wikipedia.org/wiki/Telomerase_RNA_component TERC],[https://en.wikipedia.org/wiki/Telomerase_reverse_transcriptase TERT], NOP10, NHP2, C16orf57, TCAB1 and [https://en.wikipedia.org/wiki/Poly(A)-specific_ribonuclease PARN]. TIN2 mutations are imply in several different mechanims. &lt;br /&gt;
&lt;br /&gt;
The majority of identified TIN2 dyskeratosis congenita mutations cluster is a highly conserved 30-amino-acid region near the ends of its TRF1 binding domain &amp;lt;ref&amp;gt;PMID: 15316005 &amp;lt;/ref&amp;gt;. A disruption of this domain causes a loss of TRF1 binding to TIN2, resulting in a telomeric instability&amp;lt;ref&amp;gt;PMID: 18252230 &amp;lt;/ref&amp;gt;. &lt;br /&gt;
Another proposal is that TIN2 helps TPP1, another component of the shelterin complex, in the recruitment of telomerase through an unknown mechanism that is disrupted by the TIN2 dyskeratosis congenita mutations, leading once again to a telomeric instability &amp;lt;ref&amp;gt;PMID: 18252230 &amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Moreover,TIN2 seems to regulate the effect of the [https://en.wikipedia.org/wiki/Tankyrase tankyrase 1], a poly ADP-ribose polymerase, by stabilising the formation of a TIN2–tankyrase 1–TRF1 complex. The formation of this complex stops the binding of TRF1 to the ends of telomeres. Another cause of the disease can be amino acids mutations in TIN2. There are different types of mutations involved. There are some that block the formation of the TIN2-tankyrase 1-TRF1 complex. This let TRF1 fully available to inhibitit the addition of telomeres units to telomeres ends, which is problematic during period of rapid cell growth like embryogenesis. Also, when TRF1 binds to telomeres, it recruits a protein called POT1 and form a complex with it. It&#039;s a complex that blocks access to telomerase and protects the ends of telomeres. And so, there are amino acids mutations of TIN2 that prevent TRF1 binding to telomeres when needed, an so also prevent the protection of telomeres ends that can be the target of non-specific degradation. Thus leading to telomeres shortening. &amp;lt;ref&amp;gt;PMID: 19419704 &amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
=== Revesz syndrome ===&lt;br /&gt;
&lt;br /&gt;
Revesz syndrome is characterised by bone marrow hypoplasia, nail dystrophy, growth retardation, exudative retinopathy, severe aplastic anemia &amp;lt;ref&amp;gt;PMID: 17901676 &amp;lt;/ref&amp;gt;. Revesz syndrome also appears to be part of the DKC disease spectrum. Patients with Revesz syndrome have presented with heterozygous mutations in TINF2 gene which is located on chromosome 14q12 &amp;lt;ref&amp;gt;PMID: 18252230 &amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;references group=&amp;quot;xtra&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== External Ressources ==&lt;br /&gt;
{{Wikipedia|TERF1}}&lt;br /&gt;
{{Wikipedia|TINF2}}&lt;br /&gt;
{{Wikipedia|Shelterin}&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1103&amp;diff=3144127</id>
		<title>Sandbox Reserved 1103</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1103&amp;diff=3144127"/>
		<updated>2020-01-17T14:38:15Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== TRF1 TRFH domain and TIN2 peptide complex, pdb=3BQO ==&lt;br /&gt;
The TRFH (Telomeric Repeat Factor Homology) is a domain which is in the centre of the [https://en.wikipedia.org/wiki/TERF1 TRF1](Telomeric Repeat-Binding Factor) and of about 200 amino acids.In humans TERF1 is encoded by the TERF1 gene. [https://en.wikipedia.org/wiki/TINF2 TIN2](TERF1-interacting Nuclear Factor) is a protein encoded in humans by the TINF2 gene that can bind to TRFH TRF1.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;Structure load=&#039;Dimer2.pdb&#039; size=&#039;350&#039; frame=&#039;true&#039; align=&#039;centre up&#039; scene=&#039;82/829356/Dimer/3&#039;&amp;gt;&#039;&#039;&#039;&#039;&#039;&lt;br /&gt;
== Function ==&lt;br /&gt;
&lt;br /&gt;
[https://en.wikipedia.org/wiki/TERF1 TRF1]TRF1 also called [https://en.wikipedia.org/wiki/TERF1 TERF1] is a protein part of the  [https://en.wikipedia.org/wiki/Shelterin Shelterin] complex (also called telosome) that has a crucial role in the regulation of telomeres &amp;lt;ref&amp;gt;PMID: 31261825&amp;lt;/ref&amp;gt;. TRF1 is an inhibitor of [[Telomerase]], the protein that elongates telomeres. Indeed, when TRF1 is inactivated, telomeres are getting longer with no regulation. &lt;br /&gt;
The TRFH (telomeric repeat factor homology [[1h6o]]) domain is essential to the TRF1 because it’s the sequence where the protein dimerize to form a functional homodimer. Then, the protein can interact with DNA by fixing to the repeated sequence TTAGGG, and can then remodel DNA. This activity of remodeling is enhanced by the TIN2&amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt; PMID: 18202258&amp;lt;/ref&amp;gt; . TIN2 or [https://en.wikipedia.org/wiki/TINF2 TINF2] (TERF1 interacting nuclear factor 2) is also a protein of the Shelterin that can bind to TRF1. It acts as a bridge or a link between TRF1 and TPP or [https://en.wikipedia.org/wiki/TERF2 TRF2] that are others proteins of the shelterin complex. This link will regulate their activity and can also stabilize TRF1’s interaction with DNA. &lt;br /&gt;
When TIN2 is mutated, telomeres are no longer regulated. TRF1 alone doesn’t seems to be efficient to regulate [[Telomerase]]. &lt;br /&gt;
Because of their function in telomeres regulation, TRF1 TIN2 are key proteins involved in cell aging and their dysfunction can directly leads to disease like cancer or other cell cycle diseases. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref group=&amp;quot;xtra&amp;quot;&amp;gt;PMID: 10669743&amp;lt;/ref&amp;gt;&amp;lt;ref group=&amp;quot;xtra&amp;quot;&amp;gt;PMID: 16166375&amp;lt;/ref&amp;gt;&amp;lt;ref group=&amp;quot;xtra&amp;quot;&amp;gt;PMID: 30352022&amp;lt;/ref&amp;gt;&amp;lt;ref group=&amp;quot;xtra&amp;quot;&amp;gt;PMID: 31026066&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
=== The TRF1 TRFH domain ===&lt;br /&gt;
&lt;br /&gt;
The [https://en.wikipedia.org/wiki/TERF1 TRF1] TRFH domain is a sequence motif of about 200 amino acids located in the centre of TRF1. It is entirely constituted of α helices and binds to another TRF1 TRFH to form a homodimer. The two monomers are antiparallel and form a homodimer which is symmetrical. There are three α-helices from each monomer involved in this homodimerization: &amp;lt;scene name=&#039;82/829356/Helices_1/1&#039;&amp;gt;the helices 1&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829356/Helices_2/1&#039;&amp;gt;2&amp;lt;/scene&amp;gt; &amp;lt;scene name=&#039;82/829356/Helices_9/1&#039;&amp;gt;9&amp;lt;/scene&amp;gt;. To form a dimer, the helix 1 of one monomer comes into contact with helix 1 of the other monomer, its helix 2 does it with the helix 2, and so does the helix 9. The two helices 9 stabilize the dimer interface and are perpendicular to the helices 1, forming a cross brace at the top and the bottom of it. The two helices 1 are the core of the dimer interface. This interface involves many hydrophobic interactions and a few hydrogen bonds. The amino acids &amp;lt;scene name=&#039;82/829356/Trp77/3&#039;&amp;gt;Trp77&amp;lt;/scene&amp;gt; of each helix 1 are central to the formation of the hydrophobic core. “Trp77 packs against &amp;lt;scene name=&#039;82/829356/Phe255/1&#039;&amp;gt;Phe255&amp;lt;/scene&amp;gt; (helix 9) within the monomer and between &amp;lt;scene name=&#039;82/829356/Ala259/1&#039;&amp;gt;Ala259&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829356/Ala259/1&#039;&amp;gt;Ala260&amp;lt;/scene&amp;gt; and against &amp;lt;scene name=&#039;82/829356/Val263/1&#039;&amp;gt;Val263&amp;lt;/scene&amp;gt; of helix 9 from its partner” (Fairall L et al Mol Cell.&amp;lt;ref&amp;gt;PMID: 11545737&amp;lt;/ref&amp;gt;) The hydrogen bonds involved in the dimer interface are formed between &amp;lt;scene name=&#039;82/829356/Glu71/1&#039;&amp;gt;Glu71&amp;lt;/scene&amp;gt; of one monomer with &amp;lt;scene name=&#039;82/829356/Ser85/1&#039;&amp;gt;Ser85&amp;lt;/scene&amp;gt; of the other monomer. Overall, this dimer interface is highly hydrophobic and packed. &lt;br /&gt;
&lt;br /&gt;
=== The TRF1 TRFH-TIN2 interaction ===&lt;br /&gt;
&lt;br /&gt;
The interaction between TRF1 TRFH and the TIN2 peptide involves the C-terminus of the peptide which is called TIN2 TBM (TIN2-TRFH binding motif). TIN2 TBM is the sequence of the peptide that goes from amino acid 256 to the amino acid 276. In the homodimer of TRF1 TRFH, each TRF1 TRFH interacts with one TIN2 peptide. There are not many differences between the conformation of unliganded TRF1 TRFH and TRF1 TRFH bound to TIN2, the only one is the loop L34. When “TIN2 TBM is bound, loop L34 folds back upon helices 3 and 4, sandwiched between the helices and TIN2 TBM”. “The N-terminus of TIN2 TBM (H257-F-N-L-A-Phe262) adopts an extended conformation stabilized by an extensive intermolecular hydrogen-bonding network. The side chain of L260 is therefore positioned into a deep hydrophobic pocket of TRF1 TRFH. In addition, F258 and P262 also make hydrophobic contacts with TRF1 TRFH: F258 sits on concave surface, whereas P262 stacks with TRF1-F142.” (Chen Y et al Science &amp;lt;ref&amp;gt;PMID:18202258&amp;lt;/ref&amp;gt;) C-terminus of TIN2 TBM (L263-G-R-R-R-V268) and D139-A-Q141 of TRF1 TRFH form an antiparallel β sheet. This arrangement positions the C-terminus of TIN2 TBM on the surface of loop L34, allowing R265-R-R267 of TIN2 TBM to be in contact with TRF1 TRFH through electrostatic interactions. “, R266 is nested within an acidic depression on the surface of loop L34 through a network of salt bridges and hydrogen bonds.” (Chen Y et al Science &amp;lt;ref&amp;gt;PMID:18202258&amp;lt;/ref&amp;gt;) TIN2 TBM also has the sequence F-X-L-X-P at its N-terminus, the sequence F/Y-X-L-X-P being involved in the binding of several [https://en.wikipedia.org/wiki/Shelterin shelterin]-associated proteins to TRF1 TRFH.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Disease ==&lt;br /&gt;
&lt;br /&gt;
Since TIN2 is a protein part of the shelterin complex that regulate the length of telomere, a mutation of the TINF2 gene can lead to alter the binding of TIN2 to TRF1, causing,  telomeropathies:&lt;br /&gt;
[https://en.wikipedia.org/wiki/Dyskeratosis_congenita Dyskeratosis congenita] and [https://en.wikipedia.org/wiki/Revesz_syndrome Revesz syndrome] . &lt;br /&gt;
&lt;br /&gt;
=== Dyskeratosis congenita ===&lt;br /&gt;
&lt;br /&gt;
Dyskeratosis congenita is a disorder which is characterised by bone marrow dysfunction, abnormality of the skin, mucocutaneous triad of oral leucoplakia, nail dystrophy, as well as a predisposition to cancer. &lt;br /&gt;
TINF2 is one of the nine identified genes that when mutated are related to the Dyskeratosis congenita, the others being [https://en.wikipedia.org/wiki/Dyskerin DKC1],[https://en.wikipedia.org/wiki/Telomerase_RNA_component TERC],[https://en.wikipedia.org/wiki/Telomerase_reverse_transcriptase TERT], NOP10, NHP2, C16orf57, TCAB1 and [https://en.wikipedia.org/wiki/Poly(A)-specific_ribonuclease PARN]. TIN2 mutations are imply in several different mechanims. &lt;br /&gt;
&lt;br /&gt;
The majority of identified TIN2 dyskeratosis congenita mutations cluster is a highly conserved 30-amino-acid region near the ends of its TRF1 binding domain &amp;lt;ref&amp;gt;PMID: 15316005 &amp;lt;/ref&amp;gt;. A disruption of this domain causes a loss of TRF1 binding to TIN2, resulting in a telomeric instability&amp;lt;ref&amp;gt;PMID: 18252230 &amp;lt;/ref&amp;gt;. &lt;br /&gt;
Another proposal is that TIN2 helps TPP1, another component of the shelterin complex, in the recruitment of telomerase through an unknown mechanism that is disrupted by the TIN2 dyskeratosis congenita mutations, leading once again to a telomeric instability &amp;lt;ref&amp;gt;PMID: 18252230 &amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Moreover,TIN2 seems to regulate the effect of the [https://en.wikipedia.org/wiki/Tankyrase tankyrase 1], a poly ADP-ribose polymerase, by stabilising the formation of a TIN2–tankyrase 1–TRF1 complex. The formation of this complex stops the binding of TRF1 to the ends of telomeres. Another cause of the disease can be amino acids mutations in TIN2. There are different types of mutations involved. There are some that block the formation of the TIN2-tankyrase 1-TRF1 complex. This let TRF1 fully available to inhibitit the addition of telomeres units to telomeres ends, which is problematic during period of rapid cell growth like embryogenesis. Also, when TRF1 binds to telomeres, it recruits a protein called POT1 and form a complex with it. It&#039;s a complex that blocks access to telomerase and protects the ends of telomeres. And so, there are amino acids mutations of TIN2 that prevent TRF1 binding to telomeres when needed, an so also prevent the protection of telomeres ends that can be the target of non-specific degradation. Thus leading to telomeres shortening. &amp;lt;ref&amp;gt;PMID: 19419704 &amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
=== Revesz syndrome ===&lt;br /&gt;
&lt;br /&gt;
Revesz syndrome is characterised by bone marrow hypoplasia, nail dystrophy, growth retardation, exudative retinopathy, severe aplastic anemia &amp;lt;ref&amp;gt;PMID: 17901676 &amp;lt;/ref&amp;gt;. Revesz syndrome also appears to be part of the DKC disease spectrum. Patients with Revesz syndrome have presented with heterozygous mutations in TINF2 gene which is located on chromosome 14q12 &amp;lt;ref&amp;gt;PMID: 18252230 &amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;references group=&amp;quot;xtra&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== External Ressources ==&lt;br /&gt;
{{Wikipedia|TERF1}}&lt;br /&gt;
{{Wikipedia|TINF2}}&lt;br /&gt;
{{Wikipedia|Shelterin}&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3144122</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3144122"/>
		<updated>2020-01-17T14:28:02Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The Adiponectin receptor 1&#039;&#039;&#039;==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Adiponectin receptor 1 (AdipoR1) structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
[[The Adiponectin receptor 1]] is one of the two receptors for the [http://en.wikipedia.org/wiki/Hormone hormone] called [http://en.wikipedia.org/wiki/Adiponectin adiponectin].&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
The function of adipoR1 is directly linked with the &#039;&#039;&#039;adiponectin&#039;&#039;&#039;. It is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in [http://en.wikipedia.org/wiki/Blood_plasma plasma]&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer has a molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by [http://en.wikipedia.org/wiki/Adipocyte adipocytes] present in brown and white [http://en.wikipedia.org/wiki/Adipose_tissue adipose tissues] but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver.The adiponectin receptor 1 is a receptor sensitive in particular to the globular form&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Yamauchi, Toshimasa, Junji Kamon, Yusuke Ito, Atsushi Tsuchida, Takehiko Yokomizo, Shunbun Kita, Takuya Sugiyama, et al. « Cloning of adiponectin receptors that mediate antidiabetic metabolic effects ». Nature 423, nᵒ 6941 (1 juin 2003): 762‑69. https://doi.org/10.1038/nature01705.&amp;lt;/ref&amp;gt;. These adiponectin&#039;s properties are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like [https://en.wikipedia.org/wiki/Glucose_6-phosphatase glucose-6-phosphatase], [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in [https://en.wikipedia.org/wiki/Gluconeogenesis gluconeogenesis]  &amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Capeau, Jacqueline. « The Story of Adiponectin and Its Receptors AdipoR1 and R2: To Follow ». Journal of Hepatology 47, nᵒ 5 (1 novembre 2007): 736‑38. https://doi.org/10.1016/j.jhep.2007.06.002.&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
The &#039;&#039;&#039;Adiponectin receptor&#039;&#039;&#039; 1 is an [http://en.wikipedia.org/wiki/Integral_membrane_protein integral membrane protein] composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». 2015 https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc5&amp;quot;&amp;gt; Parker-Duffen JL, Nakamura K, Silver M, Zuriaga MA, MacLauchlan S, Aprahamian TR, Walsh K et al.  «Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.» 17 April 2014 : https://www.ncbi.nlm.nih.gov/pubmed/24742672&amp;lt;/ref&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three &amp;lt;scene name=&#039;82/829353/3externalloop/1&#039;&amp;gt;extracellular loops&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/3internalloop/1&#039;&amp;gt;three intracellular loops&amp;lt;/scene&amp;gt;. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three &amp;lt;scene name=&#039;82/829353/3externalloop/1&#039;&amp;gt;extracellular loops&amp;lt;/scene&amp;gt; which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity extended from the cytoplasmic surface to the outer lipid layer where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
AdipoR1 has the capacity to form [http://en.wikipedia.org/wiki/Oligomer oligomers]. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 (2010) : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
AdipoR1 is involved in different diseases and symptoms. One major diseases linked with this proteine is the [http://en.wikipedia.org/wiki/Type_2_diabetes &#039;&#039;&#039;Type II diabete&#039;&#039;&#039;] which is caracterized by a chronic hyperglycemia. This disease is mainly present in obese or overweight people. In case of type II diabete, adiponectin level in plasma is reduced signficantly and the expression of the adiponectin receptors,AdipoR1, decreases, especially in [http://en.wikipedia.org/wiki/Skeletal_muscle skeletal muscle] and [http://en.wikipedia.org/wiki/Adipose_tissue adipose tissues] .&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Another symptom linked to adipoR1 is the &#039;&#039;&#039;insulin resistance&#039;&#039;&#039;. An [http://en.wikipedia.org/wiki/Insulin_resistance insulin resistant] organism is an organism which will require more insulin to obtain the biological effects compare to a normal organism&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Insulin resistance can be caused by any defects in the insulin signaling cascade, including problems with AdipoR1&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.[http://en.wikipedia.org/wiki/Hyperglycemia Hyperglycemia] and [http://en.wikipedia.org/wiki/Hyperinsulinemia hyperinsulinemia] are probably the cause of insulin resistance&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;. In fact, The adiponectin levels and the expression of AdipoR1 drop, reducing adiponectin sensitivity and so lead to insulin resistance&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. Then, insulin resistance provoque a drop of adiponectin secretion and circulation level, increasing hyperinsulinemia.This is the start of a vicious cycle&amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Obesity and insulin resistance also lead to [http://en.wikipedia.org/wiki/Metabolic_syndrome &#039;&#039;&#039;metabolic syndrome&#039;&#039;&#039;].Indeed,adipoR1 can display metabolic dysfunction, especially in case of the drop of its expression&amp;lt;ref name=&amp;quot;doc5&amp;quot;/&amp;gt;.However agonist of adiponectin receptor 1 should be a new treatment strategie for metabolic syndrome or obesity-linked diseases&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;.Moreover,a treatment against type II diabete and insulin resistance could be AdipoR1 overexpression. It could,in the one hand, improves insulin resistance and promotes glucose uptake in skeletal muscle,and, in the other hand, attenuates weight gain and improves glucose metabolism models of metabolic dysfunction in macrophages&amp;lt;ref name=&amp;quot;doc5&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== 3D visualisation ==&lt;br /&gt;
Use of Jsmol and Jmol &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3144031</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3144031"/>
		<updated>2020-01-16T22:33:05Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The Adiponectin receptor 1&#039;&#039;&#039;==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Adiponectin receptor 1 (AdipoR1) structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
[[The Adiponectin receptor 1]] is one of the two receptors for the [http://en.wikipedia.org/wiki/Hormone hormone] called [http://en.wikipedia.org/wiki/Adiponectin adiponectin].&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
The function of adipoR1 is directly linked with the &#039;&#039;&#039;adiponectin&#039;&#039;&#039;. It is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in [http://en.wikipedia.org/wiki/Blood_plasma plasma]&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer has a molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by [http://en.wikipedia.org/wiki/Adipocyte adipocytes] present in brown and white [http://en.wikipedia.org/wiki/Adipose_tissue adipose tissues] but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver.The adiponectin receptor 1 is a receptor sensitive in particular to the globular form&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Yamauchi, Toshimasa, Junji Kamon, Yusuke Ito, Atsushi Tsuchida, Takehiko Yokomizo, Shunbun Kita, Takuya Sugiyama, et al. « Cloning of adiponectin receptors that mediate antidiabetic metabolic effects ». Nature 423, nᵒ 6941 (1 juin 2003): 762‑69. https://doi.org/10.1038/nature01705.&amp;lt;/ref&amp;gt;. These adiponectin&#039;s properties are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like [https://en.wikipedia.org/wiki/Glucose_6-phosphatase glucose-6-phosphatase], [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in [https://en.wikipedia.org/wiki/Gluconeogenesis gluconeogenesis]  &amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Capeau, Jacqueline. « The Story of Adiponectin and Its Receptors AdipoR1 and R2: To Follow ». Journal of Hepatology 47, nᵒ 5 (1 novembre 2007): 736‑38. https://doi.org/10.1016/j.jhep.2007.06.002.&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
The &#039;&#039;&#039;Adiponectin receptor&#039;&#039;&#039; 1 is an [http://en.wikipedia.org/wiki/Integral_membrane_protein integral membrane protein] composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». 2015 https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc5&amp;quot;&amp;gt; Parker-Duffen JL, Nakamura K, Silver M, Zuriaga MA, MacLauchlan S, Aprahamian TR, Walsh K et al.  «Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.» 17 April 2014 : https://www.ncbi.nlm.nih.gov/pubmed/24742672&amp;lt;/ref&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three &amp;lt;scene name=&#039;82/829353/3externalloop/1&#039;&amp;gt;extracellular loops&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/3internalloop/1&#039;&amp;gt;three intracellular loops&amp;lt;/scene&amp;gt;. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three &amp;lt;scene name=&#039;82/829353/3externalloop/1&#039;&amp;gt;extracellular loops&amp;lt;/scene&amp;gt; which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity extended from the cytoplasmic surface to the outer lipid layer where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
AdipoR1 has the capacity to form [http://en.wikipedia.org/wiki/Oligomer oligomers]. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 (2010) : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
AdipoR1 is involved in different diseases and symptoms. One major diseases linked with this proteine is the [http://en.wikipedia.org/wiki/Type_2_diabetes Type II diabete] which is caracterized by a chronic hyperglycemia. This disease is mainly present in obese or overweight people. In case of type II diabete, adiponectin level in plasma is reduced signficantly and the expression of the adiponectin receptors,AdipoR1, decreases, especially in [http://en.wikipedia.org/wiki/Skeletal_muscle skeletal muscle] and [http://en.wikipedia.org/wiki/Adipose_tissue adipose tissues] .&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Another symptom linked to adipoR1 is the insulin resistance. An [http://en.wikipedia.org/wiki/Insulin_resistance insulin resistant] organism is an organism which will require more insulin to obtain the biological effects compare to a normal organism&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Insulin resistance can be caused by any defects in the insulin signaling cascade, including problems with AdipoR1&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.[http://en.wikipedia.org/wiki/Hyperglycemia Hyperglycemia] and [http://en.wikipedia.org/wiki/Hyperinsulinemia hyperinsulinemia] are probably the cause of insulin resistance&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;. In fact, The adiponectin levels and the expression of AdipoR1 drop, reducing adiponectin sensitivity and so lead to insulin resistance&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. Then, insulin resistance provoque a drop of adiponectin secretion and circulation level, increasing hyperinsulinemia.This is the start of a vicious cycle&amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Obesity and insulin resistance also lead to [http://en.wikipedia.org/wiki/Metabolic_syndrome metabolic syndrome].Indeed,adipoR1 can display metabolic dysfunction, especially in case of the drop of its expression&amp;lt;ref name=&amp;quot;doc5&amp;quot;/&amp;gt;.However agonist of adiponectin receptor 1 should be a new treatment strategie for metabolic syndrome or obesity-linked diseases&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;.Moreover,a treatment against type II diabete and insulin resistance could be AdipoR1 overexpression. It could,in the one hand, improves insulin resistance and promotes glucose uptake in skeletal muscle,and, in the other hand, attenuates weight gain and improves glucose metabolism models of metabolic dysfunction in macrophages&amp;lt;ref name=&amp;quot;doc5&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== 3D visualisation ==&lt;br /&gt;
Use of Jsmol and Jmol &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3144027</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3144027"/>
		<updated>2020-01-16T22:28:16Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The Adiponectin receptor 1&#039;&#039;&#039;==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Adiponectin receptor 1 (AdipoR1) structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
[[The Adiponectin receptor 1]] is one of the two receptors for the [http://en.wikipedia.org/wiki/Hormone hormone] called [http://en.wikipedia.org/wiki/Adiponectin adiponectin].&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
The function of adipoR1 is directly linked with the &#039;&#039;&#039;adiponectin&#039;&#039;&#039;. It is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in [http://en.wikipedia.org/wiki/Blood_plasma plasma]&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer has a molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by [http://en.wikipedia.org/wiki/Adipocyte adipocytes] present in brown and white [http://en.wikipedia.org/wiki/Adipose_tissue adipose tissues] but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver.The adiponectin receptor 1 is a receptor sensitive in particular to the globular form&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Yamauchi, Toshimasa, Junji Kamon, Yusuke Ito, Atsushi Tsuchida, Takehiko Yokomizo, Shunbun Kita, Takuya Sugiyama, et al. « Cloning of adiponectin receptors that mediate antidiabetic metabolic effects ». Nature 423, nᵒ 6941 (1 juin 2003): 762‑69. https://doi.org/10.1038/nature01705.&amp;lt;/ref&amp;gt;. These adiponectin&#039;s properties are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like [https://en.wikipedia.org/wiki/Glucose_6-phosphatase glucose-6-phosphatase], [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in [https://en.wikipedia.org/wiki/Gluconeogenesis gluconeogenesis]  &amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Capeau, Jacqueline. « The Story of Adiponectin and Its Receptors AdipoR1 and R2: To Follow ». Journal of Hepatology 47, nᵒ 5 (1 novembre 2007): 736‑38. https://doi.org/10.1016/j.jhep.2007.06.002.&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
The &#039;&#039;&#039;Adiponectin receptor&#039;&#039;&#039; 1 is an [http://en.wikipedia.org/wiki/Integral_membrane_protein integral membrane protein] composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». 2015 https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc5&amp;quot;&amp;gt; Parker-Duffen JL, Nakamura K, Silver M, Zuriaga MA, MacLauchlan S, Aprahamian TR, Walsh K et al.  «Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.» 17 April 2014 : https://www.ncbi.nlm.nih.gov/pubmed/24742672&amp;lt;/ref&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three &amp;lt;scene name=&#039;82/829353/3externalloop/1&#039;&amp;gt;extracellular loops&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/3internalloop/1&#039;&amp;gt;three intracellular loops&amp;lt;/scene&amp;gt;. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three &amp;lt;scene name=&#039;82/829353/3externalloop/1&#039;&amp;gt;extracellular loops&amp;lt;/scene&amp;gt; which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity extended from the cytoplasmic surface to the outer lipid layer where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
AdipoR1 has the capacity to form [http://en.wikipedia.org/wiki/Oligomer oligomers]. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 (2010) : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
AdipoR1 is involved in different diseases and symptoms. One major diseases linked with this proteine is the [http://en.wikipedia.org/wiki/Type_2_diabetes Type II diabete] which is caracterized by a chronic hyperglycemia. This disease is mainly present in obese or overweight people. In case of type II diabete, adiponectin level in plasma is reduced signficantly and the expression of the adiponectin receptors,AdipoR1, decreases, especially in [http://en.wikipedia.org/wiki/Skeletal_muscle skeletal muscle] and [http://en.wikipedia.org/wiki/Adipose_tissue adipose tissues] .&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Another symptom linked to adipoR1 is the insulin resistance. An [http://en.wikipedia.org/wiki/Insulin_resistance insulin resistant] organism is an organism which will require more insulin to obtain the biological effects compare to a normal organism&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Insulin resistance can be caused by any defects in the insulin signaling cascade, including problems with AdipoR1&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.[http://en.wikipedia.org/wiki/Hyperglycemia Hyperglycemia] and [http://en.wikipedia.org/wiki/Hyperinsulinemia hyperinsulinemia] are probably the cause of insulin resistance&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;. In fact, The adiponectin levels and the expression of AdipoR1 drop, reducing adiponectin sensitivity and so lead to insulin resistance&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. Then, insulin resistance provoque a drop of adiponectin secretion and circulation level, increasing hyperinsulinemia.This is the start of a vicious cycle&amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Obesity and insulin resistance also lead to [http://en.wikipedia.org/wiki/Metabolic_syndrome metabolic syndrome].Indeed,adipoR1 can display metabolic dysfunction, especially in case of the drop of its expression&amp;lt;ref name=&amp;quot;doc5&amp;quot;/&amp;gt;.However agonist of adiponectin receptor (AdipoR1) should be a new treatment strategie for metabolic syndrome or obesity-linked diseases&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;.Moreover,a treatment against type II diabete and insulin resistance could be AdipoR1 overexpression, which in the one hand improves insulin resistance and promotes glucose uptake in skeletal muscle,and in the other hand attenuates weight gain and improves glucose metabolism models of metabolic dysfunction in macrophages&amp;lt;ref name=&amp;quot;doc5&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== 3D visualisation ==&lt;br /&gt;
Use of Jsmol and Jmol &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3144024</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3144024"/>
		<updated>2020-01-16T22:25:33Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The Adiponectin receptor 1&#039;&#039;&#039;==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Adiponectin receptor 1 (AdipoR1) structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
[[The Adiponectin receptor 1]] is one of the two receptors for the [http://en.wikipedia.org/wiki/Hormone hormone] called [http://en.wikipedia.org/wiki/Adiponectin adiponectin].&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
The function of adipoR1 is directly linked with the &#039;&#039;&#039;adiponectin&#039;&#039;&#039;. It is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in [http://en.wikipedia.org/wiki/Blood_plasma plasma]&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer has a molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by [http://en.wikipedia.org/wiki/Adipocyte adipocytes] present in brown and white [http://en.wikipedia.org/wiki/Adipose_tissue adipose tissues] but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver.The adiponectin receptor 1 is a receptor sensitive in particular to the globular form&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Yamauchi, Toshimasa, Junji Kamon, Yusuke Ito, Atsushi Tsuchida, Takehiko Yokomizo, Shunbun Kita, Takuya Sugiyama, et al. « Cloning of adiponectin receptors that mediate antidiabetic metabolic effects ». Nature 423, nᵒ 6941 (1 juin 2003): 762‑69. https://doi.org/10.1038/nature01705.&amp;lt;/ref&amp;gt;. These adiponectin&#039;s properties are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like [https://en.wikipedia.org/wiki/Glucose_6-phosphatase glucose-6-phosphatase], [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in [https://en.wikipedia.org/wiki/Gluconeogenesis gluconeogenesis]  &amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Capeau, Jacqueline. « The Story of Adiponectin and Its Receptors AdipoR1 and R2: To Follow ». Journal of Hepatology 47, nᵒ 5 (1 novembre 2007): 736‑38. https://doi.org/10.1016/j.jhep.2007.06.002.&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
The &#039;&#039;&#039;Adiponectin receptor&#039;&#039;&#039; 1 is an [http://en.wikipedia.org/wiki/Integral_membrane_protein integral membrane protein] composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». 2015 https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc5&amp;quot;&amp;gt; Parker-Duffen JL, Nakamura K, Silver M, Zuriaga MA, MacLauchlan S, Aprahamian TR, Walsh K et al.  «Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.» 17 April 2014 : https://www.ncbi.nlm.nih.gov/pubmed/24742672&amp;lt;/ref&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three &amp;lt;scene name=&#039;82/829353/3externalloop/1&#039;&amp;gt;extracellular loops&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/3internalloop/1&#039;&amp;gt;three intracellular loops&amp;lt;/scene&amp;gt;. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three &amp;lt;scene name=&#039;82/829353/3externalloop/1&#039;&amp;gt;extracellular loops&amp;lt;/scene&amp;gt; which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity extended from the cytoplasmic surface to the outer lipid layer where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
AdipoR1 has the capacity to form [http://en.wikipedia.org/wiki/Oligomer oligomers]. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 (2010) : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
AdipoR1 is involved in different diseases and symptoms. One major diseases linked with this proteine is the [http://en.wikipedia.org/wiki/Type_2_diabetes Type II diabete] which is caracterized by a chronic hyperglycemia. This disease is mainly present in obese or overweight people. In case of type II diabete, adiponectin level in plasma is reduced signficantly and the expression of the adiponectin receptors,AdipoR1, decreases, especially in [http://en.wikipedia.org/wiki/Skeletal_muscle skeletal muscle] and [http://en.wikipedia.org/wiki/Adipose_tissue adipose tissues] .&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Another symptom linked to adipoR1 is the insulin resistance. An [http://en.wikipedia.org/wiki/Insulin_resistance insulin resistant] organism is an organism which will require more insulin to obtain the biological effects of a normal organism&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Insulin resistance can be caused by any defects in the insulin signaling cascade, including problems with AdipoR1&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.[http://en.wikipedia.org/wiki/Hyperglycemia Hyperglycemia] and [http://en.wikipedia.org/wiki/Hyperinsulinemia hyperinsulinemia] are probably the cause of insulin resistance&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;. In fact, The adiponectin levels and the expression of AdipoR1 drop, reducing adiponectin sensitivity and so lead to insulin resistance&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. Then, insulin resistance provoque a drop of adiponectin secretion and circulation level, increasing hyperinsulinemia.This is the start of a vicious cycle&amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Obesity and insulin resistance also lead to [http://en.wikipedia.org/wiki/Metabolic_syndrome metabolic syndrome].Indeed,adipoR1 can display metabolic dysfunction, especially in case of the drop of its expression&amp;lt;ref name=&amp;quot;doc5&amp;quot;/&amp;gt;.However agonist of adiponectin receptor (AdipoR1) should be a new treatment strategie for metabolic syndrome or obesity-linked diseases&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;.Moreover,a treatment against type II diabete and insulin resistance could be AdipoR1 overexpression, which improves insulin resistance and promotes glucose uptake in skeletal muscle in one hand, and attenuates weight gain and improves glucose metabolism models of metabolic dysfunction in macrophages in the other hand&amp;lt;ref name=&amp;quot;doc5&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== 3D visualisation ==&lt;br /&gt;
Use of Jsmol and Jmol &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3144022</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3144022"/>
		<updated>2020-01-16T22:24:06Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The Adiponectin receptor 1&#039;&#039;&#039;==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Adiponectin receptor 1 (AdipoR1) structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
[[The Adiponectin receptor 1]] is one of the two receptors for the [http://en.wikipedia.org/wiki/Hormone hormone] called [http://en.wikipedia.org/wiki/Adiponectin adiponectin].&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
The function of adipoR1 is directly linked with the &#039;&#039;&#039;adiponectin&#039;&#039;&#039;. It is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in [http://en.wikipedia.org/wiki/Blood_plasma plasma]&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer has a molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by [http://en.wikipedia.org/wiki/Adipocyte adipocytes] present in brown and white [http://en.wikipedia.org/wiki/Adipose_tissue adipose tissues] but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver.The adiponectin receptor 1 is a receptor sensitive in particular to the globular form&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Yamauchi, Toshimasa, Junji Kamon, Yusuke Ito, Atsushi Tsuchida, Takehiko Yokomizo, Shunbun Kita, Takuya Sugiyama, et al. « Cloning of adiponectin receptors that mediate antidiabetic metabolic effects ». Nature 423, nᵒ 6941 (1 juin 2003): 762‑69. https://doi.org/10.1038/nature01705.&amp;lt;/ref&amp;gt;. These adiponectin&#039;s properties are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like [https://en.wikipedia.org/wiki/Glucose_6-phosphatase glucose-6-phosphatase], [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in [https://en.wikipedia.org/wiki/Gluconeogenesis gluconeogenesis]  &amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Capeau, Jacqueline. « The Story of Adiponectin and Its Receptors AdipoR1 and R2: To Follow ». Journal of Hepatology 47, nᵒ 5 (1 novembre 2007): 736‑38. https://doi.org/10.1016/j.jhep.2007.06.002.&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
The &#039;&#039;&#039;Adiponectin receptor&#039;&#039;&#039; 1 is an [http://en.wikipedia.org/wiki/Integral_membrane_protein integral membrane protein] composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». 2015 https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc5&amp;quot;&amp;gt; Parker-Duffen JL, Nakamura K, Silver M, Zuriaga MA, MacLauchlan S, Aprahamian TR, Walsh K et al.  «Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.» 17 April 2014 : https://www.ncbi.nlm.nih.gov/pubmed/24742672&amp;lt;/ref&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three &amp;lt;scene name=&#039;82/829353/3externalloop/1&#039;&amp;gt;extracellular loops&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/3internalloop/1&#039;&amp;gt;three intracellular loops&amp;lt;/scene&amp;gt;. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three &amp;lt;scene name=&#039;82/829353/3externalloop/1&#039;&amp;gt;extracellular loops&amp;lt;/scene&amp;gt; which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity extended from the cytoplasmic surface to the outer lipid layer where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 has the capacity to form [http://en.wikipedia.org/wiki/Oligomer oligomers]. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 (2010) : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
AdipoR1 is involved in different diseases and symptoms. One major diseases linked with this proteine is the [http://en.wikipedia.org/wiki/Type_2_diabetes Type II diabete] which is caracterized by a chronic hyperglycemia. This disease is mainly present in obese or overweight people. In case of type II diabete, adiponectin level in plasma is reduced signficantly and the expression of the adiponectin receptors,AdipoR1, decreases, especially in [http://en.wikipedia.org/wiki/Skeletal_muscle skeletal muscle] and [http://en.wikipedia.org/wiki/Adipose_tissue adipose tissues] .&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Another symptom linked to adipoR1 is the insulin resistance. An [http://en.wikipedia.org/wiki/Insulin_resistance insulin resistant] organism is an organism which will require more insulin to obtain the biological effects of a normal organism&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Insulin resistance can be caused by any defects in the insulin signaling cascade, including problems with AdipoR1&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.[http://en.wikipedia.org/wiki/Hyperglycemia Hyperglycemia] and [http://en.wikipedia.org/wiki/Hyperinsulinemia hyperinsulinemia] are probably the cause of insulin resistance&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;. In fact, The adiponectin levels and the expression of AdipoR1 drop, reducing adiponectin sensitivity and so lead to insulin resistance&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.&lt;br /&gt;
Then, insulin resistance provoque a drop of adiponectin secretion and circulation level, increasing hyperinsulinemia.This is the start of a vicious cycle&amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Obesity and insulin resistance also lead to [http://en.wikipedia.org/wiki/Metabolic_syndrome metabolic syndrome].Indeed,adipoR1 can display metabolic dysfunction, especially in case of the drop of its expression&amp;lt;ref name=&amp;quot;doc5&amp;quot;/&amp;gt;.However agonist of adiponectin receptor (AdipoR1) should be a new treatment strategie for metabolic syndrome or obesity-linked diseases&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;.Moreover,a treatment against type II diabete and insulin resistance could be AdipoR1 overexpression, which improves insulin resistance and promotes glucose uptake in skeletal muscle in one hand, and attenuates weight gain and improves glucose metabolism models of metabolic dysfunction in macrophages in the other hand&amp;lt;ref name=&amp;quot;doc5&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== 3D visualisation ==&lt;br /&gt;
Use of Jsmol and Jmol &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3144019</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3144019"/>
		<updated>2020-01-16T22:22:51Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The Adiponectin receptor 1&#039;&#039;&#039;==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Adiponectin receptor 1 (AdipoR1) structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
[[The Adiponectin receptor 1]] is one of the two receptors for the [http://en.wikipedia.org/wiki/Hormone hormone] called [http://en.wikipedia.org/wiki/Adiponectin adiponectin].&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
The function of adipoR1 is directly linked with the &#039;&#039;&#039;adiponectin&#039;&#039;&#039;. It is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in [http://en.wikipedia.org/wiki/Blood_plasma plasma]&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer has a molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by [http://en.wikipedia.org/wiki/Adipocyte adipocytes] present in brown and white [http://en.wikipedia.org/wiki/Adipose_tissue adipose tissues] but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver.The adiponectin receptor 1 is a receptor sensitive in particular to the globular form&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Yamauchi, Toshimasa, Junji Kamon, Yusuke Ito, Atsushi Tsuchida, Takehiko Yokomizo, Shunbun Kita, Takuya Sugiyama, et al. « Cloning of adiponectin receptors that mediate antidiabetic metabolic effects ». Nature 423, nᵒ 6941 (1 juin 2003): 762‑69. https://doi.org/10.1038/nature01705.&amp;lt;/ref&amp;gt;. These adiponectin&#039;s properties are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like [https://en.wikipedia.org/wiki/Glucose_6-phosphatase glucose-6-phosphatase], [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in [https://en.wikipedia.org/wiki/Gluconeogenesis gluconeogenesis]  &amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Capeau, Jacqueline. « The Story of Adiponectin and Its Receptors AdipoR1 and R2: To Follow ». Journal of Hepatology 47, nᵒ 5 (1 novembre 2007): 736‑38. https://doi.org/10.1016/j.jhep.2007.06.002.&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
The &#039;&#039;&#039;Adiponectin receptor&#039;&#039;&#039; 1 is an [http://en.wikipedia.org/wiki/Integral_membrane_protein integral membrane protein] composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». 2015 https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc5&amp;quot;&amp;gt; Parker-Duffen JL, Nakamura K, Silver M, Zuriaga MA, MacLauchlan S, Aprahamian TR, Walsh K et al.  «Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.» 17 April 2014 : https://www.ncbi.nlm.nih.gov/pubmed/24742672&amp;lt;/ref&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three &amp;lt;scene name=&#039;82/829353/3externalloop/1&#039;&amp;gt;extracellular loops&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/3internalloop/1&#039;&amp;gt;three intracellular loops&amp;lt;/scene&amp;gt;. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three &amp;lt;scene name=&#039;82/829353/3externalloop/1&#039;&amp;gt;extracellular loops&amp;lt;/scene&amp;gt; which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity located from the cytoplasmic surface to the middle of the outer lipid layer of the membrane has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 has the capacity to form [http://en.wikipedia.org/wiki/Oligomer oligomers]. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 (2010) : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
AdipoR1 is involved in different diseases and symptoms. One major diseases linked with this proteine is the [http://en.wikipedia.org/wiki/Type_2_diabetes Type II diabete] which is caracterized by a chronic hyperglycemia. This disease is mainly present in obese or overweight people. In case of type II diabete, adiponectin level in plasma is reduced signficantly and the expression of the adiponectin receptors,AdipoR1, decreases, especially in [http://en.wikipedia.org/wiki/Skeletal_muscle skeletal muscle] and [http://en.wikipedia.org/wiki/Adipose_tissue adipose tissues] .&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Another symptom linked to adipoR1 is the insulin resistance. An [http://en.wikipedia.org/wiki/Insulin_resistance insulin resistant] organism is an organism which will require more insulin to obtain the biological effects of a normal organism&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Insulin resistance can be caused by any defects in the insulin signaling cascade included problems with AdipoR1&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.[http://en.wikipedia.org/wiki/Hyperglycemia Hyperglycemia] and [http://en.wikipedia.org/wiki/Hyperinsulinemia hyperinsulinemia] are probably the cause of insulin resistance&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;. In fact, The adiponectin levels and the expression of AdipoR1 drop, reducing adiponectin sensitivity and so lead to insulin resistance&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.&lt;br /&gt;
Then, insulin resistance provoque a drop of adiponectin secretion and circulation level, increasing hyperinsulinemia.This is the start of a vicious cycle&amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Obesity and insulin resistance also lead to [http://en.wikipedia.org/wiki/Metabolic_syndrome metabolic syndrome].Indeed,adipoR1 can display metabolic dysfunction, especially in case of the drop of its expression&amp;lt;ref name=&amp;quot;doc5&amp;quot;/&amp;gt;.However agonist of adiponectin receptor (AdipoR1) should be a new treatment strategie for metabolic syndrome or obesity-linked diseases&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;.Moreover,a treatment against type II diabete and insulin resistance could be AdipoR1 overexpression, which improves insulin resistance and promotes glucose uptake in skeletal muscle in one hand, and attenuates weight gain and improves glucose metabolism models of metabolic dysfunction in macrophages in the other hand&amp;lt;ref name=&amp;quot;doc5&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== 3D visualisation ==&lt;br /&gt;
Use of Jsmol and Jmol &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3144018</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3144018"/>
		<updated>2020-01-16T22:21:09Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The Adiponectin receptor 1&#039;&#039;&#039;==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Adiponectin receptor 1 (AdipoR1) structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
[[The Adiponectin receptor 1]] is one of the two receptors for the [http://en.wikipedia.org/wiki/Hormone hormone] called [http://en.wikipedia.org/wiki/Adiponectin adiponectin].&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
The function of adipoR1 is directly linked with the &#039;&#039;&#039;adiponectin&#039;&#039;&#039;. It is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in [http://en.wikipedia.org/wiki/Blood_plasma plasma]&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer has a molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by [http://en.wikipedia.org/wiki/Adipocyte adipocytes] present in brown and white [http://en.wikipedia.org/wiki/Adipose_tissue adipose tissues] but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver.The adiponectin receptor 1 is a receptor sensitive in particular to the globular form&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Yamauchi, Toshimasa, Junji Kamon, Yusuke Ito, Atsushi Tsuchida, Takehiko Yokomizo, Shunbun Kita, Takuya Sugiyama, et al. « Cloning of adiponectin receptors that mediate antidiabetic metabolic effects ». Nature 423, nᵒ 6941 (1 juin 2003): 762‑69. https://doi.org/10.1038/nature01705.&amp;lt;/ref&amp;gt;. These adiponectin&#039;s properties are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like [https://en.wikipedia.org/wiki/Glucose_6-phosphatase glucose-6-phosphatase], [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in [https://en.wikipedia.org/wiki/Gluconeogenesis gluconeogenesis]  &amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Capeau, Jacqueline. « The Story of Adiponectin and Its Receptors AdipoR1 and R2: To Follow ». Journal of Hepatology 47, nᵒ 5 (1 novembre 2007): 736‑38. https://doi.org/10.1016/j.jhep.2007.06.002.&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
The &#039;&#039;&#039;Adiponectin receptor&#039;&#039;&#039; 1 is an [http://en.wikipedia.org/wiki/Integral_membrane_protein integral membrane protein] composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». 2015 https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc5&amp;quot;&amp;gt; Parker-Duffen JL, Nakamura K, Silver M, Zuriaga MA, MacLauchlan S, Aprahamian TR, Walsh K et al.  «Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.» 17 April 2014 : https://www.ncbi.nlm.nih.gov/pubmed/24742672&amp;lt;/ref&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three &amp;lt;scene name=&#039;82/829353/3externalloop/1&#039;&amp;gt;extracellular loops&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/3internalloop/1&#039;&amp;gt;three intracellular loops&amp;lt;/scene&amp;gt;. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three &amp;lt;scene name=&#039;82/829353/3externalloop/1&#039;&amp;gt;extracellular loops&amp;lt;/scene&amp;gt; which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity located from the cytoplasmic surface to the middle of the outer lipid layer of the membrane has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 has the capacity to form [http://en.wikipedia.org/wiki/Oligomer oligomers]. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 (2010) : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
AdipoR1 is involved in different diseases and symptoms. One major diseases linked with this proteine is the [http://en.wikipedia.org/wiki/Type_2_diabetes Type II diabete] which is caracterized by a chronic hyperglycemia. This disease is mainly present in obese or overweight people. In case of type II diabete, adiponectin level in plasma reduce signficantly and the expression of the adiponectin receptors,AdipoR1, decreases especially in [http://en.wikipedia.org/wiki/Skeletal_muscle skeletal muscle] and [http://en.wikipedia.org/wiki/Adipose_tissue adipose tissues] .&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Another symptom linked to adipoR1 is the insulin resistance. An [http://en.wikipedia.org/wiki/Insulin_resistance insulin resistant] organism is an organism which will require more insulin to obtain the biological effects of a normal organism&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Insulin resistance can be caused by any defects in the insulin signaling cascade included problems with AdipoR1&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.[http://en.wikipedia.org/wiki/Hyperglycemia Hyperglycemia] and [http://en.wikipedia.org/wiki/Hyperinsulinemia hyperinsulinemia] are probably the cause of insulin resistance&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;. In fact, The adiponectin levels and the expression of AdipoR1 drop, reducing adiponectin sensitivity and so lead to insulin resistance&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.&lt;br /&gt;
Then, insulin resistance provoque a drop of adiponectin secretion and circulation level, increasing hyperinsulinemia.This is the start of a vicious cycle&amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Obesity and insulin resistance also lead to [http://en.wikipedia.org/wiki/Metabolic_syndrome metabolic syndrome].Indeed,adipoR1 can display metabolic dysfunction, especially in case of the drop of its expression&amp;lt;ref name=&amp;quot;doc5&amp;quot;/&amp;gt;.However agonist of adiponectin receptor (AdipoR1) should be a new treatment strategie for metabolic syndrome or obesity-linked diseases&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;.Moreover,a treatment against type II diabete and insulin resistance could be AdipoR1 overexpression, which improves insulin resistance and promotes glucose uptake in skeletal muscle in one hand, and attenuates weight gain and improves glucose metabolism models of metabolic dysfunction in macrophages in the other hand&amp;lt;ref name=&amp;quot;doc5&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== 3D visualisation ==&lt;br /&gt;
Use of Jsmol and Jmol &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3144016</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3144016"/>
		<updated>2020-01-16T22:16:28Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The Adiponectin receptor 1&#039;&#039;&#039;==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Adiponectin receptor 1 (AdipoR1) structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
[[The Adiponectin receptor 1]] is one of the two receptors for the [http://en.wikipedia.org/wiki/Hormone hormone] called [http://en.wikipedia.org/wiki/Adiponectin adiponectin].&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
The function of adipoR1 is directly linked with the &#039;&#039;&#039;adiponectin&#039;&#039;&#039;. It is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in [http://en.wikipedia.org/wiki/Blood_plasma plasma]&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer has a molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by [http://en.wikipedia.org/wiki/Adipocyte adipocytes] present in brown and white [http://en.wikipedia.org/wiki/Adipose_tissue adipose tissues] but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver.The adiponectin receptor 1 is a receptor sensitive in particular to the globular form&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Yamauchi, Toshimasa, Junji Kamon, Yusuke Ito, Atsushi Tsuchida, Takehiko Yokomizo, Shunbun Kita, Takuya Sugiyama, et al. « Cloning of adiponectin receptors that mediate antidiabetic metabolic effects ». Nature 423, nᵒ 6941 (1 juin 2003): 762‑69. https://doi.org/10.1038/nature01705.&amp;lt;/ref&amp;gt;. These adiponectin&#039;s properties are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like [https://en.wikipedia.org/wiki/Glucose_6-phosphatase glucose-6-phosphatase], [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in [https://en.wikipedia.org/wiki/Gluconeogenesis gluconeogenesis]  &amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Capeau, Jacqueline. « The Story of Adiponectin and Its Receptors AdipoR1 and R2: To Follow ». Journal of Hepatology 47, nᵒ 5 (1 novembre 2007): 736‑38. https://doi.org/10.1016/j.jhep.2007.06.002.&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
The &#039;&#039;&#039;Adiponectin receptor&#039;&#039;&#039; 1 is an [http://en.wikipedia.org/wiki/Integral_membrane_protein integral membrane protein] composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». 2015 https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc5&amp;quot;&amp;gt; Parker-Duffen JL, Nakamura K, Silver M, Zuriaga MA, MacLauchlan S, Aprahamian TR, Walsh K et al.  «Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.» 17 April 2014 : https://www.ncbi.nlm.nih.gov/pubmed/24742672&amp;lt;/ref&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three &amp;lt;scene name=&#039;82/829353/3externalloop/1&#039;&amp;gt;extracellular loops&amp;lt;/scene&amp;gt; and three &amp;lt;scene name=&#039;82/829353/3externalloop/1&#039;&amp;gt;intracellular loops&amp;lt;/scene&amp;gt;. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three &amp;lt;scene name=&#039;82/829353/3externalloop/1&#039;&amp;gt;extracellular loops&amp;lt;/scene&amp;gt; which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity located from the cytoplasmic surface to the middle of the outer lipid layer of the membrane has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 has the capacity to form [http://en.wikipedia.org/wiki/Oligomer oligomers]. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 (2010) : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
AdipoR1 is involved in different diseases and symptoms. One major diseases linked with this proteine is the [http://en.wikipedia.org/wiki/Type_2_diabetes Type II diabete] which is caracterized by a chronic hyperglycemia. This disease is mainly present in obese or overweight people. In case of type II diabete, adiponectin level in plasma reduce signficantly and the expression of the adiponectin receptors,AdipoR1, decreases especially in [http://en.wikipedia.org/wiki/Skeletal_muscle skeletal muscle] and [http://en.wikipedia.org/wiki/Adipose_tissue adipose tissues] .&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Another symptom linked to adipoR1 is the insulin resistance. An [http://en.wikipedia.org/wiki/Insulin_resistance insulin resistant] organism is an organism which will require more insulin to obtain the biological effects of a normal organism&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Insulin resistance can be caused by any defects in the insulin signaling cascade included problems with AdipoR1&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.[http://en.wikipedia.org/wiki/Hyperglycemia Hyperglycemia] and [http://en.wikipedia.org/wiki/Hyperinsulinemia hyperinsulinemia] are probably the cause of insulin resistance&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;. In fact, The adiponectin levels and the expression of AdipoR1 drop, reducing adiponectin sensitivity and so lead to insulin resistance&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.&lt;br /&gt;
Then, insulin resistance provoque a drop of adiponectin secretion and circulation level, increasing hyperinsulinemia.This is the start of a vicious cycle&amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Obesity and insulin resistance also lead to [http://en.wikipedia.org/wiki/Metabolic_syndrome metabolic syndrome].Indeed,adipoR1 can display metabolic dysfunction, especially in case of the drop of its expression&amp;lt;ref name=&amp;quot;doc5&amp;quot;/&amp;gt;.However agonist of adiponectin receptor (AdipoR1) should be a new treatment strategie for metabolic syndrome or obesity-linked diseases&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;.Moreover,a treatment against type II diabete and insulin resistance could be AdipoR1 overexpression, which improves insulin resistance and promotes glucose uptake in skeletal muscle in one hand, and attenuates weight gain and improves glucose metabolism models of metabolic dysfunction in macrophages in the other hand&amp;lt;ref name=&amp;quot;doc5&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== 3D visualisation ==&lt;br /&gt;
Use of Jsmol and Jmol &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3144009</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3144009"/>
		<updated>2020-01-16T22:10:31Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The Adiponectin receptor 1&#039;&#039;&#039;==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Adiponectin receptor 1 (AdipoR1) structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
[[The Adiponectin receptor 1]] is one of the two receptors for the [http://en.wikipedia.org/wiki/Hormone hormone] called [http://en.wikipedia.org/wiki/Adiponectin adiponectin].&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
The function of adipoR1 is directly linked with the &#039;&#039;&#039;adiponectin&#039;&#039;&#039;. It is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in [http://en.wikipedia.org/wiki/Blood_plasma plasma]&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer has a molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by [http://en.wikipedia.org/wiki/Adipocyte adipocytes] present in brown and white [http://en.wikipedia.org/wiki/Adipose_tissue adipose tissues] but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver.The adiponectin receptor 1 is a receptor sensitive in particular to the globular form&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Yamauchi, Toshimasa, Junji Kamon, Yusuke Ito, Atsushi Tsuchida, Takehiko Yokomizo, Shunbun Kita, Takuya Sugiyama, et al. « Cloning of adiponectin receptors that mediate antidiabetic metabolic effects ». Nature 423, nᵒ 6941 (1 juin 2003): 762‑69. https://doi.org/10.1038/nature01705.&amp;lt;/ref&amp;gt;. These adiponectin&#039;s properties are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like [https://en.wikipedia.org/wiki/Glucose_6-phosphatase glucose-6-phosphatase], [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in [https://en.wikipedia.org/wiki/Gluconeogenesis gluconeogenesis]  &amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Capeau, Jacqueline. « The Story of Adiponectin and Its Receptors AdipoR1 and R2: To Follow ». Journal of Hepatology 47, nᵒ 5 (1 novembre 2007): 736‑38. https://doi.org/10.1016/j.jhep.2007.06.002.&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
The &#039;&#039;&#039;Adiponectin receptor&#039;&#039;&#039; 1 is an [http://en.wikipedia.org/wiki/Integral_membrane_protein integral membrane protein] composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». 2015 https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc5&amp;quot;&amp;gt; Parker-Duffen JL, Nakamura K, Silver M, Zuriaga MA, MacLauchlan S, Aprahamian TR, Walsh K et al.  «Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.» 17 April 2014 : https://www.ncbi.nlm.nih.gov/pubmed/24742672&amp;lt;/ref&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three extracellular loops and three intracellular loops. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three extracellular loops which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity located from the cytoplasmic surface to the middle of the outer lipid layer of the membrane has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the helix II, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 has the capacity to form [http://en.wikipedia.org/wiki/Oligomer oligomers]. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 (2010) : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
AdipoR1 is involved in different diseases and symptoms. One major diseases linked with this proteine is the [http://en.wikipedia.org/wiki/Type_2_diabetes Type II diabete] which is caracterized by a chronic hyperglycemia. This disease is mainly present in obese or overweight people. In case of type II diabete, adiponectin level in plasma reduce signficantly and the expression of the adiponectin receptors,AdipoR1, decreases especially in [http://en.wikipedia.org/wiki/Skeletal_muscle skeletal muscle] and [http://en.wikipedia.org/wiki/Adipose_tissue adipose tissues] .&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Another symptom linked to adipoR1 is the insulin resistance. An [http://en.wikipedia.org/wiki/Insulin_resistance insulin resistant] organism is an organism which will require more insulin to obtain the biological effects of a normal organism&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Insulin resistance can be caused by any defects in the insulin signaling cascade included problems with AdipoR1&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.[http://en.wikipedia.org/wiki/Hyperglycemia Hyperglycemia] and [http://en.wikipedia.org/wiki/Hyperinsulinemia hyperinsulinemia] are probably the cause of insulin resistance&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;. In fact, The adiponectin levels and the expression of AdipoR1 drop, reducing adiponectin sensitivity and so lead to insulin resistance&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.&lt;br /&gt;
Then, insulin resistance provoque a drop of adiponectin secretion and circulation level, increasing hyperinsulinemia.This is the start of a vicious cycle&amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Obesity and insulin resistance also lead to [http://en.wikipedia.org/wiki/Metabolic_syndrome metabolic syndrome].Indeed,adipoR1 can display metabolic dysfunction, especially in case of the drop of its expression&amp;lt;ref name=&amp;quot;doc5&amp;quot;/&amp;gt;.However agonist of adiponectin receptor (AdipoR1) should be a new treatment strategie for metabolic syndrome or obesity-linked diseases&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;.Moreover,a treatment against type II diabete and insulin resistance could be AdipoR1 overexpression, which improves insulin resistance and promotes glucose uptake in skeletal muscle in one hand, and attenuates weight gain and improves glucose metabolism models of metabolic dysfunction in macrophages in the other hand&amp;lt;ref name=&amp;quot;doc5&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== 3D visualisation ==&lt;br /&gt;
Use of Jsmol and Jmol &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3144008</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3144008"/>
		<updated>2020-01-16T22:09:42Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The Adiponectin receptor 1&#039;&#039;&#039;==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Adiponectin receptor 1 (AdipoR1) structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
[[The Adiponectin receptor 1]] is one of the two receptors for the [http://en.wikipedia.org/wiki/Hormone hormone] called [http://en.wikipedia.org/wiki/Adiponectin adiponectin].&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
The function of adipoR1 is directly linked with the &#039;&#039;&#039;adiponectin&#039;&#039;&#039;. It is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in [http://en.wikipedia.org/wiki/Blood_plasma plasma]&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer has molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by [http://en.wikipedia.org/wiki/Adipocyte adipocytes] present in brown and white [http://en.wikipedia.org/wiki/Adipose_tissue adipose tissues] but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver.The adiponectin receptor 1 is a receptor sensitive in particular to the globular form&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Yamauchi, Toshimasa, Junji Kamon, Yusuke Ito, Atsushi Tsuchida, Takehiko Yokomizo, Shunbun Kita, Takuya Sugiyama, et al. « Cloning of adiponectin receptors that mediate antidiabetic metabolic effects ». Nature 423, nᵒ 6941 (1 juin 2003): 762‑69. https://doi.org/10.1038/nature01705.&amp;lt;/ref&amp;gt;. These adiponectin&#039;s properties are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like [https://en.wikipedia.org/wiki/Glucose_6-phosphatase glucose-6-phosphatase], [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in [https://en.wikipedia.org/wiki/Gluconeogenesis gluconeogenesis]  &amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Capeau, Jacqueline. « The Story of Adiponectin and Its Receptors AdipoR1 and R2: To Follow ». Journal of Hepatology 47, nᵒ 5 (1 novembre 2007): 736‑38. https://doi.org/10.1016/j.jhep.2007.06.002.&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
The &#039;&#039;&#039;Adiponectin receptor&#039;&#039;&#039; 1 is an [http://en.wikipedia.org/wiki/Integral_membrane_protein integral membrane protein] composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». 2015 https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc5&amp;quot;&amp;gt; Parker-Duffen JL, Nakamura K, Silver M, Zuriaga MA, MacLauchlan S, Aprahamian TR, Walsh K et al.  «Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.» 17 April 2014 : https://www.ncbi.nlm.nih.gov/pubmed/24742672&amp;lt;/ref&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three extracellular loops and three intracellular loops. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three extracellular loops which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity located from the cytoplasmic surface to the middle of the outer lipid layer of the membrane has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the helix II, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 has the capacity to form [http://en.wikipedia.org/wiki/Oligomer oligomers]. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 (2010) : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
AdipoR1 is involved in different diseases and symptoms. One major diseases linked with this proteine is the [http://en.wikipedia.org/wiki/Type_2_diabetes Type II diabete] which is caracterized by a chronic hyperglycemia. This disease is mainly present in obese or overweight people. In case of type II diabete, adiponectin level in plasma reduce signficantly and the expression of the adiponectin receptors,AdipoR1, decreases especially in [http://en.wikipedia.org/wiki/Skeletal_muscle skeletal muscle] and [http://en.wikipedia.org/wiki/Adipose_tissue adipose tissues] .&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Another symptom linked to adipoR1 is the insulin resistance. An [http://en.wikipedia.org/wiki/Insulin_resistance insulin resistant] organism is an organism which will require more insulin to obtain the biological effects of a normal organism&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Insulin resistance can be caused by any defects in the insulin signaling cascade included problems with AdipoR1&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.[http://en.wikipedia.org/wiki/Hyperglycemia Hyperglycemia] and [http://en.wikipedia.org/wiki/Hyperinsulinemia hyperinsulinemia] are probably the cause of insulin resistance&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;. In fact, The adiponectin levels and the expression of AdipoR1 drop, reducing adiponectin sensitivity and so lead to insulin resistance&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.&lt;br /&gt;
Then, insulin resistance provoque a drop of adiponectin secretion and circulation level, increasing hyperinsulinemia.This is the start of a vicious cycle&amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Obesity and insulin resistance also lead to [http://en.wikipedia.org/wiki/Metabolic_syndrome metabolic syndrome].Indeed,adipoR1 can display metabolic dysfunction, especially in case of the drop of its expression&amp;lt;ref name=&amp;quot;doc5&amp;quot;/&amp;gt;.However agonist of adiponectin receptor (AdipoR1) should be a new treatment strategie for metabolic syndrome or obesity-linked diseases&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;.Moreover,a treatment against type II diabete and insulin resistance could be AdipoR1 overexpression, which improves insulin resistance and promotes glucose uptake in skeletal muscle in one hand, and attenuates weight gain and improves glucose metabolism models of metabolic dysfunction in macrophages in the other hand&amp;lt;ref name=&amp;quot;doc5&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== 3D visualisation ==&lt;br /&gt;
Use of Jsmol and Jmol &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3144006</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3144006"/>
		<updated>2020-01-16T22:08:49Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The Adiponectin receptor 1&#039;&#039;&#039;==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Adiponectin receptor 1 (AdipoR1) structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
[[The Adiponectin receptor 1]] is one of the two receptors for the [http://en.wikipedia.org/wiki/Hormone hormone] called [http://en.wikipedia.org/wiki/Adiponectin adiponectin].&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
The function of adipoR1 is directly linked with the &#039;&#039;&#039;adiponectin&#039;&#039;&#039;. It is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in [http://en.wikipedia.org/wiki/Blood_plasma plasma]&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer as molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by [http://en.wikipedia.org/wiki/Adipocyte adipocytes] present in brown and white [http://en.wikipedia.org/wiki/Adipose_tissue adipose tissues] but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver.The adiponectin receptor 1 is a receptor sensitive in particular to the globular form&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Yamauchi, Toshimasa, Junji Kamon, Yusuke Ito, Atsushi Tsuchida, Takehiko Yokomizo, Shunbun Kita, Takuya Sugiyama, et al. « Cloning of adiponectin receptors that mediate antidiabetic metabolic effects ». Nature 423, nᵒ 6941 (1 juin 2003): 762‑69. https://doi.org/10.1038/nature01705.&amp;lt;/ref&amp;gt;. These adiponectin&#039;s properties are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like glucose-6-phosphatase, [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in [https://en.wikipedia.org/wiki/Gluconeogenesis gluconeogenesis]  &amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Capeau, Jacqueline. « The Story of Adiponectin and Its Receptors AdipoR1 and R2: To Follow ». Journal of Hepatology 47, nᵒ 5 (1 novembre 2007): 736‑38. https://doi.org/10.1016/j.jhep.2007.06.002.&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
The &#039;&#039;&#039;Adiponectin receptor&#039;&#039;&#039; 1 is an [http://en.wikipedia.org/wiki/Integral_membrane_protein integral membrane protein] composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». 2015 https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc5&amp;quot;&amp;gt; Parker-Duffen JL, Nakamura K, Silver M, Zuriaga MA, MacLauchlan S, Aprahamian TR, Walsh K et al.  «Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.» 17 April 2014 : https://www.ncbi.nlm.nih.gov/pubmed/24742672&amp;lt;/ref&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three extracellular loops and three intracellular loops. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three extracellular loops which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity located from the cytoplasmic surface to the middle of the outer lipid layer of the membrane has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the helix II, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 has the capacity to form [http://en.wikipedia.org/wiki/Oligomer oligomers]. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 (2010) : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
AdipoR1 is involved in different diseases and symptoms. One major diseases linked with this proteine is the [http://en.wikipedia.org/wiki/Type_2_diabetes Type II diabete] which is caracterized by a chronic hyperglycemia. This disease is mainly present in obese or overweight people. In case of type II diabete, adiponectin level in plasma reduce signficantly and the expression of the adiponectin receptors,AdipoR1, decreases especially in [http://en.wikipedia.org/wiki/Skeletal_muscle skeletal muscle] and [http://en.wikipedia.org/wiki/Adipose_tissue adipose tissues] .&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Another symptom linked to adipoR1 is the insulin resistance. An [http://en.wikipedia.org/wiki/Insulin_resistance insulin resistant] organism is an organism which will require more insulin to obtain the biological effects of a normal organism&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Insulin resistance can be caused by any defects in the insulin signaling cascade included problems with AdipoR1&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.[http://en.wikipedia.org/wiki/Hyperglycemia Hyperglycemia] and [http://en.wikipedia.org/wiki/Hyperinsulinemia hyperinsulinemia] are probably the cause of insulin resistance&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;. In fact, The adiponectin levels and the expression of AdipoR1 drop, reducing adiponectin sensitivity and so lead to insulin resistance&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.&lt;br /&gt;
Then, insulin resistance provoque a drop of adiponectin secretion and circulation level, increasing hyperinsulinemia.This is the start of a vicious cycle&amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Obesity and insulin resistance also lead to [http://en.wikipedia.org/wiki/Metabolic_syndrome metabolic syndrome].Indeed,adipoR1 can display metabolic dysfunction, especially in case of the drop of its expression&amp;lt;ref name=&amp;quot;doc5&amp;quot;/&amp;gt;.However agonist of adiponectin receptor (AdipoR1) should be a new treatment strategie for metabolic syndrome or obesity-linked diseases&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;.Moreover,a treatment against type II diabete and insulin resistance could be AdipoR1 overexpression, which improves insulin resistance and promotes glucose uptake in skeletal muscle in one hand, and attenuates weight gain and improves glucose metabolism models of metabolic dysfunction in macrophages in the other hand&amp;lt;ref name=&amp;quot;doc5&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== 3D visualisation ==&lt;br /&gt;
Use of Jsmol and Jmol &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3144001</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3144001"/>
		<updated>2020-01-16T22:03:49Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The Adiponectin receptor 1&#039;&#039;&#039;==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Adiponectin receptor 1 (AdipoR1) structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
[[The Adiponectin receptor 1]] is one of the two receptors for the [http://en.wikipedia.org/wiki/Hormone hormone] called [http://en.wikipedia.org/wiki/Adiponectin adiponectin].&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
The function of adipoR1 is directly linked with the &#039;&#039;&#039;adiponectin&#039;&#039;&#039;. It is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in [http://en.wikipedia.org/wiki/Blood_plasma plasma]&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer as molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by [http://en.wikipedia.org/wiki/Adipocyte adipocytes] present in brown and white [http://en.wikipedia.org/wiki/Adipose_tissue adipose tissues] but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver.The adiponectin receptor 1 is a receptor sensitive in particular to the globular form&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Yamauchi, Toshimasa, Junji Kamon, Yusuke Ito, Atsushi Tsuchida, Takehiko Yokomizo, Shunbun Kita, Takuya Sugiyama, et al. « Cloning of adiponectin receptors that mediate antidiabetic metabolic effects ». Nature 423, nᵒ 6941 (1 juin 2003): 762‑69. https://doi.org/10.1038/nature01705.&amp;lt;/ref&amp;gt;. These properties of the adiponectin are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like glucose-6-phosphatase, [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in gluconeogenesis&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Capeau, Jacqueline. « The Story of Adiponectin and Its Receptors AdipoR1 and R2: To Follow ». Journal of Hepatology 47, nᵒ 5 (1 novembre 2007): 736‑38. https://doi.org/10.1016/j.jhep.2007.06.002.&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
The &#039;&#039;&#039;Adiponectin receptor&#039;&#039;&#039; 1 is an [http://en.wikipedia.org/wiki/Integral_membrane_protein integral membrane protein] composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». 2015 https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc5&amp;quot;&amp;gt; Parker-Duffen JL, Nakamura K, Silver M, Zuriaga MA, MacLauchlan S, Aprahamian TR, Walsh K et al.  «Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.» 17 April 2014 : https://www.ncbi.nlm.nih.gov/pubmed/24742672&amp;lt;/ref&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three extracellular loops and three intracellular loops. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three extracellular loops which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity located from the cytoplasmic surface to the middle of the outer lipid layer of the membrane has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the helix II, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 has the capacity to form [http://en.wikipedia.org/wiki/Oligomer oligomers]. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 (2010) : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
AdipoR1 is involved in different diseases and symptoms. One major diseases linked with this proteine is the [http://en.wikipedia.org/wiki/Type_2_diabetes Type II diabete] which is caracterized by a chronic hyperglycemia. This disease is mainly present in obese or overweight people. In case of type II diabete, adiponectin level in plasma reduce signficantly and the expression of the adiponectin receptors,AdipoR1, decreases especially in [http://en.wikipedia.org/wiki/Skeletal_muscle skeletal muscle] and [http://en.wikipedia.org/wiki/Adipose_tissue adipose tissues] .&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Another symptom linked to adipoR1 is the insulin resistance. An [http://en.wikipedia.org/wiki/Insulin_resistance insulin resistant] organism is an organism which will require more insulin to obtain the biological effects of a normal organism&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Insulin resistance can be caused by any defects in the insulin signaling cascade included problems with AdipoR1&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.[http://en.wikipedia.org/wiki/Hyperglycemia Hyperglycemia] and [http://en.wikipedia.org/wiki/Hyperinsulinemia hyperinsulinemia] are probably the cause of insulin resistance&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;. In fact, The adiponectin levels and the expression of AdipoR1 drop, reducing adiponectin sensitivity and so lead to insulin resistance&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.&lt;br /&gt;
Then, insulin resistance provoque a drop of adiponectin secretion and circulation level, increasing hyperinsulinemia.This is the start of a vicious cycle&amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Obesity and insulin resistance also lead to [http://en.wikipedia.org/wiki/Metabolic_syndrome metabolic syndrome]. But agonist of adiponectin receptor (AdipoR1) should be a new treatment strategie for metabolic syndrome or obesity-linked diseases. &amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 can display metabolic dysfunction, especially in case of the drop of its expression. &amp;lt;ref name=&amp;quot;doc5&amp;quot;/&amp;gt;&lt;br /&gt;
A treatment against type II diabete and insulin resistance could be AdipoR1 overexpression that improves insulin resistance and promotes glucose uptake in skeletal muscle in one hand, and attenuates weight gain and improves glucose metabolism models of metabolic dysfunction in macrophages.  &amp;lt;ref name=&amp;quot;doc5&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== 3D visualisation ==&lt;br /&gt;
Use of Jsmol and Jmol &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143998</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143998"/>
		<updated>2020-01-16T21:56:38Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The Adiponectin receptor 1&#039;&#039;&#039;==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Adiponectin receptor 1 (AdipoR1) structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
[[The Adiponectin receptor 1]] is one of the two receptors for the [http://en.wikipedia.org/wiki/Hormone hormone] called [http://en.wikipedia.org/wiki/Adiponectin adiponectin].&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
The function of adipoR1 is directly linked with the &#039;&#039;&#039;adiponectin&#039;&#039;&#039;. It is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in [http://en.wikipedia.org/wiki/Blood_plasma plasma]&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer as molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by [http://en.wikipedia.org/wiki/Adipocyte adipocytes] present in brown and white [http://en.wikipedia.org/wiki/Adipose_tissue adipose tissues] but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver.The adiponectin receptor 1 is a receptor sensitive in particular to the globular form&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Yamauchi, Toshimasa, Junji Kamon, Yusuke Ito, Atsushi Tsuchida, Takehiko Yokomizo, Shunbun Kita, Takuya Sugiyama, et al. « Cloning of adiponectin receptors that mediate antidiabetic metabolic effects ». Nature 423, nᵒ 6941 (1 juin 2003): 762‑69. https://doi.org/10.1038/nature01705.&amp;lt;/ref&amp;gt;. These properties of the adiponectin are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like glucose-6-phosphatase, [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in gluconeogenesis&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Capeau, Jacqueline. « The Story of Adiponectin and Its Receptors AdipoR1 and R2: To Follow ». Journal of Hepatology 47, nᵒ 5 (1 novembre 2007): 736‑38. https://doi.org/10.1016/j.jhep.2007.06.002.&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
The &#039;&#039;&#039;Adiponectin receptor&#039;&#039;&#039; 1 is an [http://en.wikipedia.org/wiki/Integral_membrane_protein integral membrane protein] composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». 2015 https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc5&amp;quot;&amp;gt; Parker-Duffen JL, Nakamura K, Silver M, Zuriaga MA, MacLauchlan S, Aprahamian TR, Walsh K et al.  «Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.» 17 April 2014 : https://www.ncbi.nlm.nih.gov/pubmed/24742672&amp;lt;/ref&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three extracellular loops and three intracellular loops. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three extracellular loops which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity located from the cytoplasmic surface to the middle of the outer lipid layer of the membrane has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the helix II, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 has the capacity to form [http://en.wikipedia.org/wiki/Oligomer oligomers]. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 (2010) : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
AdipoR1 is involved in different diseases and symptoms. One major diseases linked with this proteine is the [http://en.wikipedia.org/wiki/Type_2_diabetes Type II diabete] which is caracterized by a chronic hyperglycemia. This disease is mainly present in obese or overweight people. In case of type II diabete, adiponectin level in plasma reduce signficantly and the expression of the adiponectin receptors,AdipoR1, decreases especially in [http://en.wikipedia.org/wiki/Skeletal_muscle skeletal muscle] and [http://en.wikipedia.org/wiki/Adipose_tissue adipose tissues] .&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Another symptom linked to adipoR1 is the insulin resistance. An [http://en.wikipedia.org/wiki/Insulin_resistance insulin resistant] organism is an organism which will require more insulin to obtain the biological effects of a normal organism.&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;From [http://en.wikipedia.org/wiki/Hyperglycemia hyperglycemia] and [http://en.wikipedia.org/wiki/Hyperinsulinemia hyperinsulinemia] is probably led insulin resistance.&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt; The adiponectin levels and the expression of AdipoR1 (and AdipoR2) drop, thereby reduce adiponectin sensitivity and lead to insulin resistance. &amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;&lt;br /&gt;
Then, insulin resistance provoque a drop of adiponectin secretion and circulation level, increase hyperinsulinemia and start a vicious cycle. &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;&lt;br /&gt;
Insulin resistance can be caused by any defects in the insulin signaling cascade included problems with AdipoR1.&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Obesity and insulin resistance also lead to [http://en.wikipedia.org/wiki/Metabolic_syndrome metabolic syndrome]. But agonist of adiponectin receptor (AdipoR1) should be a new treatment strategie for metabolic syndrome or obesity-linked diseases. &amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 can display metabolic dysfunction, especially in case of the drop of its expression. &amp;lt;ref name=&amp;quot;doc5&amp;quot;/&amp;gt;&lt;br /&gt;
A treatment against type II diabete and insulin resistance could be AdipoR1 overexpression that improves insulin resistance and promotes glucose uptake in skeletal muscle in one hand, and attenuates weight gain and improves glucose metabolism models of metabolic dysfunction in macrophages.  &amp;lt;ref name=&amp;quot;doc5&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== 3D visualisation ==&lt;br /&gt;
Use of Jsmol and Jmol &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143995</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143995"/>
		<updated>2020-01-16T21:52:32Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The Adiponectin receptor 1&#039;&#039;&#039;==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Adiponectin receptor 1 (AdipoR1) structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
[[The Adiponectin receptor 1]] is one of the two receptors for the [http://en.wikipedia.org/wiki/Hormone hormone] called [http://en.wikipedia.org/wiki/Adiponectin adiponectin].&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
The function of adipoR1 is directly linked with the &#039;&#039;&#039;adiponectin&#039;&#039;&#039;. It is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in [http://en.wikipedia.org/wiki/Blood_plasma plasma]&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer as molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by [http://en.wikipedia.org/wiki/Adipocyte adipocytes] present in brown and white [http://en.wikipedia.org/wiki/Adipose_tissue adipose tissues] but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver.The adiponectin receptor 1 is a receptor sensitive in particular to the globular form&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Yamauchi, Toshimasa, Junji Kamon, Yusuke Ito, Atsushi Tsuchida, Takehiko Yokomizo, Shunbun Kita, Takuya Sugiyama, et al. « Cloning of adiponectin receptors that mediate antidiabetic metabolic effects ». Nature 423, nᵒ 6941 (1 juin 2003): 762‑69. https://doi.org/10.1038/nature01705.&amp;lt;/ref&amp;gt;. These properties of the adiponectin are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like glucose-6-phosphatase, [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in gluconeogenesis&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Capeau, Jacqueline. « The Story of Adiponectin and Its Receptors AdipoR1 and R2: To Follow ». Journal of Hepatology 47, nᵒ 5 (1 novembre 2007): 736‑38. https://doi.org/10.1016/j.jhep.2007.06.002.&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
The &#039;&#039;&#039;Adiponectin receptor&#039;&#039;&#039; 1 is an [http://en.wikipedia.org/wiki/Integral_membrane_protein integral membrane protein] composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». 2015 https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc5&amp;quot;&amp;gt; Parker-Duffen JL, Nakamura K, Silver M, Zuriaga MA, MacLauchlan S, Aprahamian TR, Walsh K et al.  «Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.» 17 April 2014 : https://www.ncbi.nlm.nih.gov/pubmed/24742672&amp;lt;/ref&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three extracellular loops and three intracellular loops. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three extracellular loops which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity located from the cytoplasmic surface to the middle of the outer lipid layer of the membrane has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the helix II, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 has the capacity to form [http://en.wikipedia.org/wiki/Oligomer oligomers]. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 (2010) : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
AdipoR1 is involved in different diseases and symptoms. One major diseases linked with this proteine is the [http://en.wikipedia.org/wiki/Type_2_diabetes Type II diabete] which is caracterized by a chronic hyperglycemia. This disease is mainly present in obese or overweight people. In case of type II diabete, adiponectin level in plasma reduce signficantly and the expression of the adiponectin receptors,AdipoR1, decreases especially in [http://en.wikipedia.org/wiki/Skeletal_muscle skeletal muscle] and [http://en.wikipedia.org/wiki/Adipose_tissue adipose tissues] .&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
An [http://en.wikipedia.org/wiki/Insulin_resistance insulin resistant] organism means that the organism will require more insulin to obtain the biological effects of a normal organism.&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;From [http://en.wikipedia.org/wiki/Hyperglycemia hyperglycemia] and [http://en.wikipedia.org/wiki/Hyperinsulinemia hyperinsulinemia] is probably led insulin resistance.&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt; The adiponectin levels and the expression of AdipoR1 (and AdipoR2) drop, thereby reduce adiponectin sensitivity and lead to insulin resistance. &amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;&lt;br /&gt;
Then, insulin resistance provoque a drop of adiponectin secretion and circulation level, increase hyperinsulinemia and start a vicious cycle. &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;&lt;br /&gt;
Insulin resistance can be caused by any defects in the insulin signaling cascade included problems with AdipoR1.&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Obesity and insulin resistance also lead to [http://en.wikipedia.org/wiki/Metabolic_syndrome metabolic syndrome]. But agonist of adiponectin receptor (AdipoR1) should be a new treatment strategie for metabolic syndrome or obesity-linked diseases. &amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 can display metabolic dysfunction, especially in case of the drop of its expression. &amp;lt;ref name=&amp;quot;doc5&amp;quot;/&amp;gt;&lt;br /&gt;
A treatment against type II diabete and insulin resistance could be AdipoR1 overexpression that improves insulin resistance and promotes glucose uptake in skeletal muscle in one hand, and attenuates weight gain and improves glucose metabolism models of metabolic dysfunction in macrophages.  &amp;lt;ref name=&amp;quot;doc5&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== 3D visualisation ==&lt;br /&gt;
Use of Jsmol and Jmol &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143992</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143992"/>
		<updated>2020-01-16T21:46:37Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The Adiponectin receptor 1&#039;&#039;&#039;==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Adiponectin receptor 1 (AdipoR1) structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
[[The Adiponectin receptor 1]] is one of the two receptors for the [http://en.wikipedia.org/wiki/Hormone hormone] called [http://en.wikipedia.org/wiki/Adiponectin adiponectin].&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
The function of adipoR1 is directly linked with the &#039;&#039;&#039;adiponectin&#039;&#039;&#039;. It is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in [http://en.wikipedia.org/wiki/Blood_plasma plasma]&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer as molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by [http://en.wikipedia.org/wiki/Adipocyte adipocytes] present in brown and white [http://en.wikipedia.org/wiki/Adipose_tissue adipose tissues] but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver.The adiponectin receptor 1 is a receptor sensitive in particular to the globular form&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Yamauchi, Toshimasa, Junji Kamon, Yusuke Ito, Atsushi Tsuchida, Takehiko Yokomizo, Shunbun Kita, Takuya Sugiyama, et al. « Cloning of adiponectin receptors that mediate antidiabetic metabolic effects ». Nature 423, nᵒ 6941 (1 juin 2003): 762‑69. https://doi.org/10.1038/nature01705.&amp;lt;/ref&amp;gt;. These properties of the adiponectin are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like glucose-6-phosphatase, [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in gluconeogenesis&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Capeau, Jacqueline. « The Story of Adiponectin and Its Receptors AdipoR1 and R2: To Follow ». Journal of Hepatology 47, nᵒ 5 (1 novembre 2007): 736‑38. https://doi.org/10.1016/j.jhep.2007.06.002.&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
The &#039;&#039;&#039;Adiponectin receptor&#039;&#039;&#039; 1 is an [http://en.wikipedia.org/wiki/Integral_membrane_protein integral membrane protein] composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». 2015 https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc5&amp;quot;&amp;gt; Parker-Duffen JL, Nakamura K, Silver M, Zuriaga MA, MacLauchlan S, Aprahamian TR, Walsh K et al.  «Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.» 17 April 2014 : https://www.ncbi.nlm.nih.gov/pubmed/24742672&amp;lt;/ref&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three extracellular loops and three intracellular loops. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three extracellular loops which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity located from the cytoplasmic surface to the middle of the outer lipid layer of the membrane has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the helix II, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 has the capacity to form [http://en.wikipedia.org/wiki/Oligomer oligomers]. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 (2010) : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
AdipoR1 is involved in different diseases and symptom. One major diseases linked with this proteine is the Type 2 diabetes. [http://en.wikipedia.org/wiki/Type_2_diabetes Type II diabete] is caracterized by a chronic hyperglycemia and this disease is the most of the time found in obese or overweight people most. In case of type 2 diabete, adiponectin level in plasma signficantly reduced signficantly and the expression adiponectin receptors AdipoR1 (and AdipoR2) decreases in [http://en.wikipedia.org/wiki/Skeletal_muscle skeletal muscle] and [http://en.wikipedia.org/wiki/Adipose_tissue adipose tissues] especially.&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
An [http://en.wikipedia.org/wiki/Insulin_resistance insulin resistant] organism means that the organism will require more insulin to obtain the biological effects of a normal organism.&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;From [http://en.wikipedia.org/wiki/Hyperglycemia hyperglycemia] and [http://en.wikipedia.org/wiki/Hyperinsulinemia hyperinsulinemia] is probably led insulin resistance.&amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt; The adiponectin levels and the expression of AdipoR1 (and AdipoR2) drop, thereby reduce adiponectin sensitivity and lead to insulin resistance. &amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;&lt;br /&gt;
Then, insulin resistance provoque a drop of adiponectin secretion and circulation level, increase hyperinsulinemia and start a vicious cycle. &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;&lt;br /&gt;
Insulin resistance can be caused by any defects in the insulin signaling cascade included problems with AdipoR1.&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Obesity and insulin resistance also lead to [http://en.wikipedia.org/wiki/Metabolic_syndrome metabolic syndrome]. But agonist of adiponectin receptor (AdipoR1) should be a new treatment strategie for metabolic syndrome or obesity-linked diseases. &amp;lt;ref name=&amp;quot;doc3&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 can display metabolic dysfunction, especially in case of the drop of its expression. &amp;lt;ref name=&amp;quot;doc5&amp;quot;/&amp;gt;&lt;br /&gt;
A treatment against type II diabete and insulin resistance could be AdipoR1 overexpression that improves insulin resistance and promotes glucose uptake in skeletal muscle in one hand, and attenuates weight gain and improves glucose metabolism models of metabolic dysfunction in macrophages.  &amp;lt;ref name=&amp;quot;doc5&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== 3D visualisation ==&lt;br /&gt;
Use of Jsmol and Jmol &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143571</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143571"/>
		<updated>2020-01-15T21:15:17Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The Adiponectin receptor 1&#039;&#039;&#039;==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Adiponectin receptor 1 (AdipoR1) structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
[[The Adiponectin receptor 1]] is one of the two receptors for the hormone called adiponectin.&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
The function of adipoR1 is directly linked with the &#039;&#039;&#039;adiponectin&#039;&#039;&#039;. It is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in plasma&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer as molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by adipocytes present in brown and white adipose tissues but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver.The adiponectin receptor 1 is a receptor sensitive in particular to the globular form&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Yamauchi, Toshimasa, Junji Kamon, Yusuke Ito, Atsushi Tsuchida, Takehiko Yokomizo, Shunbun Kita, Takuya Sugiyama, et al. « Cloning of adiponectin receptors that mediate antidiabetic metabolic effects ». Nature 423, nᵒ 6941 (1 juin 2003): 762‑69. https://doi.org/10.1038/nature01705.&amp;lt;/ref&amp;gt;. These properties of the adiponectin are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like glucose-6-phosphatase, [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in gluconeogenesis&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Capeau, Jacqueline. « The Story of Adiponectin and Its Receptors AdipoR1 and R2: To Follow ». Journal of Hepatology 47, nᵒ 5 (1 novembre 2007): 736‑38. https://doi.org/10.1016/j.jhep.2007.06.002.&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
The &#039;&#039;&#039;Adiponectin receptor&#039;&#039;&#039; 1 is an integral membrane protein composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». 2015 https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc5&amp;quot;&amp;gt; Parker-Duffen JL, Nakamura K, Silver M, Zuriaga MA, MacLauchlan S, Aprahamian TR, Walsh K et al.  «Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.» 17 April 2014 : https://www.ncbi.nlm.nih.gov/pubmed/24742672&amp;lt;/ref&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three extracellular loops and three intracellular loops. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three extracellular loops which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity located from the cytoplasmic surface to the middle of the outer lipid layer of the membrane has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the helix II, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 has the capacity to form oligomers. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 (2010) : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== 3D visualisation ==&lt;br /&gt;
Use of Jsmol and Jmol &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143570</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143570"/>
		<updated>2020-01-15T21:14:46Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The Adiponectin receptor 1&#039;&#039;&#039;==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Adiponectin receptor 1 (AdipoR1) structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
[[The Adiponectin receptor 1]] is one of the two receptors for the hormone called adiponectin.&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
The function of adipoR1 is directly linked with the &#039;&#039;&#039;adiponectin&#039;&#039;&#039;. It is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in plasma&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer as molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by adipocytes present in brown and white adipose tissues but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver.The adiponectin receptor 1 is a receptor sensitive in particular to the globular form&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Yamauchi, Toshimasa, Junji Kamon, Yusuke Ito, Atsushi Tsuchida, Takehiko Yokomizo, Shunbun Kita, Takuya Sugiyama, et al. « Cloning of adiponectin receptors that mediate antidiabetic metabolic effects ». Nature 423, nᵒ 6941 (1 juin 2003): 762‑69. https://doi.org/10.1038/nature01705.&amp;lt;/ref&amp;gt;. These properties of the adiponectin are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like glucose-6-phosphatase, [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in gluconeogenesis&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Capeau, Jacqueline. « The Story of Adiponectin and Its Receptors AdipoR1 and R2: To Follow ». Journal of Hepatology 47, nᵒ 5 (1 novembre 2007): 736‑38. https://doi.org/10.1016/j.jhep.2007.06.002.&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
The &#039;&#039;&#039;Adiponectin receptor&#039;&#039;&#039; 1 is an integral membrane protein composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». 2015 https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc5&amp;quot;&amp;gt; Parker-Duffen JL, Nakamura K, Silver M, Zuriaga MA, MacLauchlan S, Aprahamian TR, Walsh K et al.  «Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.» 17 April 2014 : https://www.ncbi.nlm.nih.gov/pubmed/24742672&amp;lt;/ref&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three extracellular loops and three intracellular loops. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three extracellular loops which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity located from the cytoplasmic surface to the middle of the outer lipid layer of the membrane has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the helix II, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 has the capacity to form oligomers. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 (2010) : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== 3D visualisation ==&lt;br /&gt;
Use of Jsmol and Jmol &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143569</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143569"/>
		<updated>2020-01-15T21:12:20Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The Adiponectin receptor 1&#039;&#039;&#039;==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Adiponectin receptor 1 (AdipoR1) structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
[[The Adiponectin receptor 1]] is one of the two receptors for the hormone called adiponectin.&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
The function of adipoR1 is directly linked with the &#039;&#039;&#039;adiponectin&#039;&#039;&#039;. It is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in plasma&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer as molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by adipocytes present in brown and white adipose tissues but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver.The adiponectin receptor 1 is a receptor sensitive in particular to the globular form&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Yamauchi, Toshimasa, Junji Kamon, Yusuke Ito, Atsushi Tsuchida, Takehiko Yokomizo, Shunbun Kita, Takuya Sugiyama, et al. « Cloning of adiponectin receptors that mediate antidiabetic metabolic effects ». Nature 423, nᵒ 6941 (1 juin 2003): 762‑69. https://doi.org/10.1038/nature01705.&amp;lt;/ref&amp;gt;. These properties of the adiponectin are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like glucose-6-phosphatase, [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in gluconeogenesis&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Capeau, Jacqueline. « The Story of Adiponectin and Its Receptors AdipoR1 and R2: To Follow ». Journal of Hepatology 47, nᵒ 5 (1 novembre 2007): 736‑38. https://doi.org/10.1016/j.jhep.2007.06.002.&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
The &#039;&#039;&#039;Adiponectin receptor&#039;&#039;&#039; 1 is an integral membrane protein composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». 2015 https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc5&amp;quot;&amp;gt; Parker-Duffen JL, Nakamura K, Silver M, Zuriaga MA, MacLauchlan S, Aprahamian TR, Walsh K et al.  «Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.» 17 April 2014 : https://www.ncbi.nlm.nih.gov/pubmed/24742672&amp;lt;/ref&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three extracellular loops and three intracellular loops. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three extracellular loops which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity located from the cytoplasmic surface to the middle of the outer lipid layer of the membrane has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the helix II, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 has the capacity to form oligomers. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 (2010) : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== 3D visualisation ==&lt;br /&gt;
Use of Jsmol and Jmol &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143568</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143568"/>
		<updated>2020-01-15T21:11:11Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The Adiponectin receptor 1&#039;&#039;&#039;==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Adiponectin receptor 1 (AdipoR1) structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
[[The Adiponectin receptor 1]] is one of the two receptors for the hormone called adiponectin.&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
The function of adipoR1 is directly linked with the &#039;&#039;&#039;adiponectin&#039;&#039;&#039;. It is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in plasma&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer as molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by adipocytes present in brown and white adipose tissues but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver.The adiponectin receptor 1 is a receptor sensitive in particular to the globular form&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Yamauchi, Toshimasa, Junji Kamon, Yusuke Ito, Atsushi Tsuchida, Takehiko Yokomizo, Shunbun Kita, Takuya Sugiyama, et al. « Cloning of adiponectin receptors that mediate antidiabetic metabolic effects ». Nature 423, nᵒ 6941 (1 juin 2003): 762‑69. https://doi.org/10.1038/nature01705.&amp;lt;/ref&amp;gt;. These properties of the adiponectin are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like glucose-6-phosphatase, [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in gluconeogenesis&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Capeau, Jacqueline. « The Story of Adiponectin and Its Receptors AdipoR1 and R2: To Follow ». Journal of Hepatology 47, nᵒ 5 (1 novembre 2007): 736‑38. https://doi.org/10.1016/j.jhep.2007.06.002.&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
The &#039;&#039;&#039;Adiponectin receptor&#039;&#039;&#039; 1 is an integral membrane protein composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». 2015 https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc5&amp;quot;&amp;gt; Parker-Duffen JL, Nakamura K, Silver M, Zuriaga MA, MacLauchlan S, Aprahamian TR, Walsh K et al.  «Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.» 17 April 2014 : https://www.ncbi.nlm.nih.gov/pubmed/24742672&amp;lt;/ref&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three extracellular loops and three intracellular loops. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three extracellular loops which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity located from the cytoplasmic surface to the middle of the outer lipid layer of the membrane has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the helix II, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 has the capacity to form oligomers. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 (2010) : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== 3D visualisation ==&lt;br /&gt;
Use of Jsmol and Jmol &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143567</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143567"/>
		<updated>2020-01-15T21:10:41Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The Adiponectin receptor 1&#039;&#039;&#039;==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Adiponectin receptor 1 (AdipoR1) structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
[[The Adiponectin receptor 1]] is one of the two receptors for the hormone called adiponectin.&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
The function of adipoR1 is directly linked with the &#039;&#039;&#039;adiponectin&#039;&#039;&#039;. It is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in plasma&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer as molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by adipocytes present in brown and white adipose tissues but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver.The adiponectin receptor 1 is a receptor sensitive in particular to the globular form&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Yamauchi, Toshimasa, Junji Kamon, Yusuke Ito, Atsushi Tsuchida, Takehiko Yokomizo, Shunbun Kita, Takuya Sugiyama, et al. « Cloning of adiponectin receptors that mediate antidiabetic metabolic effects ». Nature 423, nᵒ 6941 (1 juin 2003): 762‑69. https://doi.org/10.1038/nature01705.&amp;lt;/ref&amp;gt;. These properties of the adiponectin are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like glucose-6-phosphatase, [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in gluconeogenesis&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Capeau, Jacqueline. « The Story of Adiponectin and Its Receptors AdipoR1 and R2: To Follow ». Journal of Hepatology 47, nᵒ 5 (1 novembre 2007): 736‑38. https://doi.org/10.1016/j.jhep.2007.06.002.&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
&lt;br /&gt;
The &#039;&#039;&#039;Adiponectin receptor&#039;&#039;&#039; 1 is an integral membrane protein composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». 2015 https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc5&amp;quot;&amp;gt; Parker-Duffen JL, Nakamura K, Silver M, Zuriaga MA, MacLauchlan S, Aprahamian TR, Walsh K et al.  «Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.» 17 April 2014 : https://www.ncbi.nlm.nih.gov/pubmed/24742672&amp;lt;/ref&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three extracellular loops and three intracellular loops. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three extracellular loops which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity located from the cytoplasmic surface to the middle of the outer lipid layer of the membrane has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the helix II, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 has the capacity to form oligomers. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 (2010) : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== 3D visualisation ==&lt;br /&gt;
Use of Jsmol and Jmol &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143566</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143566"/>
		<updated>2020-01-15T21:09:53Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The Adiponectin receptor 1&#039;&#039;&#039;==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Adiponectin receptor 1 (AdipoR1) structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
[[The Adiponectin receptor 1]] is one of the two receptors for the hormone called adiponectin.&lt;br /&gt;
&lt;br /&gt;
== FUNCTION ==&lt;br /&gt;
The function of adipoR1 is directly linked with the &#039;&#039;&#039;adiponectin&#039;&#039;&#039;. It is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in plasma&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer as molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by adipocytes present in brown and white adipose tissues but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver.The adiponectin receptor 1 is a receptor sensitive in particular to the globular form&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Yamauchi, Toshimasa, Junji Kamon, Yusuke Ito, Atsushi Tsuchida, Takehiko Yokomizo, Shunbun Kita, Takuya Sugiyama, et al. « Cloning of adiponectin receptors that mediate antidiabetic metabolic effects ». Nature 423, nᵒ 6941 (1 juin 2003): 762‑69. https://doi.org/10.1038/nature01705.&amp;lt;/ref&amp;gt;. These properties of the adiponectin are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like glucose-6-phosphatase, [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in gluconeogenesis&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Capeau, Jacqueline. « The Story of Adiponectin and Its Receptors AdipoR1 and R2: To Follow ». Journal of Hepatology 47, nᵒ 5 (1 novembre 2007): 736‑38. https://doi.org/10.1016/j.jhep.2007.06.002.&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== STRUCTURE ==&lt;br /&gt;
&lt;br /&gt;
The &#039;&#039;&#039;Adiponectin receptor&#039;&#039;&#039; 1 is an integral membrane protein composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». 2015 https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc5&amp;quot;&amp;gt; Parker-Duffen JL, Nakamura K, Silver M, Zuriaga MA, MacLauchlan S, Aprahamian TR, Walsh K et al.  «Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.» 17 April 2014 : https://www.ncbi.nlm.nih.gov/pubmed/24742672&amp;lt;/ref&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three extracellular loops and three intracellular loops. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three extracellular loops which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity located from the cytoplasmic surface to the middle of the outer lipid layer of the membrane has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the helix II, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 has the capacity to form oligomers. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 (2010) : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== 3D visualisation ==&lt;br /&gt;
Use of Jsmol and Jmol &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143565</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143565"/>
		<updated>2020-01-15T21:08:48Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The Adiponectin receptor 1&#039;&#039;&#039;==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Adiponectin receptor 1 (AdipoR1) structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
[[The Adiponectin receptor 1]] is one of the two receptors for the hormone called adiponectin.&lt;br /&gt;
&lt;br /&gt;
== FUNCTION ==&lt;br /&gt;
The function of adipoR1 is directly linked with the &#039;&#039;&#039;adiponectin&#039;&#039;&#039;. It is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in plasma&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer as molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by adipocytes present in brown and white adipose tissues but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver.The adiponectin receptor 1 is a receptor sensitive in particular to the globular form&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Yamauchi, Toshimasa, Junji Kamon, Yusuke Ito, Atsushi Tsuchida, Takehiko Yokomizo, Shunbun Kita, Takuya Sugiyama, et al. « Cloning of adiponectin receptors that mediate antidiabetic metabolic effects ». Nature 423, nᵒ 6941 (1 juin 2003): 762‑69. https://doi.org/10.1038/nature01705.&amp;lt;/ref&amp;gt;. These properties of the adiponectin are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like glucose-6-phosphatase, [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in gluconeogenesis&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Capeau, Jacqueline. « The Story of Adiponectin and Its Receptors AdipoR1 and R2: To Follow ». Journal of Hepatology 47, nᵒ 5 (1 novembre 2007): 736‑38. https://doi.org/10.1016/j.jhep.2007.06.002.&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== STRUCTURE ==&lt;br /&gt;
&lt;br /&gt;
The &#039;&#039;&#039;Adiponectin receptor&#039;&#039;&#039; 1 is an integral membrane protein composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». 2015 https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc5&amp;quot;&amp;gt; Parker-Duffen JL, Nakamura K, Silver M, Zuriaga MA, MacLauchlan S, Aprahamian TR, Walsh K et al.  «Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.» 17 April 2014 : https://www.ncbi.nlm.nih.gov/pubmed/24742672&amp;lt;/ref&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three extracellular loops and three intracellular loops. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three extracellular loops which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity located from the cytoplasmic surface to the middle of the outer lipid layer of the membrane has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the helix II, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 has the capacity to form oligomers. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 (2010) : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== 3D visualisation ==&lt;br /&gt;
Use of Jsmol and Jmol &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143564</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143564"/>
		<updated>2020-01-15T21:08:16Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The Adiponectin receptor 1&#039;&#039;&#039;==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Adiponectin receptor 1 (AdipoR1) structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
[[The Adiponectin receptor 1]] is one of the two receptors for the hormone called adiponectin.&lt;br /&gt;
&lt;br /&gt;
== FUNCTION ==&lt;br /&gt;
The function of adipoR1 is directly linked with the &#039;&#039;&#039;adiponectin&#039;&#039;&#039;. It is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in plasma&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer as molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by adipocytes present in brown and white adipose tissues but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver.The adiponectin receptor 1 is a receptor sensitive in particular to the globular form&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Yamauchi, Toshimasa, Junji Kamon, Yusuke Ito, Atsushi Tsuchida, Takehiko Yokomizo, Shunbun Kita, Takuya Sugiyama, et al. « Cloning of adiponectin receptors that mediate antidiabetic metabolic effects ». Nature 423, nᵒ 6941 (1 juin 2003): 762‑69. https://doi.org/10.1038/nature01705.&amp;lt;/ref&amp;gt;. These properties of the adiponectin are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like glucose-6-phosphatase, [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in gluconeogenesis&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Capeau, Jacqueline. « The Story of Adiponectin and Its Receptors AdipoR1 and R2: To Follow ». Journal of Hepatology 47, nᵒ 5 (1 novembre 2007): 736‑38. https://doi.org/10.1016/j.jhep.2007.06.002.&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== STRUCTURE ==&lt;br /&gt;
&lt;br /&gt;
The &#039;&#039;&#039;Adiponectin receptor&#039;&#039;&#039; 1 is an integral membrane protein composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». 2015 https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc5&amp;quot;&amp;gt; Parker-Duffen JL, Nakamura K, Silver M, Zuriaga MA, MacLauchlan S, Aprahamian TR, Walsh K et al.  «Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.» 17 April 2014 : https://www.ncbi.nlm.nih.gov/pubmed/24742672&amp;lt;/ref&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three extracellular loops and three intracellular loops. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three extracellular loops which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity located from the cytoplasmic surface to the middle of the outer lipid layer of the membrane has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the helix II, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 has the capacity to form oligomers. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 (2010) : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== 3D visualisation ==&lt;br /&gt;
Use of Jsmol and Jmol &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143563</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143563"/>
		<updated>2020-01-15T21:07:37Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The Adiponectin receptor 1&#039;&#039;&#039;==&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Adiponectin receptor 1 (AdipoR1) structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
[[The Adiponectin receptor 1]] is one of the two receptors for the hormone called adiponectin.&lt;br /&gt;
&lt;br /&gt;
== FUNCTION ==&lt;br /&gt;
The function of adipoR1 is directly linked with the &#039;&#039;&#039;adiponectin&#039;&#039;&#039;. It is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in plasma&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer as molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by adipocytes present in brown and white adipose tissues but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver.The adiponectin receptor 1 is a receptor sensitive in particular to the globular form&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Yamauchi, Toshimasa, Junji Kamon, Yusuke Ito, Atsushi Tsuchida, Takehiko Yokomizo, Shunbun Kita, Takuya Sugiyama, et al. « Cloning of adiponectin receptors that mediate antidiabetic metabolic effects ». Nature 423, nᵒ 6941 (1 juin 2003): 762‑69. https://doi.org/10.1038/nature01705.&amp;lt;/ref&amp;gt;. These properties of the adiponectin are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like glucose-6-phosphatase, [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in gluconeogenesis&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Capeau, Jacqueline. « The Story of Adiponectin and Its Receptors AdipoR1 and R2: To Follow ». Journal of Hepatology 47, nᵒ 5 (1 novembre 2007): 736‑38. https://doi.org/10.1016/j.jhep.2007.06.002.&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== STRUCTURE ==&lt;br /&gt;
&lt;br /&gt;
The &#039;&#039;&#039;Adiponectin receptor&#039;&#039;&#039; 1 is an integral membrane protein composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». 2015 https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc5&amp;quot;&amp;gt; Parker-Duffen JL, Nakamura K, Silver M, Zuriaga MA, MacLauchlan S, Aprahamian TR, Walsh K et al.  «Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.» 17 April 2014 : https://www.ncbi.nlm.nih.gov/pubmed/24742672&amp;lt;/ref&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three extracellular loops and three intracellular loops. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three extracellular loops which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity located from the cytoplasmic surface to the middle of the outer lipid layer of the membrane has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the helix II, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 has the capacity to form oligomers. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 (2010) : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== 3D visualisation ==&lt;br /&gt;
Use of Jsmol and Jmol &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143562</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143562"/>
		<updated>2020-01-15T21:06:35Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The Adiponectin receptor 1&#039;&#039;&#039;==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Adiponectin receptor 1 (AdipoR1) structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
[[The Adiponectin receptor 1]] is one of the two receptors for the hormone called adiponectin.&lt;br /&gt;
&lt;br /&gt;
== FUNCTION ==&lt;br /&gt;
The function of adipoR1 is directly linked with the &#039;&#039;&#039;adiponectin&#039;&#039;&#039;. It is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in plasma&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer as molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by adipocytes present in brown and white adipose tissues but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver.The adiponectin receptor 1 is a receptor sensitive in particular to the globular form&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Yamauchi, Toshimasa, Junji Kamon, Yusuke Ito, Atsushi Tsuchida, Takehiko Yokomizo, Shunbun Kita, Takuya Sugiyama, et al. « Cloning of adiponectin receptors that mediate antidiabetic metabolic effects ». Nature 423, nᵒ 6941 (1 juin 2003): 762‑69. https://doi.org/10.1038/nature01705.&amp;lt;/ref&amp;gt;. These properties of the adiponectin are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like glucose-6-phosphatase, [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in gluconeogenesis&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Capeau, Jacqueline. « The Story of Adiponectin and Its Receptors AdipoR1 and R2: To Follow ». Journal of Hepatology 47, nᵒ 5 (1 novembre 2007): 736‑38. https://doi.org/10.1016/j.jhep.2007.06.002.&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== STRUCTURE ==&lt;br /&gt;
&lt;br /&gt;
The &#039;&#039;&#039;Adiponectin receptor&#039;&#039;&#039; 1 is an integral membrane protein composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». 2015 https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc5&amp;quot;&amp;gt; Parker-Duffen JL, Nakamura K, Silver M, Zuriaga MA, MacLauchlan S, Aprahamian TR, Walsh K et al.  «Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.» 17 April 2014 : https://www.ncbi.nlm.nih.gov/pubmed/24742672&amp;lt;/ref&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three extracellular loops and three intracellular loops. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three extracellular loops which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity located from the cytoplasmic surface to the middle of the outer lipid layer of the membrane has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the helix II, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 has the capacity to form oligomers. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 (2010) : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== 3D visualisation ==&lt;br /&gt;
Use of Jsmol and Jmol &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143561</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143561"/>
		<updated>2020-01-15T21:05:38Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The Adiponectin receptor 1&#039;&#039;&#039;==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Adiponectin receptor 1 (AdipoR1) structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
[[The Adiponectin receptor 1]] is one of the two receptors for the hormone called adiponectin.&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== FUNCTION ==&lt;br /&gt;
The function of adipoR1 is directly linked with the &#039;&#039;&#039;adiponectin&#039;&#039;&#039;. It is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in plasma&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer as molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by adipocytes present in brown and white adipose tissues but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver.The adiponectin receptor 1 is a receptor sensitive in particular to the globular form&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Yamauchi, Toshimasa, Junji Kamon, Yusuke Ito, Atsushi Tsuchida, Takehiko Yokomizo, Shunbun Kita, Takuya Sugiyama, et al. « Cloning of adiponectin receptors that mediate antidiabetic metabolic effects ». Nature 423, nᵒ 6941 (1 juin 2003): 762‑69. https://doi.org/10.1038/nature01705.&amp;lt;/ref&amp;gt;. These properties of the adiponectin are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like glucose-6-phosphatase, [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in gluconeogenesis&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Capeau, Jacqueline. « The Story of Adiponectin and Its Receptors AdipoR1 and R2: To Follow ». Journal of Hepatology 47, nᵒ 5 (1 novembre 2007): 736‑38. https://doi.org/10.1016/j.jhep.2007.06.002.&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== STRUCTURE ==&lt;br /&gt;
&lt;br /&gt;
The &#039;&#039;&#039;Adiponectin receptor&#039;&#039;&#039; 1 is an integral membrane protein composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». 2015 https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc5&amp;quot;&amp;gt; Parker-Duffen JL, Nakamura K, Silver M, Zuriaga MA, MacLauchlan S, Aprahamian TR, Walsh K et al.  «Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.» 17 April 2014 : https://www.ncbi.nlm.nih.gov/pubmed/24742672&amp;lt;/ref&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three extracellular loops and three intracellular loops. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three extracellular loops which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity located from the cytoplasmic surface to the middle of the outer lipid layer of the membrane has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the helix II, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 has the capacity to form oligomers. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 (2010) : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== 3D visualisation ==&lt;br /&gt;
Use of Jsmol and Jmol &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143560</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143560"/>
		<updated>2020-01-15T21:04:24Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The Adiponectin receptor 1&#039;&#039;&#039;==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Adiponectin receptor 1 (AdipoR1) structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
[[The Adiponectin receptor 1]] is one of the two receptors for the hormone called adiponectin.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== FUNCTION ==&lt;br /&gt;
The function of adipoR1 is directly linked with the &#039;&#039;&#039;adiponectin&#039;&#039;&#039;. It is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in plasma&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer as molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by adipocytes present in brown and white adipose tissues but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver.The adiponectin receptor 1 is a receptor sensitive in particular to the globular form&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Yamauchi, Toshimasa, Junji Kamon, Yusuke Ito, Atsushi Tsuchida, Takehiko Yokomizo, Shunbun Kita, Takuya Sugiyama, et al. « Cloning of adiponectin receptors that mediate antidiabetic metabolic effects ». Nature 423, nᵒ 6941 (1 juin 2003): 762‑69. https://doi.org/10.1038/nature01705.&amp;lt;/ref&amp;gt;. These properties of the adiponectin are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like glucose-6-phosphatase, [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in gluconeogenesis&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Capeau, Jacqueline. « The Story of Adiponectin and Its Receptors AdipoR1 and R2: To Follow ». Journal of Hepatology 47, nᵒ 5 (1 novembre 2007): 736‑38. https://doi.org/10.1016/j.jhep.2007.06.002.&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== STRUCTURE ==&lt;br /&gt;
&lt;br /&gt;
The &#039;&#039;&#039;Adiponectin receptor&#039;&#039;&#039; 1 is an integral membrane protein composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». 2015 https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc5&amp;quot;&amp;gt; Parker-Duffen JL, Nakamura K, Silver M, Zuriaga MA, MacLauchlan S, Aprahamian TR, Walsh K et al.  «Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.» 17 April 2014 : https://www.ncbi.nlm.nih.gov/pubmed/24742672&amp;lt;/ref&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three extracellular loops and three intracellular loops. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three extracellular loops which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity located from the cytoplasmic surface to the middle of the outer lipid layer of the membrane has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the helix II, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 has the capacity to form oligomers. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 (2010) : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== 3D visualisation ==&lt;br /&gt;
Use of Jsmol and Jmol &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143559</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143559"/>
		<updated>2020-01-15T21:03:26Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The Adiponectin receptor 1&#039;&#039;&#039;==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Adiponectin receptor 1 (AdipoR1) structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
[[The Adiponectin receptor 1]] is one of the two receptors for the hormone called adiponectin.&lt;br /&gt;
&lt;br /&gt;
== FUNCTION ==&lt;br /&gt;
The function of adipoR1 is directly linked with the &#039;&#039;&#039;adiponectin&#039;&#039;&#039;. It is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in plasma&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer as molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by adipocytes present in brown and white adipose tissues but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver.The adiponectin receptor 1 is a receptor sensitive in particular to the globular form&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Yamauchi, Toshimasa, Junji Kamon, Yusuke Ito, Atsushi Tsuchida, Takehiko Yokomizo, Shunbun Kita, Takuya Sugiyama, et al. « Cloning of adiponectin receptors that mediate antidiabetic metabolic effects ». Nature 423, nᵒ 6941 (1 juin 2003): 762‑69. https://doi.org/10.1038/nature01705.&amp;lt;/ref&amp;gt;. These properties of the adiponectin are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like glucose-6-phosphatase, [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in gluconeogenesis&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Capeau, Jacqueline. « The Story of Adiponectin and Its Receptors AdipoR1 and R2: To Follow ». Journal of Hepatology 47, nᵒ 5 (1 novembre 2007): 736‑38. https://doi.org/10.1016/j.jhep.2007.06.002.&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== STRUCTURE ==&lt;br /&gt;
&lt;br /&gt;
The &#039;&#039;&#039;Adiponectin receptor&#039;&#039;&#039; 1 is an integral membrane protein composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». 2015 https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc5&amp;quot;&amp;gt; Parker-Duffen JL, Nakamura K, Silver M, Zuriaga MA, MacLauchlan S, Aprahamian TR, Walsh K et al.  «Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.» 17 April 2014 : https://www.ncbi.nlm.nih.gov/pubmed/24742672&amp;lt;/ref&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three extracellular loops and three intracellular loops. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three extracellular loops which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity located from the cytoplasmic surface to the middle of the outer lipid layer of the membrane has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the helix II, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 has the capacity to form oligomers. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 (2010) : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
This is a sample scene created with SAT to &amp;lt;scene name=&amp;quot;/12/3456/Sample/1&amp;quot;&amp;gt;color&amp;lt;/scene&amp;gt; by Group, and another to make &amp;lt;scene name=&amp;quot;/12/3456/Sample/2&amp;quot;&amp;gt;a transparent representation&amp;lt;/scene&amp;gt; of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== 3D visualisation ==&lt;br /&gt;
Use of Jsmol and Jmol &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143558</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143558"/>
		<updated>2020-01-15T20:59:09Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The Adiponectin receptor 1&#039;&#039;&#039;==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Adiponectin receptor 1 (AdipoR1) structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
[[The Adiponectin receptor 1]] is one of the two receptors for the hormone called adiponectin.&lt;br /&gt;
&lt;br /&gt;
== FUNCTION ==&lt;br /&gt;
The function of adipoR1 is directly linked with the &#039;&#039;&#039;adiponectin&#039;&#039;&#039;. It is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in plasma&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer as molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by adipocytes present in brown and white adipose tissues but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver.The adiponectin receptor 1 is a receptor sensitive in particular to the globular form&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Yamauchi, Toshimasa, Junji Kamon, Yusuke Ito, Atsushi Tsuchida, Takehiko Yokomizo, Shunbun Kita, Takuya Sugiyama, et al. « Cloning of adiponectin receptors that mediate antidiabetic metabolic effects ». Nature 423, nᵒ 6941 (1 juin 2003): 762‑69. https://doi.org/10.1038/nature01705.&amp;lt;/ref&amp;gt;. These properties of the adiponectin are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like glucose-6-phosphatase, [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in gluconeogenesis&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Capeau, Jacqueline. « The Story of Adiponectin and Its Receptors AdipoR1 and R2: To Follow ». Journal of Hepatology 47, nᵒ 5 (1 novembre 2007): 736‑38. https://doi.org/10.1016/j.jhep.2007.06.002.&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== STRUCTURE ==&lt;br /&gt;
&lt;br /&gt;
The &#039;&#039;&#039;Adiponectin receptor&#039;&#039;&#039; 1 is an integral membrane protein composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». 2015 https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc5&amp;quot;&amp;gt; Parker-Duffen JL, Nakamura K, Silver M, Zuriaga MA, MacLauchlan S, Aprahamian TR, Walsh K et al.  «Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.» 17 April 2014 : https://www.ncbi.nlm.nih.gov/pubmed/24742672&amp;lt;/ref&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three extracellular loops and three intracellular loops. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three extracellular loops which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity located from the cytoplasmic surface to the middle of the outer lipid layer of the membrane has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the helix II, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 has the capacity to form oligomers. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 (2010) : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== 3D visualisation ==&lt;br /&gt;
Use of Jsmol and Jmol &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143557</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143557"/>
		<updated>2020-01-15T20:58:12Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==Your Heading Here (maybe something like &#039;Structure&#039;)==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;1stp&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Caption for this structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
This is a default text for your page &#039;&#039;&#039;&#039;&#039;&#039;. Click above on &#039;&#039;&#039;edit this page&#039;&#039;&#039; to modify. Be careful with the &amp;amp;lt; and &amp;amp;gt; signs.&lt;br /&gt;
You may include any references to papers as in: the use of JSmol in Proteopedia &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt; or to the article describing Jmol &amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt; to the rescue.&lt;br /&gt;
{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The Adiponectin receptor 1&#039;&#039;&#039;==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Adiponectin receptor 1 (AdipoR1) structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
[[The Adiponectin receptor 1]] is one of the two receptors for the hormone called adiponectin.&lt;br /&gt;
&lt;br /&gt;
== FUNCTION ==&lt;br /&gt;
The function of adipoR1 is directly linked with the &#039;&#039;&#039;adiponectin&#039;&#039;&#039;. It is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in plasma&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer as molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by adipocytes present in brown and white adipose tissues but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver.The adiponectin receptor 1 is a receptor sensitive in particular to the globular form&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Yamauchi, Toshimasa, Junji Kamon, Yusuke Ito, Atsushi Tsuchida, Takehiko Yokomizo, Shunbun Kita, Takuya Sugiyama, et al. « Cloning of adiponectin receptors that mediate antidiabetic metabolic effects ». Nature 423, nᵒ 6941 (1 juin 2003): 762‑69. https://doi.org/10.1038/nature01705.&amp;lt;/ref&amp;gt;. These properties of the adiponectin are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like glucose-6-phosphatase, [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in gluconeogenesis&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Capeau, Jacqueline. « The Story of Adiponectin and Its Receptors AdipoR1 and R2: To Follow ». Journal of Hepatology 47, nᵒ 5 (1 novembre 2007): 736‑38. https://doi.org/10.1016/j.jhep.2007.06.002.&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== STRUCTURE ==&lt;br /&gt;
&lt;br /&gt;
The &#039;&#039;&#039;Adiponectin receptor&#039;&#039;&#039; 1 is an integral membrane protein composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». 2015 https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc5&amp;quot;&amp;gt; Parker-Duffen JL, Nakamura K, Silver M, Zuriaga MA, MacLauchlan S, Aprahamian TR, Walsh K et al.  «Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.» 17 April 2014 : https://www.ncbi.nlm.nih.gov/pubmed/24742672&amp;lt;/ref&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three extracellular loops and three intracellular loops. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three extracellular loops which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity located from the cytoplasmic surface to the middle of the outer lipid layer of the membrane has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the helix II, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 has the capacity to form oligomers. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 (2010) : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== 3D visualisation ==&lt;br /&gt;
Use of Jsmol and Jmol &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143554</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143554"/>
		<updated>2020-01-15T20:45:31Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The Adiponectin receptor 1&#039;&#039;&#039;==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Adiponectin receptor 1 (AdipoR1) structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
[[The Adiponectin receptor 1]] is one of the two receptors for the hormone called adiponectin.&lt;br /&gt;
&lt;br /&gt;
== FUNCTION ==&lt;br /&gt;
The function of adipoR1 is directly linked with the &#039;&#039;&#039;adiponectin&#039;&#039;&#039;. It is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in plasma&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer as molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by adipocytes present in brown and white adipose tissues but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver.The adiponectin receptor 1 is a receptor sensitive in particular to the globular form&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Yamauchi, Toshimasa, Junji Kamon, Yusuke Ito, Atsushi Tsuchida, Takehiko Yokomizo, Shunbun Kita, Takuya Sugiyama, et al. « Cloning of adiponectin receptors that mediate antidiabetic metabolic effects ». Nature 423, nᵒ 6941 (1 juin 2003): 762‑69. https://doi.org/10.1038/nature01705.&amp;lt;/ref&amp;gt;. These properties of the adiponectin are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like glucose-6-phosphatase, [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in gluconeogenesis&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Capeau, Jacqueline. « The Story of Adiponectin and Its Receptors AdipoR1 and R2: To Follow ». Journal of Hepatology 47, nᵒ 5 (1 novembre 2007): 736‑38. https://doi.org/10.1016/j.jhep.2007.06.002.&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== STRUCTURE ==&lt;br /&gt;
&lt;br /&gt;
The &#039;&#039;&#039;Adiponectin receptor&#039;&#039;&#039; 1 is an integral membrane protein composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». 2015 https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc5&amp;quot;&amp;gt; Parker-Duffen JL, Nakamura K, Silver M, Zuriaga MA, MacLauchlan S, Aprahamian TR, Walsh K et al.  «Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.» 17 April 2014 : https://www.ncbi.nlm.nih.gov/pubmed/24742672&amp;lt;/ref&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three extracellular loops and three intracellular loops. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three extracellular loops which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity located from the cytoplasmic surface to the middle of the outer lipid layer of the membrane has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the helix II, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 has the capacity to form oligomers. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 (2010) : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== 3D visualisation ==&lt;br /&gt;
Use of Jsmol and Jmol &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143553</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143553"/>
		<updated>2020-01-15T20:43:23Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The Adiponectin receptor 1&#039;&#039;&#039;==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Adiponectin receptor 1 (AdipoR1) structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[The Adiponectin receptor 1]] is one of the two receptors for the hormone called adiponectin.&lt;br /&gt;
&lt;br /&gt;
== FUNCTION ==&lt;br /&gt;
The function of adipoR1 is directly linked with the &#039;&#039;&#039;adiponectin&#039;&#039;&#039;. It is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in plasma&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer as molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by adipocytes present in brown and white adipose tissues but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver.The adiponectin receptor 1 is a receptor sensitive in particular to the globular form&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Yamauchi, Toshimasa, Junji Kamon, Yusuke Ito, Atsushi Tsuchida, Takehiko Yokomizo, Shunbun Kita, Takuya Sugiyama, et al. « Cloning of adiponectin receptors that mediate antidiabetic metabolic effects ». Nature 423, nᵒ 6941 (1 juin 2003): 762‑69. https://doi.org/10.1038/nature01705.&amp;lt;/ref&amp;gt;. These properties of the adiponectin are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like glucose-6-phosphatase, [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in gluconeogenesis&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Capeau, Jacqueline. « The Story of Adiponectin and Its Receptors AdipoR1 and R2: To Follow ». Journal of Hepatology 47, nᵒ 5 (1 novembre 2007): 736‑38. https://doi.org/10.1016/j.jhep.2007.06.002.&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== STRUCTURE ==&lt;br /&gt;
&lt;br /&gt;
The &#039;&#039;&#039;Adiponectin receptor&#039;&#039;&#039; 1 is an integral membrane protein composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». 2015 https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc5&amp;quot;&amp;gt; Parker-Duffen JL, Nakamura K, Silver M, Zuriaga MA, MacLauchlan S, Aprahamian TR, Walsh K et al.  «Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.» 17 April 2014 : https://www.ncbi.nlm.nih.gov/pubmed/24742672&amp;lt;/ref&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three extracellular loops and three intracellular loops. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three extracellular loops which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity located from the cytoplasmic surface to the middle of the outer lipid layer of the membrane has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the helix II, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 has the capacity to form oligomers. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 (2010) : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== 3D visualisation ==&lt;br /&gt;
Use of Jsmol and Jmol &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143550</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143550"/>
		<updated>2020-01-15T20:37:58Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The Adiponectin receptor 1&#039;&#039;&#039;==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Adiponectin receptor 1 (AdipoR1) structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt; &lt;br /&gt;
&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[The Adiponectin receptor 1]] is one of the two receptors for the hormone called adiponectin.&lt;br /&gt;
&lt;br /&gt;
== FUNCTION ==&lt;br /&gt;
The function of adipoR1 is directly linked with the &#039;&#039;&#039;adiponectin&#039;&#039;&#039;. It is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in plasma&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer as molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by adipocytes present in brown and white adipose tissues but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver.The adiponectin receptor 1 is a receptor sensitive in particular to the globular form&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Yamauchi, Toshimasa, Junji Kamon, Yusuke Ito, Atsushi Tsuchida, Takehiko Yokomizo, Shunbun Kita, Takuya Sugiyama, et al. « Cloning of adiponectin receptors that mediate antidiabetic metabolic effects ». Nature 423, nᵒ 6941 (1 juin 2003): 762‑69. https://doi.org/10.1038/nature01705.&amp;lt;/ref&amp;gt;. These properties of the adiponectin are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like glucose-6-phosphatase, [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in gluconeogenesis&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Capeau, Jacqueline. « The Story of Adiponectin and Its Receptors AdipoR1 and R2: To Follow ». Journal of Hepatology 47, nᵒ 5 (1 novembre 2007): 736‑38. https://doi.org/10.1016/j.jhep.2007.06.002.&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== STRUCTURE ==&lt;br /&gt;
&lt;br /&gt;
The &#039;&#039;&#039;Adiponectin receptor&#039;&#039;&#039; 1 is an integral membrane protein composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». 2015 https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc5&amp;quot;&amp;gt; Parker-Duffen JL, Nakamura K, Silver M, Zuriaga MA, MacLauchlan S, Aprahamian TR, Walsh K et al.  «Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.» 17 April 2014 : https://www.ncbi.nlm.nih.gov/pubmed/24742672&amp;lt;/ref&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three extracellular loops and three intracellular loops. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three extracellular loops which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity located from the cytoplasmic surface to the middle of the outer lipid layer of the membrane has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the helix II, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 has the capacity to form oligomers. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 (2010) : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143549</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143549"/>
		<updated>2020-01-15T20:37:10Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The Adiponectin receptor 1&#039;&#039;&#039;==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Adiponectin receptor 1 (AdipoR1) structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt; &lt;br /&gt;
&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The [[adiponectin receptor 1]] is one of the two receptors for the hormone called adiponectin.&lt;br /&gt;
&lt;br /&gt;
== FUNCTION ==&lt;br /&gt;
The function of adipoR1 is directly linked with the &#039;&#039;&#039;adiponectin&#039;&#039;&#039;. It is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in plasma&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer as molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by adipocytes present in brown and white adipose tissues but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver.The adiponectin receptor 1 is a receptor sensitive in particular to the globular form&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Yamauchi, Toshimasa, Junji Kamon, Yusuke Ito, Atsushi Tsuchida, Takehiko Yokomizo, Shunbun Kita, Takuya Sugiyama, et al. « Cloning of adiponectin receptors that mediate antidiabetic metabolic effects ». Nature 423, nᵒ 6941 (1 juin 2003): 762‑69. https://doi.org/10.1038/nature01705.&amp;lt;/ref&amp;gt;. These properties of the adiponectin are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like glucose-6-phosphatase, [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in gluconeogenesis&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Capeau, Jacqueline. « The Story of Adiponectin and Its Receptors AdipoR1 and R2: To Follow ». Journal of Hepatology 47, nᵒ 5 (1 novembre 2007): 736‑38. https://doi.org/10.1016/j.jhep.2007.06.002.&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== STRUCTURE ==&lt;br /&gt;
&lt;br /&gt;
The &#039;&#039;&#039;Adiponectin receptor&#039;&#039;&#039; 1 is an integral membrane protein composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». 2015 https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc5&amp;quot;&amp;gt; Parker-Duffen JL, Nakamura K, Silver M, Zuriaga MA, MacLauchlan S, Aprahamian TR, Walsh K et al.  «Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.» 17 April 2014 : https://www.ncbi.nlm.nih.gov/pubmed/24742672&amp;lt;/ref&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three extracellular loops and three intracellular loops. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three extracellular loops which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity located from the cytoplasmic surface to the middle of the outer lipid layer of the membrane has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the helix II, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 has the capacity to form oligomers. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 (2010) : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143548</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143548"/>
		<updated>2020-01-15T20:36:28Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The Adiponectin receptor 1&#039;&#039;&#039;==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Adiponectin receptor 1 (AdipoR1) structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt; &lt;br /&gt;
&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The [[&#039;&#039;&#039;adiponectin receptor 1&#039;&#039;&#039;]] is one of the two receptors for the hormone called adiponectin.&lt;br /&gt;
&lt;br /&gt;
== FUNCTION ==&lt;br /&gt;
The function of adipoR1 is directly linked with the &#039;&#039;&#039;adiponectin&#039;&#039;&#039;. It is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in plasma&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer as molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by adipocytes present in brown and white adipose tissues but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver.The adiponectin receptor 1 is a receptor sensitive in particular to the globular form&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Yamauchi, Toshimasa, Junji Kamon, Yusuke Ito, Atsushi Tsuchida, Takehiko Yokomizo, Shunbun Kita, Takuya Sugiyama, et al. « Cloning of adiponectin receptors that mediate antidiabetic metabolic effects ». Nature 423, nᵒ 6941 (1 juin 2003): 762‑69. https://doi.org/10.1038/nature01705.&amp;lt;/ref&amp;gt;. These properties of the adiponectin are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like glucose-6-phosphatase, [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in gluconeogenesis&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Capeau, Jacqueline. « The Story of Adiponectin and Its Receptors AdipoR1 and R2: To Follow ». Journal of Hepatology 47, nᵒ 5 (1 novembre 2007): 736‑38. https://doi.org/10.1016/j.jhep.2007.06.002.&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== STRUCTURE ==&lt;br /&gt;
&lt;br /&gt;
The &#039;&#039;&#039;Adiponectin receptor&#039;&#039;&#039; 1 is an integral membrane protein composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». 2015 https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc5&amp;quot;&amp;gt; Parker-Duffen JL, Nakamura K, Silver M, Zuriaga MA, MacLauchlan S, Aprahamian TR, Walsh K et al.  «Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.» 17 April 2014 : https://www.ncbi.nlm.nih.gov/pubmed/24742672&amp;lt;/ref&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three extracellular loops and three intracellular loops. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three extracellular loops which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity located from the cytoplasmic surface to the middle of the outer lipid layer of the membrane has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the helix II, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 has the capacity to form oligomers. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 (2010) : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143527</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143527"/>
		<updated>2020-01-15T20:17:51Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The AdipoR1 receptor&#039;&#039;&#039;==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Caption for this structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt; &lt;br /&gt;
&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== FUNCTION ==&lt;br /&gt;
The protein adiponectin receptor 1 is one of the two receptors for the hormone called adiponectin. The adiponectin is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in plasma&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer as molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by adipocytes present in brown and white adipose tissues but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver.The adiponectin receptor 1 is a receptor sensitive in particular to the globular form&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Yamauchi, Toshimasa, Junji Kamon, Yusuke Ito, Atsushi Tsuchida, Takehiko Yokomizo, Shunbun Kita, Takuya Sugiyama, et al. « Cloning of adiponectin receptors that mediate antidiabetic metabolic effects ». Nature 423, nᵒ 6941 (1 juin 2003): 762‑69. https://doi.org/10.1038/nature01705.&amp;lt;/ref&amp;gt;. These properties of the adiponectin are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like glucose-6-phosphatase, [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in gluconeogenesis&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Capeau, Jacqueline. « The Story of Adiponectin and Its Receptors AdipoR1 and R2: To Follow ». Journal of Hepatology 47, nᵒ 5 (1 novembre 2007): 736‑38. https://doi.org/10.1016/j.jhep.2007.06.002.&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== STRUCTURE ==&lt;br /&gt;
&lt;br /&gt;
The Adiponectin receptor 1 is an integral membrane protein composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;doc5&amp;quot;&amp;gt; Parker-Duffen JL, Nakamura K, Silver M, Zuriaga MA, MacLauchlan S, Aprahamian TR, Walsh K et al.  «Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.» 17 April 2014 : https://www.ncbi.nlm.nih.gov/pubmed/24742672 /&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three extracellular loops and three intracellular loops. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three extracellular loops which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity located from the cytoplasmic surface to the middle of the outer lipid layer of the membrane has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the helix II, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 has the capacity to form oligomers. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143525</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143525"/>
		<updated>2020-01-15T20:14:09Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The AdipoR1 receptor&#039;&#039;&#039;==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Caption for this structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt; &lt;br /&gt;
&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== FUNCTION ==&lt;br /&gt;
The protein adiponectin receptor 1 is one of the two receptors for the hormone called adiponectin. The adiponectin is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in plasma&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer as molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by adipocytes present in brown and white adipose tissues but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver.The adiponectin receptor 1 is a receptor sensitive in particular to the globular form&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Yamauchi, Toshimasa, Junji Kamon, Yusuke Ito, Atsushi Tsuchida, Takehiko Yokomizo, Shunbun Kita, Takuya Sugiyama, et al. « Cloning of adiponectin receptors that mediate antidiabetic metabolic effects ». Nature 423, nᵒ 6941 (1 juin 2003): 762‑69. https://doi.org/10.1038/nature01705.&amp;lt;/ref&amp;gt;. These properties of the adiponectin are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like glucose-6-phosphatase, [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in gluconeogenesis. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== STRUCTURE ==&lt;br /&gt;
&lt;br /&gt;
The Adiponectin receptor 1 is an integral membrane protein composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three extracellular loops and three intracellular loops. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three extracellular loops which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity located from the cytoplasmic surface to the middle of the outer lipid layer of the membrane has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the helix II, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 has the capacity to form oligomers. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143524</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143524"/>
		<updated>2020-01-15T20:14:07Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The AdipoR1 receptor&#039;&#039;&#039;==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Caption for this structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt; &lt;br /&gt;
&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== FUNCTION ==&lt;br /&gt;
The protein adiponectin receptor 1 is one of the two receptors for the hormone called adiponectin. The adiponectin is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in plasma&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer as molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by adipocytes present in brown and white adipose tissues but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver.The adiponectin receptor 1 is a receptor sensitive in particular to the globular form&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity&amp;lt;ref name=&amp;quot;doc9&amp;quot;&amp;gt;Yamauchi, Toshimasa, Junji Kamon, Yusuke Ito, Atsushi Tsuchida, Takehiko Yokomizo, Shunbun Kita, Takuya Sugiyama, et al. « Cloning of adiponectin receptors that mediate antidiabetic metabolic effects ». Nature 423, nᵒ 6941 (1 juin 2003): 762‑69. https://doi.org/10.1038/nature01705.&amp;lt;/ref&amp;gt;. These properties of the adiponectin are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like glucose-6-phosphatase, [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in gluconeogenesis. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== STRUCTURE ==&lt;br /&gt;
&lt;br /&gt;
The Adiponectin receptor 1 is an integral membrane protein composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three extracellular loops and three intracellular loops. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three extracellular loops which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity located from the cytoplasmic surface to the middle of the outer lipid layer of the membrane has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the helix II, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 has the capacity to form oligomers. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc4&amp;quot;/&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143519</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143519"/>
		<updated>2020-01-15T20:07:29Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The AdipoR1 receptor&#039;&#039;&#039;==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Caption for this structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt; &lt;br /&gt;
&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== FUNCTION ==&lt;br /&gt;
The protein adiponectin receptor 1 is one of the two receptors for the hormone called adiponectin. The adiponectin is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in plasma&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer as molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by adipocytes present in brown and white adipose tissues but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;/&amp;gt;.. Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver. The adiponectin receptor 1 is a receptor for the globular form. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity. These properties of the adiponectin are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like glucose-6-phosphatase, [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in gluconeogenesis. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== STRUCTURE ==&lt;br /&gt;
&lt;br /&gt;
The Adiponectin receptor 1 is an integral membrane protein composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three extracellular loops and three intracellular loops. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three extracellular loops which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity located from the cytoplasmic surface to the middle of the outer lipid layer of the membrane has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the helix II, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 has the capacity to form oligomers. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143517</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143517"/>
		<updated>2020-01-15T20:06:46Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The AdipoR1 receptor&#039;&#039;&#039;==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Caption for this structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt; &lt;br /&gt;
&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== FUNCTION ==&lt;br /&gt;
The protein adiponectin receptor 1 is one of the two receptors for the hormone called adiponectin. The adiponectin is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in plasma&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;.The human adiponectin monomer as molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by adipocytes present in brown and white adipose tissues but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;. Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver. The adiponectin receptor 1 is a receptor for the globular form. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity. These properties of the adiponectin are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like glucose-6-phosphatase, [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in gluconeogenesis. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== STRUCTURE ==&lt;br /&gt;
&lt;br /&gt;
The Adiponectin receptor 1 is an integral membrane protein composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three extracellular loops and three intracellular loops. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three extracellular loops which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity located from the cytoplasmic surface to the middle of the outer lipid layer of the membrane has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the helix II, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
AdipoR1 has the capacity to form oligomers. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143514</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143514"/>
		<updated>2020-01-15T20:05:47Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The AdipoR1 receptor&#039;&#039;&#039;==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Caption for this structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt; &lt;br /&gt;
&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== FUNCTION ==&lt;br /&gt;
The protein adiponectin receptor 1 is one of the two receptors for the hormone called adiponectin. The adiponectin is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in plasma&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;. The human adiponectin monomer as molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by adipocytes present in brown and white adipose tissues but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;. Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver. The adiponectin receptor 1 is a receptor for the globular form. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity. These properties of the adiponectin are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like glucose-6-phosphatase, [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in gluconeogenesis. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== STRUCTURE ==&lt;br /&gt;
&lt;br /&gt;
The Adiponectin receptor 1 is an integral membrane protein composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three extracellular loops and three intracellular loops. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three extracellular loops which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity located from the cytoplasmic surface to the middle of the outer lipid layer of the membrane has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the helix II, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt;&lt;br /&gt;
AdipoR1 has the capacity to form oligomers. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143513</id>
		<title>Sandbox Reserved 1100</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_Reserved_1100&amp;diff=3143513"/>
		<updated>2020-01-15T20:04:26Z</updated>

		<summary type="html">&lt;p&gt;Judith Weber: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Sandbox_ESBS_2019}}&amp;lt;!-- PLEASE ADD YOUR CONTENT BELOW HERE --&amp;gt;&lt;br /&gt;
==&#039;&#039;&#039;The AdipoR1 receptor&#039;&#039;&#039;==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;3wxv&#039; size=&#039;340&#039; side=&#039;right&#039; caption=&#039;Caption for this structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
&amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt; &lt;br /&gt;
&amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== FUNCTION ==&lt;br /&gt;
The protein adiponectin receptor 1 is one of the two receptors for the hormone called adiponectin. The adiponectin is an hormone, and more precisely an adipokine &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;doc8&amp;quot;&amp;gt;Kadowaki, Takashi et al. “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.” The Journal of clinical investigation vol. 116,7 (2006): 1784-92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483172/&amp;lt;/ref&amp;gt;, present in the blood at high concentration, approximatively 0,01 % of the total amount of proteins in plasma&amp;lt;ref name=&amp;quot;doc7&amp;quot;&amp;gt;Whitehead, J. P., A. A. Richards, I. J. Hickman, G. A. Macdonald, et J. B. Prins. « Adiponectin – a Key Adipokine in the Metabolic Syndrome ». Diabetes, Obesity and Metabolism 8, nᵒ 3 (2006): 264‑80. https://doi.org/10.1111/j.1463-1326.2005.00510.x.&amp;lt;/ref&amp;gt;. The human adiponectin monomer as molecular weight of about 28 kDa and is composed of 244 amino acids. However, the molecular weight of the hormone depends on the multimerization of this one &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;.  The hormone is mainly created by adipocytes present in brown and white adipose tissues but according to researches it could also be produced in some non-adipose tissues as in skeletal muscle &amp;lt;ref name=&amp;quot;doc7&amp;quot;/&amp;gt;. Two forms of adiponectin exist: the full-length adiponectin, presents in the liver and the globular adiponectin presents in skeletal muscles and in the liver. The adiponectin receptor 1 is a receptor for the globular form. This hormone is known to be anti-diabetic, antiatherogenic and a regulator of tissue inflammation and insulin sensitivity. These properties of the adiponectin are linked to the fatty oxidation trigger by the hormone and the adipoR1 receptor. Different fatty acid oxidation pathway exists. The major pathway regulated by adipoR1 is the AMP kinase channel, but this pathway is not completely known. However, several studies show that adipoR1 decreases the hepatic glucose production by activating this channel. AdipoR1 is also able to limit the expression of enzymes, like glucose-6-phosphatase, [[phosphoenolpyruvate carboxykinase]] and carboxykinase1, involved in gluconeogenesis. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== STRUCTURE ==&lt;br /&gt;
&lt;br /&gt;
The Adiponectin receptor 1 is an integral membrane protein composed of 375 amino acids and its molecular weight is 42,4 kDa. This protein can be decomposed into different parts: an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; (residues 89 to 120), a short intracellular domain called &amp;lt;scene name=&#039;82/829353/Helice0/2&#039;&amp;gt;helix 0&amp;lt;/scene&amp;gt; (residues 121 to 129), &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; (residues 134 to 364) and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt; (residues 365 to 375). &amp;lt;ref name=&amp;quot;doc1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The organisation of the structure of the Adiponectin receptor 1 is the opposite to [[G protein-coupled receptor]] family. Indeed, the Adiponectin receptor has an internal &amp;lt;scene name=&#039;82/829353/N-terminus_domain/2&#039;&amp;gt;N-terminus domain&amp;lt;/scene&amp;gt; and an external &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  while the G-protein family has an internal N-terminus domain and an external C-terminus domain. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt;&lt;br /&gt;
The Adiponectin receptor 1 contains &amp;lt;scene name=&#039;82/829353/7helices/1&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; linked thanks to three extracellular loops and three intracellular loops. The &amp;lt;scene name=&#039;82/829353/Helix1/2&#039;&amp;gt;helix I&amp;lt;/scene&amp;gt; is formed by the residues 135 to 157, &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt; by the residues 169 to 192, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; by the residues 198 to 227, the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; by the residues 232 to 252, the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; by the residues 264 to 288 &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;heliX VI&amp;lt;/scene&amp;gt; by the residues 305 to 319 and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt; by the residues 336 to 364 .Besides, the &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices. These &amp;lt;scene name=&#039;82/829353/7tm/2&#039;&amp;gt;seven transmembrane helices&amp;lt;/scene&amp;gt; have a clockwise circular specific organisation (from helix I to helix VII) and form a bundle. &lt;br /&gt;
Concerning the extracellular faces, the three extracellular loops which connect the transmembrane helices are exposed and it is the same for the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;. Besides, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;helix III&amp;lt;/scene&amp;gt; and the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are longer than the other helices and as a result the &amp;lt;scene name=&#039;82/829353/C-terminus_domain/3&#039;&amp;gt;C-terminus domain&amp;lt;/scene&amp;gt;  two turns of the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; are exposed too. &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt;&lt;br /&gt;
In the middle of the seven transmembrane helices there is a large internal cavity where a &amp;lt;scene name=&#039;82/829353/Zinc-binding_site/2&#039;&amp;gt;zinc-binding site&amp;lt;/scene&amp;gt; can be found. This cavity located from the cytoplasmic surface to the middle of the outer lipid layer of the membrane has small openings between the &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;, and between the &amp;lt;scene name=&#039;82/829353/Helix4/2&#039;&amp;gt;helice IV&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix6/2&#039;&amp;gt;VI&amp;lt;/scene&amp;gt;. It has been assumed that these openings are involved in the entrance and exit of both substrate and product.&lt;br /&gt;
In this cavity, there is a zinc ion which is coordinated thanks to three histidine residues. These three histidine residues are &amp;lt;scene name=&#039;82/829353/H191/2&#039;&amp;gt;H191&amp;lt;/scene&amp;gt; in the helix II, &amp;lt;scene name=&#039;82/829353/H337/2&#039;&amp;gt;H337&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/H341/2&#039;&amp;gt;H341&amp;lt;/scene&amp;gt; in the &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;helix VII&amp;lt;/scene&amp;gt;. As a result, the zinc ion is in the intracellular layer of the membrane, in the neighbourhood of 4° deep from the inner surface of the plasma membrane. Thanks to its tetrahedral coordination, this zinc ion binds the &amp;lt;scene name=&#039;82/829353/Helix2/2&#039;&amp;gt;helix II&amp;lt;/scene&amp;gt;, &amp;lt;scene name=&#039;82/829353/Helix3/2&#039;&amp;gt;III&amp;lt;/scene&amp;gt; and &amp;lt;scene name=&#039;82/829353/Helix7/2&#039;&amp;gt;VII&amp;lt;/scene&amp;gt; together. The adiponectin-stimulated AMPK phosphorylation doesn’t directly require the zinc binding site, nevertheless it has been supposed that the zinc ion allows a stabilizing effect. &amp;lt;ref name=&amp;quot;doc1&amp;quot;&amp;gt;Tanabe, Hiroaki, Yoshifumi Fujii, Miki Okada-Iwabu, Masato Iwabu, Yoshihiro Nakamura, Toshiaki Hosaka, Kanna Motoyama, et al. « Crystal structures of the human adiponectin receptors ». Nature 520, nᵒ 7547 (1 avril 2015): 312‑16. https://doi.org/10.1038/nature14301&amp;lt;/ref&amp;gt;&lt;br /&gt;
AdipoR1 has the capacity to form oligomers. &amp;lt;ref name=&amp;quot;doc3&amp;quot;&amp;gt; Takashi Kadowaki and Toshimasa Yamauchi et al. « Adiponectin and adiponectin receptors». https://www.ncbi.nlm.nih.gov/pubmed/15897298&amp;lt;/ref&amp;gt; Indeed in living cell both monomers and oligomers are present. A specific motif was identified to contribute to the AdipoR1 dimerization: it is the motif GxxxG in the transmembrane &amp;lt;scene name=&#039;82/829353/Helice5/2&#039;&amp;gt;helix V&amp;lt;/scene&amp;gt;. Besides, the dimerization of AdipoR1 is also regulated.  This dimerization is inhibited by the fixation of the full-length adiponectin while the globular adiponectin has any impact on the dimerization level of the AdipoR1 receptor. Thanks to mutant experiment, it can be supposed that the collagen-like domain of the full-length adiponectin is responsible to the dimer dissociation. There are strong evidences that dimerization of the AdipoR1 receptor has a role during the biosynthesis, the trafficking and the signalling of the seven transmembrane receptors. &amp;lt;ref name=&amp;quot;doc4&amp;quot;&amp;gt; Kosel D, Heiker JT, Juhl C, Wottawah CM, Blüher M, Mörl K, Beck-Sickinger AG et al. « Dimerization of adiponectin 1 is inhibited by adiponectin » Journal of Cell Science 123, 1320-1328 : https://www.ncbi.nlm.nih.gov/pubmed/20332107&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Diseases ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Judith Weber</name></author>
	</entry>
</feed>